UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 

 

SCHEDULE 14A 

 

Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No.)

 

Filed by the Registrant
Filed by a Party other than the Registrant ☐

 

Check the appropriate box:

 

Preliminary Proxy Statement

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material Pursuant to §240.14a-12

 

National Research Corporation

 

(Name of Registrant as Specified In Its Charter) 

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

No fee required.

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

  

 

(1)

 

Title of each class of securities to which transaction applies:

    

 

(2)

 

Aggregate number of securities to which transaction applies:

    

 

(3)

 

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

    

 

(4)

 

Proposed maximum aggregate value of transaction:

    

 

(5)

 

Total fee paid:

    

Fee paid previously with preliminary materials.

 

 

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

  

 

(1)

 

Amount Previously Paid:

    

 

(2)

 

Form, Schedule or Registration Statement No.:

    

 

(3)

 

Filing Party:

    

 

(4)

 

Date Filed: 

 

 

 

 

National Research Corporation

D/B/A NRC Health

 

NOTICE OF ANNUALSPECIAL MEETING OF SHAREHOLDERS

To Be Held MayNovember 9, 2017[●],2017

 

To the Shareholders of

National Research Corporation:

 

NOTICE IS HEREBY GIVEN that the Annuala Special Meeting of Shareholders of National Research Corporation (the “Company,” “we,” “us” or “our”) will be held on Tuesday, May 9,[●], November [●], 2017, at 3:00 P.M.[●], local time, at the Embassy Suites hotelour corporate offices located at 1040 P1245 Q Street, Lincoln Nebraska 68508, for the following purposes:

 

1.     To elect two directorsapprove an amendment to hold office until the 2020 annual meetingCompany’s Amended and Restated Articles of shareholdersIncorporation to effect a reverse stock split of our class B common stock, with such split being exempted from the application of any provision in our Amended and until their successors are duly electedRestated Articles of Incorporation to the contrary, including, without limitation, Section B(4) of Article 2 (the “Reverse Split”), at a ratio of 1-for-1,764,560 and qualified.the repurchase of the resulting fractional shares held by each holder of class B common stock with less than one share of class B common stock after the Reverse Split.

 

2.     To ratifyapprove an amendment to the appointmentCompany’s Amended and Restated Articles of KPMG LLP asIncorporation to effect a forward stock split of the remaining class B common stock, with such split being exempted from the application of any provision in our independent registered public accounting firm for 2017.Amended and Restated Articles of Incorporation to the contrary, including, without limitation, Section B(4) of Article 2 (the “Forward Split” and collectively with the Reverse Split and the repurchase of the resulting fractional shares, the “Proposed Transaction”), at a ratio of 1,764,560-for-1 immediately following the Reverse Split.

 

3.As a result of the      To conduct an advisory voteProposed Transaction, (a) each shareholder owning less than one share of class B common stock after the Reverse Split will receive $53.44 in cash, without interest, for each class B common share owned by such shareholder immediately prior to approve the compensationReverse Split and will no longer be a holder of class B common stock, and (b) the sole remaining holder of one or more shares of class B common stock after the Reverse Split, Michael D. Hays, our founder, chief executive officer and a director, will continue to hold class B common stock equal to the number of shares of class B common stock he held immediately prior to the effective date of the Reverse Split. The Proposed Transaction is designed to eliminate the current public market trading confusion relating to the Company’s two classes of common stock (the class A common stock and class B common stock) and to provide a timely and cost-effective liquidity event for the holders of our named executive officersclass B common stock, other than Mr. Hays. Mr. Hays agreed to not have his shares of class B common stock be cashed out in the Reverse Split so the Company could maintain a moderate debt burden as disclosed ina result of the Proposed Transaction. Forms of the proposed amendments to the Company’s Amended and Restated Articles of Incorporation to effect the Reverse Split and the Forward Split are attached as Appendix A and Appendix B, respectively, to the accompanying proxy statement. Although both the Reverse Split and the Forward Split will be voted on separately, the Company will not implement either the Reverse Split or the Forward Split unless both are approved by the Company’s shareholders and the Board of Directors gives final approval to implement them.

 

4.The Company      To conduct an advisory vote ons Board of Directors has carefully considered and unanimously determined that the frequencyProposed Transaction is advisable, fair to and in the best interests of the advisory shareholderCompanys shareholders, and recommends that the Companys shareholders vote onFOR the compensation of our named executive officers.Reverse Split andFORthe Forward Split.

 

5.     To consider and act upon such other business as may properly come before the meeting or any adjournment or postponement thereof.


 

The close of business on MarchOctober 14,[●], 2017, has been fixed as the record date for the determination of shareholders entitled to notice of, and to vote at, the meeting and any adjournment or postponement thereof.

 

A proxy card for the meeting and a proxy statement are enclosed herewith.

 

By Order of the Board of Directors

NATIONAL RESEARCH CORPORATION

 Kevin R. Karas 
  
Secretary 

Kevin R. Karas

Secretary

Lincoln, Nebraska

April 3,October [●], 2017

 

Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting To Be Held on May 9, 2017November [●], 2017. The National Research Corporation notice of meeting, proxy statement and proxy card for the 2017Special Annual Meeting of Shareholders and,as well asa Schedule 13E-3 filed by the 20Company on 16[●], 2017, Annual Report to Shareholders are available at https://www.rdgir.com/national-research-corporation.

 

YOUR VOTE IS IMPORTANT NO MATTER HOW LARGE OR SMALL YOUR HOLDINGS MAY BE. TO ASSURE YOUR REPRESENTATION AT THE MEETING, PLEASE DATE THE ENCLOSED PROXY, WHICH IS SOLICITED BY THE BOARD OF DIRECTORS, SIGN EXACTLY AS YOUR NAME APPEARS THEREON AND RETURN IMMEDIATELY.

 

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THE PROPOSED TRANSACTION, PASSED UPON THE MERITS OR FAIRNESS OF THE PROPOSED TRANSACTION, OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE INFORMATION CONTAINED IN THIS PROXY STATEMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

 

 

 

 

National Research Corporation

D/B/A NRC Health

1245 Q Street

Lincoln, Nebraska 68508

 

PROXY STATEMENT

FORFOR

ANNUALSPECIAL MEETING OF SHAREHOLDERS

To Be Held May 9, 2017November [●], 2017

 

This proxy statement is being furnished to shareholders by the Board of Directors (the “Board”) of National Research Corporation, doing business as NRC Health (the “Company”“Company,” “we,” “us” or “our”), beginning on or about April 3,October [●], 2017, in connection with a solicitation of proxies by the Board for use at the AnnualSpecial Meeting of Shareholders to be held on Tuesday, May 9,[●], November [●], 2017, at 3:00 P.M.[●], local time, at the Embassy Suites hotelour corporate offices located at 1040 P1245 Q Street, Lincoln Nebraska 68508, and all adjournments or postponements thereof (the “Annual“Special Meeting”), for the purposes set forth in the attached Notice of AnnualSpecial Meeting of Shareholders.

 

Execution of a proxy given in response to this solicitation will not affect a shareholder’s right to attend the AnnualSpecial Meeting and to vote in person. Presence at the AnnualSpecial Meeting of a shareholder who has signed a proxy does not in itself revoke a proxy. Any shareholder giving a proxy may revoke it at any time before it is exercised by giving notice thereof to the Company in writing or in open meeting.

 

A proxy card, in the enclosed form, which is properly executed, duly returned to the Company and not revoked, will be voted in accordance with the instructions contained therein. The shares represented by executed but unmarked proxies will be voted as follows:

 

 

FOR approval of an amendment to the two persons nominated for election as directors referredCompany’s Amended and Restated Articles of Incorporation (the “Articles”) to herein;effect a reverse stock split of our class B common stock, with such split being exempted from the application of any provision in our Articles to the contrary, including, without limitation, Section B(4) of Article 2 (the “Reverse Split”), at a ratio of 1-for-1,764,560 and the repurchase of the resulting fractional shares held by each holder of class B common stock with less than one share of class B common stock after the Reverse Split; and

 

 

FOR approval of an amendment to the ratificationCompany’s Articles to effect a forward stock split of the appointmentremaining class B common stock, with such split being exempted from the application of KPMG LLP asany provision in our independent registered public accounting firm for 2017;

FORArticles to the advisory vote to approvecontrary, including, without limitation, Section B(4) of Article 2 (the “Forward Split” and collectively with the compensationReverse Split and the repurchase of the individuals named inresulting fractional shares, the Summary Compensation Table set forth below in this proxy statement (such group“Proposed Transaction”), at a ratio of individuals are sometimes referred to as our named executive officers);

FOR submitting1,764,560-for-1 immediately following the advisory vote on the compensation of our named executive officers to our shareholders EVERY YEAR; and

On such other business or matters which may properly come before the Annual Meeting in accordance with the best judgment of the persons named as proxies in the enclosed form of proxy.Reverse Split.

 

Other than the election of two directors, the ratificationapproval of the appointment of KPMG LLP as our independent registered public accounting firm for 2017, the advisory vote to approve the compensation of our named executive officersReverse Split and the advisory vote on the frequency of the advisory shareholder vote on the compensation of our named executive officers,Forward Split, the Board has no knowledge of any matters to be presented for action by the shareholders at the AnnualSpecial Meeting.


 

Only holders of record of the Company’s class A common stock and class B common stock (sometimes referred to collectively as the “Common Stock”) at the close of business on March 14,October [●], 2017 (the “Record Date”) are entitled to vote at the AnnualSpecial Meeting. On that date, the Company had outstanding and entitled to vote: (a) 20,913,343[●] shares of class A common stock, each of which is entitled to one-one-hundredth (1/100th) of one vote per share, with an aggregate of 209,133.43[●] votes; and (b) 3,543,463[●] shares of class B common stock, each of which is entitled to one vote per share, with an aggregate of 3,543,463[●] votes. The presence of a majority of the votes entitled to be cast by each “voting group” shall constitute a quorum for the purpose of transacting business at the AnnualSpecial Meeting. See the section entitled “Meeting and Voting Information— Voting Groups; Required Votes; Quorum; Abstentions; Broker Non-Votes” for additional information about the voting groups entitled to vote at the Special Meeting. Abstentions and broker non-votes will be counted as present in determining whether there is a quorum.quorum of each voting group.

Although both the Reverse Split and the Forward Split will be voted on separately, the Company will not implement either the Reverse Split or the Forward Split unless both are approved by all required votes of the Company’s shareholders and the Board gives final approval to implement them.

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THE PROPOSED TRANSACTION, PASSED UPON THE MERITS OR FAIRNESS OF THE PROPOSED TRANSACTION, OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE INFORMATION CONTAINED IN THIS PROXY STATEMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

 


 

ELECTIONTABLE OF CONTENTS

SUMMARY TERM SHEET

5

The Company

5

The Proposed Transaction5
Purpose of the Proposed Transaction6
Effects of the Reverse Split7
Effects of the Forward Split8
Interests of Officers, Directors and Affiliates of the Company8
Fairness of the Proposed Transaction9
Votes Required for Approval of the Proposed Transaction at the Special Meeting10
Effectiveness of the Proposed Transaction11
Financing for the Reverse Split11
Dissenters’ Rights12
Tax Information12
Other Matters12

QUESTIONS AND ANSWERS ABOUT THE PROPOSED TRANSACTION AND THE SPECIAL MEETING

13

PROPOSALS — REVERSE SPLIT AND FORWARD SPLIT

15
Board Recommendation15
Summary and Structure15

SPECIAL FACTORS

16
Purpose of the Proposed Transaction16
Background of the Proposed Transaction17
Reasons for the Proposed Transaction21
Effects of the Proposed Transaction23
Strategic Alternatives Considered By the Board29
How the Board Will Determine Whether to Effect the Proposed Transaction30
Fairness of the Proposed Transaction31

ADDITIONAL INFORMATION REGARDING THE PROPOSED TRANSACTION

36
Special Interests of the Affiliated Persons36
Shareholder Approval37
Effective Date37
Payment for Fractional Shares38
Unavailability of Appraisal or Dissenters’ Rights38
Source and Amount of Funds and Expenses39
Material U.S. Federal Income Tax Consequences41
Escheat Laws43
Accounting Treatment44
Regulatory Approvals44

MEETING AND VOTING INFORMATION

44
Time and Place44
Who May Vote44
Voting45
Revoking Your Voting Instructions to Your Proxy Holders45


Voting Groups; Required Votes; Quorum; Abstentions; Broker Non-Votes45

INFORMATION ABOUT THE COMPANY

46

MARKET PRICE OF COMMON STOCK

47
Market Information47
Shareholders47
Common Stock Repurchase Information47
Purchases/Sales of Class B Common Stock by Directors and Executive Officers48

FINANCIAL INFORMATION

48
Pro Forma Consolidated Financial Statements (Unaudited)48
Historical Financial Statements52

EXECUTIVE OFFICERS AND DIRECTORS

53

PRINCIPAL SHAREHOLDERS

55

TRANSACTIONS WITH RELATED PERSONS

56

AVAILABLE INFORMATION

56

INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

57

FORWARD-LOOKING STATEMENTS

57

MISCELLANEOUS

58
Expenses58
Shareholder Proposals59
Multiple Shareholders Sharing the Same Address60
Appendix A – PROPOSED FORM OF REVERSE STOCK SPLIT AMENDMENT    A-1
Appendix B – PROPOSED FORM OF FORWARD STOCK SPLIT AMENDMENTB-1


SUMMARY TERM SHEET

The following is a summary of the material terms of the Proposed Transaction, which terms are described in greater detail elsewhere in this proxy statement. You are urged to read carefully the remainder of this proxy statement for a more complete description of all material information regarding the Proposed Transaction. We have included section references to direct you to a more complete description of the topics described in this summary.

 

The Company

The Company is a Wisconsin corporation headquartered in Lincoln, Nebraska. ’s By-Laws provide that the directors shall beThe Company’s outstanding stock is divided into threetwo classes with staggered terms of three years each. At the Annual Meeting, the shareholders will elect two directors to hold office until the 2020 annual meeting of shareholders and until their successors are duly elected and qualified. Unless shareholders otherwise specify, the shares represented by the proxies received will be voted in favor of the election as directors of the two persons named as nominees herein. The Board has no reason to believe that the listed nominees will be unable or unwilling to serve as directors if elected.  However, in the event that any nominee should be unable to serve or for good cause will not serve, the shares represented by proxies received will be voted for another nominee selected by the Board. Each director will be elected by a plurality of the votes cast at the Annual Meeting (assuming a quorum is present). Consequently, any shares not voted at the Annual Meeting, whether due to abstentions, broker non-votes or otherwise, will have no impact on the election of the directors. Votes will be tabulated by an inspector of elections appointed by the Board. Shares of the Company’scommon stock: class A common stock and class B common stock, voteboth of which are currently traded on the NASDAQ Global Market (“Nasdaq”) under the symbols “NRCIA” and “NRCIB,” respectively. Please see the section of this proxy statement entitled “Information About the Company” for a more detailed discussion of the Company and its business.

The Proposed Transaction

Our Board, which is comprised of four independent directors in addition to Michael D. Hays, our founder, majority shareholder and chief executive officer (sometimes referred to herein as “Mr. Hays”), has reviewed and recommended, and has unanimously approved, a 1-for-1,764,560 Reverse Split of our class B common stock, followed immediately by a 1,764,560-for-1 Forward Split of the class B common stock. To be effective, the Proposed Transaction must be duly approved by holders of our outstanding class A common stock, class B common stock, and class A common stock and class B common stock together as a single class, voting at a meeting at which a quorum of each such “voting group” is present in person or by proxy. Mr. Hays and the Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009 (the “Grandchildren’s Trust”), which individually or collectively hold a majority of our class A common stock and class B common stock, have informed us that they intend to be present for and vote in favor of the Proposed Transaction (both the Reverse Split and the Forward Split). In addition, our other executive officers and directors have indicated to us that they intend to vote in favor of the Proposed Transaction. Accordingly, the Proposed Transaction is expected to be approved. The Proposed Transaction is conditioned upon the closing of financing to fund the Proposed Transaction. Please see the section entitled “Additional Information Regarding the Proposed Transaction – Source and Amount of Funds and Expenses” beginning on page 39 for a more detailed discussion of the electioncredit facilities with which we expect to partially fund the costs of directors.the Proposed Transaction.

 

The Proposed Transaction will consist of the following sets forthsteps:

The Proposed Transaction will take effect on the date (the “Effective Date”) that the State of Wisconsin accepts for filing Articles of Amendment to our Articles (one amendment effecting the Reverse Split and a second amendment effecting the Forward Split as discussed in the section entitled “Proposals – Reverse Split and Forward Split – Summary and Structure” beginning on page 15), or on any later date that we may specify in our Articles of Amendment.

On the Effective Date, we will first effect a 1-for-1,764,560 Reverse Split of our class B common stock.

Each holder of less than one whole share of class B common stock after the Reverse Split will receive cash instead of a fractional share and will no longer be a holder of class B common stock. If such holders do not hold our class A common stock, they will no longer be shareholders of the Company. We will pay to each of these fractional shareholders $53.44 in cash, without interest (the “Cash-Out Price”), for each share of class B common stock held by such shareholder immediately before giving effect to the Reverse Split. See the section entitled “Fairness of the Proposed Transaction – Fairness of the Substance of the Proposed Transaction – Current and Historical Market Prices” beginning on page 31 for more information on how we determined the Cash-Out Price.


On the Effective Date, following the completion of the Reverse Split, we will effect a 1,764,560-for-1 Forward Split of the class B common stock.

The sole remaining holder of one or more shares of class B common stock immediately after the Reverse Split, Mr. Hays, will not be entitled to receive any cash for his shares of class B common stock in the Reverse Split and will instead participate in the Forward Split, resulting in Mr. Hays holding the same number of shares after the Forward Split as he held immediately prior to the Reverse Split. As a result, the total number of shares of our class B common stock Mr. Hays directly holds will not change following the Proposed Transaction. As discussed in more detail in the section entitled “Special Factors – Reasons for the Proposed Transaction” beginning on page 21, Mr. Hays agreed to not have his shares of class B common stock be cashed out in the Reverse Split so the Company could maintain a moderate debt burden as a result of the Proposed Transaction. In connection with the Proposed Transaction, Mr. Hays will, however, receive approximately $208,000 as a result of the cashing out of his class B common stock options.

Please see the section entitled “Proposals – Reverse Split and Forward Split – Summary and Structure” beginning on page 15 for a more detailed discussion of the Proposed Transaction.

Purpose of the Proposed Transaction

The Proposed Transaction is designed to eliminate the current public market trading confusion relating to the Company’s two classes of common stock (the class A common stock and class B common stock) and to provide a timely and cost-effective liquidity event for the holders of our class B common stock, other than Mr. Hays. We also expect that the liquidity of our class A common stock will be positively affected by the Proposed Transaction over time due to the elimination of the confusion in the public market regarding our dual class structure.

The Proposed Transaction will delist the class B common stock from trading on Nasdaq and deregister and suspend our reporting obligations with respect to the class B common stock under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). As a result of the Proposed Transaction, our class B common stock will no longer be quoted on Nasdaq. Our class A common stock, however, will continue to be traded on Nasdaq and we will continue to have reporting obligations under the Exchange Act. The Board has concluded that the Proposed Transaction is fair to, and in the best interests of, all of our shareholders, including those being cashed out pursuant to the terms of the Proposed Transaction.

In 2013, the Board approved, and the shareholders adopted, a recapitalization plan (the “2013 Recapitalization “) pursuant to which we (i) established two classes of common stock, each of which is currently publicly traded on Nasdaq, consisting of a new class of common stock with 1/100th of a vote per share and with the right to receive 1/6th of the dividend, if any, paid on the other class of common stock, designated as class A common stock, and a new class of common stock with one vote per share and with the right to receive six times the dividend, if any, paid on the other class of common stock, designated as class B common stock, (ii) issued a dividend of three shares of class A common stock for each share of our then-existing common stock and (iii) reclassified each share of the then existing common stock as one-half of one share of class B common stock. The reasoning and desired effects of the 2013 Recapitalization included increasing liquidity of our publicly traded shares and expanding our institutional ownership base, enhancing shareholder value, and increasing flexibility for us and our shareholders.


Since the 2013 Recapitalization was implemented, however, we have received negative commentary from shareholders concerning our dual class common stock structure, especially the disconnect in valuation of the two classes of common stock given the 6-to-1 dividend differential and the “equal status” provision of our Articles whereby both the class A common stock and the class B common stock receive equal consideration in the event of certain information,extraordinary transactions, such as a sale of March 14, 2017, about the Board’s nomineesCompany. In addition, there has been a lack of comparable research coverage for election ateach of the Annual Meetingtwo classes and minimal trading in the class B common stock. Accordingly, we and our shareholders have not realized certain benefits that were anticipated in implementing the 2013 Recapitalization, such as increased liquidity of our publicly traded shares.

Our reasons for proposing the Proposed Transaction include:

Addressing the existing confusion in the public market surrounding our dual class common stock structure by delisting and deregistering the class B common stock, with the expectation of increasing liquidity in our class A common stock over time.

Providing a cost-effective liquidity event for shareholders holding less than 1,764,560 shares of class B common stock at a time when our class B common stock is trading at or near an all-time high, without encumbering our operations and growth prospects with excessive debt.

Increasing the earnings per share of our class A common stock.

Increasing the percentage of total dividends payable to the class A common stock from 49.6% before the Proposed Transaction to 66.4% after the Proposed Transaction.

Please see the sections entitled “Special Factors – Purpose of the Proposed Transaction” beginning on page 16 and “Special Factors – Reasons for the Proposed Transaction” beginning on page 21 for a more detailed description of the purpose of and reasons for the Proposed Transaction.

Effects of the Reverse Split

As a result of the Reverse Split:

The number of record holders of our class B common stock will be reduced to one, which will allow us to terminate the registration of our class B common stock under the Exchange Act. In addition, shares of our class B common stock will no longer be quoted on Nasdaq and trades in such shares would only be possible through privately negotiated transactions. The repurchased fractional shares would be retired.

Our class A common stock is not and will not be directly affected by the Proposed Transaction. The class A common stock will continue to be traded on Nasdaq and we will continue to have reporting obligations under the Exchange Act with respect to our class A common stock.

Holders of less than one share of our class B common stock after effecting the Reverse Split will receive cash in exchange for their shares of our class B common stock and will no longer be holders of class B common stock. If such holders do not hold our class A common stock, they will no longer have any ownership interest in us and shall cease to participate in any of our future earnings or growth. The Cash-Out Price will be equal to $53.44, without interest, for each share of class B common stock held by such shareholders immediately before giving effect to the Reverse Split.

The sole remaining holder of one share or more of our class B common stock after effecting the Reverse Split, Mr. Hays, will not receive any payment for his shares in the Reverse Split.


The rights of the holders of class A common stock to be treated equally in the Reverse Split under our Articles, including, without limitation, Section B(4) of Article 2 of our Articles, will be waived pursuant to the amendment to our Articles giving effect to the Reverse Split.

Please see the section entitled “Special Factors – Effects of the Proposed Transaction” beginning on page 23 for a more detailed description of the effects of the Reverse Split.

Effects of the Forward Split

Mr. Hays, the sole remaining holder of one share or more of our class B common stock after the Reverse Split will, as a result of the Forward Split, continue to hold the same number of shares as he did before the Reverse Split. The Forward Split is necessary to restore the class B common stock to its relative pre-split rights under our Articles, which provide that the class B common stock is entitled to one vote per share (relative to 1/100th of one vote per share that the class A common stock is entitled to) and 6 times the dividends paid on class A common stock.

Holders of less than one share of our class B common stock after the Reverse Split will receive cash in exchange for their shares of our class B common stock and will not be included in the Forward Split.

The rights of the holders of class A common stock to be treated equally in the Forward Split under our Articles, including, without limitation, Section B(4) of Article 2 of our Articles, will be waived pursuant to the amendment to our Articles giving effect to the Forward Split.

Please see the section entitled “Special Factors – Effects of the Proposed Transaction” beginning on page 23 for a more detailed description of the effects of the Forward Split.

Interests of Officers, Directors and Affiliates of the Company

As of the Record Date, Mr. Hays, our founder, chief executive officer and a director, owned approximately 26% of our class A common stock and 1,973,205 shares, or approximately 56%, of our class B common stock, and that collectively constituted approximately 54% of the Company’s total voting power. As a result, Mr. Hays is our controlling shareholder. Mr. Hays has participated in Board discussions relating to the approval of the Proposed Transaction. However, the independent directors, who constitute four of our five directors, met separately, without Mr. Hays, six times to discuss the Proposed Transaction and they also fully participated in the Board meetings and deliberations with Mr. Hays. Each independent director approved the terms and conditions of the Proposed Transaction.

As of the Record Date, the Grandchildren’s Trust, which was originally established by and received all of its shares of Common Stock from Mr. Hays, owned approximately 28% of our class A common stock and 125,355 shares, or approximately 3.5%, of our class B common stock, and that collectively constituted approximately 5% of the Company’s total voting power. In connection with, but incidental to, the Proposed Transaction, Mr. Hays and the Grandchildren’s Trust will effect a stock swap pursuant to which the Grandchildren’s Trust will receive 208,645 shares of class B common stock from Mr. Hays in return for the Grandchildren’s Trust transferring to Mr. Hays an equivalent value amount of shares of class A common stock (the “Swap”). The Swap is being effected in order to provide the Grandchildren’s Trust with a liquidity event in connection with the Proposed Transaction on the same basis as all other holders of class B common stock (except Mr. Hays), and will result in the Grandchildren’s Trust receiving a larger payment from the Company in the Reverse Split since it will own 208,645 more shares of class B common stock after the Swap that will be cashed out in the Reverse Split.


In light of the elimination of all shares of class B common stock in the Proposed Transaction (other than the shares that will continue to be held by Mr. Hays), the Compensation Committee of the Board, which is comprised solely of three independent directors, determined that it was in the best interests of the Company whose termand its shareholders to eliminate all equity awards tied to the class B common stock. See the section entitled “Special Factors— Background of the Proposed Transaction” beginning on page 17 for further discussion of the Board’s deliberation with respect to outstanding equity awards tied to our class B common stock. Accordingly, all outstanding options to purchase class B common stock and restricted shares of class B common stock, will, continue afterimmediately prior to the Annual Meeting.Effective Date of the Proposed Transaction, vest in full and be paid out as if they were cashed out pursuant to the Reverse Split. As a result, all of our directors and executive officers, as well as all other Company associates (i.e., employees) with existing equity awards tied to the class B common stock, including Mr. Hays, will receive a payment from us in connection with the Proposed Transaction to cash out their class B common stock equity awards.

Please see the sections entitled “Special Factors — Fairness of the Proposed Transaction — Procedural Fairness” beginning on page 34 and “Additional Information Regarding the Proposed Transaction — Special Interests of the Affiliated Persons” beginning on page 36.

 

NomineesFairness of the Proposed Transaction

The Board has unanimously approved the Proposed Transaction. The independent members of the Board, as well as the full Board including Mr. Hays acting as a director, has determined that the Proposed Transaction and the price to be paid for Election at the Annual Meetingfractional shares resulting from the Reverse Split are substantively and procedurally fair to and in the best interest of us and our unaffiliated shareholders (including both unaffiliated shareholders who will remain holders of our class A common stock and those whose entire interest will be cashed out).

 

Terms expiring atThe independent members of the 2020 Annual MeetingBoard, as well as the full Board including Mr. Hays acting as a director, considered various factors regarding the substantive fairness of the Proposed Transaction to us and our unaffiliated shareholders, including the following:

The Proposed Transaction is expected to reduce or eliminate market confusion and shareholder concerns regarding the Company’s dual class common stock structure.

The shareholders of class B common stock will experience a liquidity event while the class B common stock is trading at or near an all-time high, without paying any brokerage or service fees, commissions or other transaction costs.

The Cash-Out Price is based on historical market prices of the class B common stock.

Shareholders may participate in future increases in the value of the Company by purchasing our class A common stock which will remain listed with Nasdaq after the Proposed Transaction.

The Company can address shareholder concerns on the dual class common stock structure while maintaining a moderately leveraged capital structure.

Shareholders whose interests are cashed out in the Proposed Transaction will not be able to participate in any future increases in the value of our class B common stock.


The independent members of the Board, as well as the full Board including Mr. Hays acting as a director, also considered various factors regarding the procedural fairness of the Proposed Transaction to us and our unaffiliated shareholders, including the following:

The Proposed Transaction was unanimously approved by our independent directors, each of whom the Board determined had the independence and experience to fairly represent the interests of the unaffiliated shareholders and had a sufficient opportunity to discuss and form his or her own conclusions as to the fairness of the Proposed Transaction. The independent directors comprise well more than a majority of the Board, representing four out of the five directorships.

Unaffiliated and affiliated shareholders will be treated the same in the Proposed Transaction.

In determining that the Proposed Transaction is procedurally fair to the Company and unaffiliated shareholders, the Board did not retain a representative or advisor on behalf of the unaffiliated shareholders since the Board concluded that the procedural safeguards described above were already sufficient safeguards without the expense of retaining an external representative or advisor, particularly since unaffiliated and affiliated shareholders would be treated the same in the Proposed Transaction. In addition, the Board determined not to condition approval of the Proposed Transaction on approval by a majority of our unaffiliated shareholders because the Board concluded any such vote would not provide meaningful additional protection to those unaffiliated shareholders. The Board also considered that, as of the Record Date, approximately [●]% of our outstanding class B common stock is held by non-affiliates, and allowing a minority of investors to make a determination with respect to the Proposed Transaction alone would not be in the best interests of the Company and the shareholders. The Board was also concerned that shareholders representing disproportionately few shares could unduly influence the vote, especially if minority shareholder participation in the voting were limited.

Please see the section entitled “Special Factors — Fairness of the Proposed Transaction” beginning on page 31 for a more detailed analysis regarding the fairness of the Proposed Transaction.

 

JoAnn M. MartinVote, 62, has served as a directors Required for Approval of the Company since June 2001. Ms. Martin was elected President and Chief Executive Officer of Ameritas Life Insurance Corp., an insurance and financial services company, in July 2005. From April 2003 to July 2005, she served Ameritas Life Insurance Corp. as President and Chief Operating Officer. Prior thereto, Ms. Martin served as Senior Vice President and Chief Financial Officer of Ameritas for more thanProposed Transaction at the last five years. In April 2009, Ms. Martin was elected President and Chief Executive Officer of Ameritas Holding Company and Ameritas Mutual Holding Company (previously named UNIFI Mutual Holding Company), where she had served as Executive Vice President and Chief Financial Officer for more than the last five years. Ms. Martin has served as an officer of Ameritas and/or its affiliates since 1988. Ms. Martin also serves as a director of Ameritas Life Insurance Corp. Separate Accounts (since 2003). Ms. Martin’s financial background as a certified public accountant and as the former Chief Financial Officer and current President and Chief Executive Officer of a mutual insurance holding company, as well as her past leadership experiences as a director of the Omaha Branch of the Federal Reserve Bank of Kansas City and other organizations, led to the conclusion that she should serve as a director of the Company.Special Meeting

 

Barbara J. MowryUnder Wisconsin law and the Company, 69, has served’s Articles, the following three “voting groups” must approve both the Reverse Split and the Forward Split: (1) the holders of the class A common stock and the class B common stock, voting together as a directorsingle class; (2) the holders of the Company since May 2014. Ms. Mowry founded,class A common stock, voting separately as an independent voting group; and (3) the holders of the class B common stock, voting separately as an independent voting group. Assuming a quorum of each voting group is currentlypresent at the Chief Executive OfficerSpecial Meeting, the number of GoreCreek Advisors,votes cast within the voting group for approval of each of the Reverse Split and the Forward Split must exceed the number of votes cast against it.

As a management consulting firm. Priorresult of his stock holdings, Mr. Hays has the power to founding GoreCreek Advisors, Ms. Mowry served as Senior Vice President - Data Integrationapprove, on behalf of Oracle Corporation, an industry leading software, hardwareboth the holders of the class B common stock and services company, from January 2010 through March 2011,the holders of the class A and as President and Chief Executive Officer of Silver Creek Systems, Inc., a data quality solutions software company, from January 2003 to December 2009. Ms. Mowry servedclass B common stock, voting together as a director of Axion Health (from 2012 to 2014)group, both the Reverse Split and the Federal Reserve BankForward Split without the affirmative vote of Kansas City (from 2012any other shareholder. In addition, Mr. Hays and the Grandchildren’s Trust, as a result of their collective stock holdings, have the power to 2014) where she was Chairapprove, on behalf of the Board from 2013 to 2014. Ms. Mowry also serves as a directorholders of several not-for-profit organizations, including the Kauffman Foundation (since 2013),class A common stock, both the University of Minnesota Executive Committee, Carlson School of ManagementReverse Split and the BoardForward Split without the affirmative vote of Overseers (since 2004), the Colorado Innovation Network (since 2013)any other shareholder. Mr. Hays and the National Association of Corporate Directors Colorado Chapter where she is a Leadership Fellow. Ms. Mowry previously served as a director of Gaiam, Inc. (from 1999Grandchildren’s Trust have indicated to 2013), Real Goods Solar, Inc. (from 2008us that they intend to 2013)vote “FOR” both the Reverse Split and the Denver BranchForward Split. Please see the sections entitled “Principal Shareholders” beginning on page 55, “Special Factors — Effects of the Federal Reserve BankProposed Transaction — Effect on Affiliated Holders of Kansas City (from 2008 to 2011). Ms. Mowry’s financial background as a former President1,764,560 or More Shares of Class B Common Stock and Chief Executive OfficerRemaining Holders of several companies, a former member ofClass A Common Stock and Class B Common Stock Generally” beginning on page 28 and “Additional Information Regarding the audit and compensation committees of the boards of directors of Gaiam, Inc. and Real Goods Solar, Inc. and as the current Chief Executive Officer of GoreCreek Advisors, led to the conclusion that she should serve as a director of the Company.Proposed Transaction — Shareholder Approval” beginning on page 37.

 


 

THE BOARD RECOMMENDS THE FOREGOING NOMINEES FOR ELECTION AS DIRECTORS AND URGES EACH SHAREHOLDER TO VOTE “FOR” SUCH NOMINEES. SHARES OF THE COMPANYEff’S COMMON STOCK REPRESENTED BY EXECUTED BUT UNMARKED PROXIES WILL BE VOTED “FOR” SUCH NOMINEES.ectiveness of the Proposed Transaction

 

Directors We anticipate that the Reverse Split and the Forward Split will be effected as soon as practicable on or after the date of the Special Meeting. Please see the sections entitled “Additional Information Regarding the Proposed Transaction — Effective Date” beginning on page 37 and “Additional Information Regarding the Proposed Transaction – Payment for Fractional Shares” beginning on page 38.

Financing for the Reverse Split

We estimate that approximately $101 million will be required to pay for the fractional shares of class B common stock resulting from the Reverse Split and for cashing out the holders of options to purchase class B common stock and restricted shares of class B common stock in connection with the Proposed Transaction, and that we will incur approximately $1.175 million in expenses relating to the evaluation of various alternatives, including the Proposed Transaction, the preparation and distribution of this proxy statement, and the financing and consummation of the Proposed Transaction. These amounts could be larger or smaller depending on, among other things, the number of shares that will be outstanding as a result of purchases, sales, and other transfers of shares of class B common stock by our shareholders and the number of shares that are actually cashed out in the Proposed Transaction, or an increase or decrease in the costs and expenses of the Proposed Transaction.

We anticipate that the costs of the Proposed Transaction will be funded with approximately $31 million of cash on hand and $70 million of borrowings under a new credit facility to be entered into with First National Bank of Omaha (“FNB”). We have received a commitment letter from FNB with respect to funding $70 million toward the Proposed Transaction and expect to enter into definitive agreements contemporaneously with the Special Meeting to approve the Proposed Transaction. However, we do not currently have any definitive agreements with FNB to loan funds to us to fund the costs of the Proposed Transaction.

On September 18, 2017, we entered into a commitment letter (as amended, restated, supplemented, or modified from time to time, the “Commitment Letter”) with FNB, which expires on December 29, 2017, to provide (i) a senior secured term loan of $70 million (the “Term Loan”), (ii) a senior secured delayed draw term loan facility of $20 million (the “Delayed Draw Term Loan”) and (iii) a senior secured revolving line of credit facility in an amount equal to $10 million (the “Line of Credit” and, collectively with the Term Loan and the Delayed Draw Term Loan, the “Credit Facilities”), in each case subject to the terms and conditions set forth in the Commitment Letter, as further described in the section entitled “Additional Information Regarding the Proposed Transaction – Source and Amount of Funds and Expenses” beginning on page 39. Should we enter into definitive documentation relating to the Credit Facilities with FNB, we will use the Term Loan to fund, in part, the Reverse Split, the cashing out of outstanding stock options and restricted shares tied to the class B common stock and the costs of the Proposed Transaction. The Delayed Draw Term Loan, if used, is designated to fund any future business acquisitions or repurchasing of class A common stock. We do not presently have plans for any acquisitions or class A common stock repurchases. We will use the Line of Credit to fund ongoing working capital needs and for other general corporate purposes.

We do not currently have any alternative financing arrangement or alternative financing plans in the event borrowings from FNB are not available.

Please see the section entitled “Additional Information Regarding the Proposed Transaction – Source and Amount of Funds and Expenses” beginning on page 39 for a more detailed discussion of the Credit Facilities and the estimated expenses of the Proposed Transaction.


Dissenters’ Rights

Under Wisconsin law, no appraisal or dissenters’ rights are available to shareholders in connection with the Proposed Transaction. Please see the section entitled “Additional Information Regarding the Proposed Transaction — Unavailability of Appraisal or Dissenters’ Rights” beginning on page 38 for a more detailed discussion of the foregoing.

Tax Information

You should be aware of and consider the potential United States federal income tax consequences of the Proposed Transaction. The tax consequences for a shareholder are governed by a number of complex rules, but, generally, a shareholder that receives cash in exchange for shares of class B common stock as a result of the Proposed Transaction will recognize a gain or loss for United States federal income tax purposes. Please see the section entitled “Additional Information Regarding the Proposed Transaction — Material U.S. Federal Income Tax Consequences” beginning on page 41 for further information.

Other Matters

Pursuant to our By-Laws, no matters may be brought before the Special Meeting other than as set forth in the attached Notice of Special Meeting of Shareholders.


QUESTIONS AND ANSWERS ABOUT THE PROPOSED TRANSACTION
AND THE SPECIAL MEETING

Q:

What is the date, time and place of the Special Meeting?

A:

The Special Meeting will be held on [●], November [●], 2017 at [●], local time, at our corporate offices located at 1245 Q Street, Lincoln Nebraska 68508.

Q:

What am I being asked to vote upon at the Special Meeting?

A:

Our shareholders will consider and vote upon the Proposed Transaction, which consists of two proposals to amend the Company’s Articles—first to effect a 1-for-1,764,560 Reverse Split and second to effect a 1,764,560-for-1 Forward Split immediately following the Reverse Split.

Q:

What is the purpose of the Proposed Transaction?

A:

The purpose of the Proposed Transaction is to eliminate the existing public market trading confusion relating to our two classes of common stock (the class A common stock and the class B common stock) and to provide a timely and cost-effective liquidity event for holders of our class B common stock, other than Michael D. Hays. We also expect that the liquidity of our class A common stock will be positively affected by the Proposed Transaction over time.

Q:

What will I receive in the Proposed Transaction?

A:

If you are the owner of fewer than 1,764,560 shares of class B common stock before the Effective Date, you will receive $53.44 in cash, without interest, from us for each share of class B common stock you own immediately prior to the Reverse Split. As of the Effective Date, it is expected that Mr. Hays will be the only owner of one or more shares of class B common stock following the Reverse Split. As such, Mr. Hays will not receive any cash payment for his shares in the Reverse Split and will continue to hold the same number of shares of class B common stock as he did immediately before the Effective Date. Mr. Hays will, however, receive approximately $208,000 as a result of the cashing out of his class B common stock options in connection with the Proposed Transaction.

Q:

When is the Proposed Transaction expected to be completed?

A:

If the Reverse Split and the Forward Split are approved at the Special Meeting, we expect the Proposed Transaction to be completed as soon as practicable thereafter. We must file amendments to our Articles with the State of Wisconsin to effect each of the stock splits in the Proposed Transaction, and we expect to complete such filings on the date of the Special Meeting.

Q:

Who is entitled to vote at the Special Meeting?

A:

Only holders of record of the Company’s class A common stock and class B common stock at the close of business on the Record Date (i.e., October [●], 2017) are entitled to vote at the Special Meeting. Each share of class A common stock is entitled to one-one-hundredth (1/100th) of one vote and each share of class B common stock is entitled to one vote.

Q:

What votes are required by our shareholders to approve the Proposed Transaction?

A:

Under Wisconsin law and our Articles, the following three “voting groups” must approve the Proposed Transaction (both the Reverse Split and the Forward Split): (1) the holders of the class A common stock and the class B common stock, voting together as a single class; (2) the holders of the class A common stock, voting separately as an independent voting group; and (3) the holders of the class B common stock, voting separately as an independent voting group. Assuming a quorum of each voting group is present at the Special Meeting, the number of votes cast within the voting group for approval of each of the Reverse Split and the Forward Split must exceed the number of votes cast against it.


Q:

What happens if I do not return my proxy card?

A:

Unless you vote in person, a failure to return your proxy card will neither constitute a vote “FOR” or a vote “AGAINST” the Reverse Split and the Forward Split.

Q:

How do I vote?

A:

If a broker, bank or other nominee holds your shares, you will receive instructions from them that you must follow in order to have your shares voted. If a bank, broker or other nominee holds your shares and you wish to attend the Special Meeting and vote in person, you must obtain a “legal proxy” from the record holder of the shares giving you the right to vote the shares.

If you hold your shares in your own name as a holder of record, you may instruct the proxy holders how to vote your shares by completing, signing and dating the enclosed proxy card where indicated and by mailing or otherwise returning the card to us before the Special Meeting. This proxy statement, including Appendix A and Appendix B hereto, the proxy card and any other proxy solicitations materials will be available on the Internet at https://www.rdgir.com/national-research-corporation. The proxy holders will vote your shares in accordance with your instructions. If you sign and return a proxy card without giving specific voting instructions, your shares will be voted ‘FOR” the Reverse Split and “FOR” the Forward Split. Of course, you may also choose to attend the meeting and vote your shares in person.

Q:

Can I change my vote after I have mailed my proxy card?

A:

Yes. You may change your proxy instructions at any time before your proxy is voted at the Special Meeting. If you are a holder of record and you vote by proxy, you may later revoke your proxy instructions by:

sending a written statement to that effect to Kevin R. Karas, Secretary, National Research Corporation, 1245 Q Street, Lincoln, Nebraska 68508;

submitting a proxy card with a later date and signed as your name appears on the shareholder account; or

voting in person at the Special Meeting (although attendance at the meeting will not, by itself, revoke a proxy).

If a broker, bank or other nominee holds your shares and you vote by proxy, you may later revoke your proxy instructions by informing the broker, bank or other nominee in accordance with that entity’s procedures.

Q:

Will I have appraisal or dissenters rights in connection with the Proposed Transaction?

A:

No. Under Wisconsin law, no appraisal or dissenters’ rights are available to shareholders in connection with the Proposed Transaction.

Q:

Should I send in my class B common stock certificates now?

A:

No. If the Proposed Transaction is approved, you will receive instructions for exchanging any existing class B common stock certificates you may have for cash payment.


PROPOSALS — REVERSE SPLIT AND FORWARD SPLIT

Board Recommendation

The Board has authorized and recommends that you approve the Proposed Transaction, which consists of both (1) an amendment to the Company’s Articles to effect the 1-for-1,764,560 Reverse Split of our class B common stock and waive the application to such Reverse Split of any provision in our Articles to the contrary, including, without limitation, Section B(4) of Article 2, following which we will repurchase the resulting fractional shares held by each shareholder with less than one share of class B common stock after the Reverse Split, and (2) an amendment to the Company’s Articles to effect a 1,764,560-for-1 Forward Split of the class B common stock and waive the application to such Forward Split of any provision in our Articles to the contrary, including, without limitation, Section B(4) of Article 2, immediately following the Reverse Split. As a result of the Proposed Transaction: (a) each shareholder owning fewer than 1,764,560 shares of outstanding class B common stock immediately before the Reverse Split will receive $53.44 in cash, without interest, for each share of class B common stock owned by such shareholder immediately prior to the Reverse Split and will no longer be a holder of class B common stock; and (b) the sole remaining holder of one or more shares of class B common stock after the Reverse Split, Michael D. Hays, our founder, chief executive officer and a director, will continue to hold class B common stock equal to the number of class B common stock he held immediately prior to the effective date of the Reverse Split. The Proposed Transaction is designed to eliminate the current public market trading confusion relating to the Company’s two classes of common stock (the class A common stock and class B common stock) and to provide a liquidity event for the holders of our class B common stock, other than Mr. Hays, without a significant discount to its trading price. Mr. Hays agreed to not have his shares of class B common stock be cashed out in the Reverse Split so the Company could maintain a moderate debt burden as a result of the Proposed Transaction.

The Board has unanimously determined that the Proposed Transaction (both the Reverse Split and the Forward Split) is in the best interests of the Company and is fair to the Company’s shareholders, including those who would not retain their interest in class B common stock of the Company after the Proposed Transaction.

THE BOARD UNANIMOUSLY RECOMMENDS THAT THE SHAREHOLDERS VOTE “FOR” APPROVAL OF THE REVERSE SPLIT AND “FOR” APPROVAL OF THE FORWARD SPLIT.

The Board reserves the right to abandon or delay the implementation of the Proposed Transaction even if the shareholders approve the Reverse Split and the Forward Split. Please see the section entitled “Special Factors — How the Board Will Determine Whether to Effect the Proposed Transaction” for a more detailed discussion of the foregoing.

Summary and Structure

The Proposed Transaction consists of two steps. First, the Company will conduct a 1-for-1,764,560 Reverse Split of the class B common stock. In the Reverse Split: (a) each lot of 1,764,560 shares of class B common stock held by a shareholder of the Company prior to the Reverse Split will be converted into one whole share of class B common stock after the Reverse Split; and (b) any shares of class B common stock held by a shareholder owning fewer than 1,764,560 shares will not be converted into a whole share and, instead, will be cancelled and exchanged for a cash payment equal to the number of shares of class B common stock held immediately prior to the Effective Date multiplied by the Cash-Out Price of $53.44, without interest. After the Reverse Split is completed, it will be followed immediately by a 1,764,560-for-1 Forward Split of the class B common stock, which will convert each whole share of class B common stock outstanding after the Reverse Split back into 1,764,560 shares of class B common stock. The Proposed Transaction is intended to take effect on the Effective Date (i.e., the date the State of Wisconsin accepts for filing Articles of Amendment to our Articles to effect the Reverse Split and the Forward Split, or any later date that we may specify in the Articles of Amendment to our Articles). Forms of the proposed amendments to our Articles to effect the Reverse Split and the Forward Split are attached to this proxy statement as Appendix A and Appendix B, respectively, and are incorporated herein by reference. Although both the Reverse Split and the Forward Split will be voted on separately, the Company will not implement either the Reverse Split or the Forward Split unless both are approved by shareholders and the Board gives final approval to implement them.


Shareholders will receive payment for their shares of class B common stock that are exchanged for cash in lieu of issuing fractional shares in accordance with the procedures described in the section entitled “Additional Information Regarding the Proposed Transaction — Payment for Fractional Shares.”

The following three “voting groups” must approve the Proposed Transaction (both the Reverse Split and the Forward Split): (1) the holders of the class A common stock and the class B common stock, voting together as a single class; (2) the holders of the class A common stock, voting separately as an independent voting group; and (3) the holders of the class B common stock, voting separately as an independent voting group. Assuming a quorum of each voting group is present at the Special Meeting, the number of votes cast within the voting group for approval of each of the Reverse Split and the Forward Split must exceed the number of votes cast against it.

After the Record Date, but prior to the Effective Date, Michael D. Hays and the Grandchildren’s Trust will effect a Swap pursuant to which the Grandchildren’s Trust will receive 208,645 shares of class B common stock from Mr. Hays in return for the Grandchildren’s Trust transferring to Mr. Hays an equivalent value amount of shares of class A common stock. The Swap is being effected in order to provide the Grandchildren’s Trust with a liquidity event in connection with the Proposed Transaction on the same basis as the other holders of class B common stock (except Mr. Hays). Mr. Hays will not receive any cash payment as a result of the Reverse Split, but his class B common stock options will, along with all other holders of the same and of restricted shares of class B common stock, immediately prior to the Effective Date of the Proposed Transaction, vest in full and be paid out as if they were cashed out in connection with the Proposed Transaction, which will result in a payment of approximately $208,000 to Mr. Hays. Please see the section entitled “Additional Information Regarding the Proposed Transaction — Special Interests of the Affiliated Persons” for additional information.

The executive officers, directors and affiliates of the Company, who, as of the Record Date, together (a) beneficially own approximately [●]% of the class A common stock entitled to vote at the Special Meeting and approximately [●]% of the class B common stock entitled to vote at the Special Meeting, and (b) have approximately [●]% of the Company’s total voting power entitled to vote at the Special Meeting, have indicated that they intend to vote in favor of each of the Reverse Split and the Forward Split.

In connection with the Proposed Transaction, we have filed, as required by the Exchange Act, a Rule 13e-3 Transaction Statement on Schedule 13E-3 (the “Schedule 13E-3”) with the Securities and Exchange Commission (“SEC”). Please see the section entitled “Available Information.”

SPECIAL FACTORS

Purpose of the Proposed Transaction

The Proposed Transaction is designed to eliminate the current public market trading confusion relating to the Company’s two classes of common stock (the class A common stock and class B common stock) and to provide a timely and cost-effective liquidity event for the holders of our class B common stock, other than Mr. Hays. We also expect that the liquidity of our class A common stock will be positively affected by the Proposed Transaction over time due to the elimination of the confusion in the public market regarding our dual class structure.


The Proposed Transaction will delist the class B common stock from trading on Nasdaq and deregister and suspend our reporting obligations with respect to the class B common stock under the Exchange Act. As a result of the Proposed Transaction, our class B common stock will no longer be quoted on Nasdaq. Our class A common stock, however, will continue to be traded on Nasdaq and we will continue to have reporting obligations under the Exchange Act. The Board has concluded that the Proposed Transaction is fair to, and in the best interests of, all of our shareholders, including those being cashed out pursuant to the terms of the Proposed Transaction.

In 2013, the Board approved, and the shareholders adopted, the 2013 Recapitalization, pursuant to which we (i) established two classes of common stock, each of which is currently publicly traded on Nasdaq, consisting of a new class of common stock with 1/100th of a vote per share and with the right to receive 1/6th of the dividend, if any, paid on the other class of common stock, designated as class A common stock, and a new class of common stock with one vote per share and with the right to receive six times the dividend, if any, paid on the other class of common stock, designated as class B common stock, (ii) issued a dividend of three shares of class A common stock for each share of our then-existing common stock, and (iii) reclassified each share of our then-existing common stock as one-half of one share of class B common stock. The reasoning and desired effects of the 2013 Recapitalization included increasing liquidity of our traded shares and expanding our institutional ownership base, enhancing shareholder value, and increasing flexibility for us and our shareholders. Since the 2013 Recapitalization was implemented, however, we have received negative commentary from shareholders concerning our dual class common stock structure, especially the disconnect in valuation of the two classes of common stock given the 6-to-1 dividend differential and the “equal status” provision of our Articles whereby both the class A common stock and the class B common stock receive equal consideration in the event of certain extraordinary transactions, such as a sale of the Company. In addition, there has been a lack of comparable research coverage for each of the two classes and minimal trading in the class B common stock. Accordingly, we and our shareholders have not realized certain benefits that were anticipated in implementing the 2013 Recapitalization, such as increased liquidity of our publicly traded shares.

The Board has determined that the 2013 Recapitalization has resulted in shareholder dissatisfaction regarding our dual class common stock structure and has not had the desired effect of enhancing the trading volumes in our class A common stock and class B common stock to acceptable levels. After considering various alternatives, the Board decided that pursuing the Proposed Transaction would strike the most desirable balance among addressing shareholder concerns, recognizing that the majority shareholder did not support a sale of the Company, and maintaining an appropriate capital structure and level of indebtedness. For this reason, we propose to undertake the Proposed Transaction for the purpose of reducing the number of record shareholders of our class B common stock to one so that we can terminate registration of our class B common stock under the Exchange Act and delist our class B common stock from Nasdaq. As a result, shares of our class B common stock would no longer be quoted on Nasdaq and trades in such shares would only be possible through privately negotiated transactions. Our class A common stock is not and will not be directly affected by the Proposed Transaction. The class A common stock will continue to be traded on Nasdaq and we will continue to have reporting obligations under the Exchange Act.

See the section below entitled “– Reasons for the Proposed Transaction” for additional information about our reasons for proceeding with the Proposed Transaction at this time.

Background of the Proposed Transaction

Because certain desired effects of the 2013 Recapitalization were not ultimately realized, in late 2015, the Board began to discuss methods to address illiquidity in our two classes of publicly traded common stock and confusion in the public market over our dual class common stock structure. With the Board’s support, Mr. Hays led an evaluation of various alternatives that would address these concerns.


In October 2015, at a regularly scheduled Board update call, the Board discussed certain communications from institutional shareholders, whereby such shareholders expressed concern and confusion over our dual class common stock structure. In response, between October 2015 and January 2017, the Board discussed and explored various alternative transactions to address illiquidity in our two classes of publicly traded common stock and confusion in the public market over our dual class common stock structure. Please see the section below entitled “– Strategic Alternatives Considered By the Board” for a detailed description of the alternatives that the Board considered.

In January 2017, we began discussions with FNB regarding the potential financing of a transaction, with the structure of such transaction remaining under consideration by the Board.

In late February 2017, our class A common stock and class B common stock both began to experience a period of steady increase in quoted price per share.

During March, April and May 2017, the Board continued discussions with FNB regarding the terms and conditions of a possible credit facility to fund a potential transaction. During this time, with the quoted stock price per share of both the class A common stock and the class B common stock continuing on an upward trajectory, the Board began to focus on pursuing a transaction that would affect only one class of our common stock, and potentially less than the entire class of such class of common stock, with the goal of maintaining a moderate debt burden for the Company as a result of any such transaction.

In late April and early May of 2017, Mr. Hays and the Board engaged in further discussions which focused on (i) the alternative forms such a transaction could take, (ii) the treatment of shares held by affiliated shareholders, including Mr. Hays, the Grandchildren’s Trust and certain other family affiliated entities and (iii) whether such affiliated shareholders would be excluded from the transaction or issued alternative consideration (for example, issuing notes to be repaid at a later date in lieu of cash payment). During this timeframe, Mr. Hays considered, and ultimately indicated, that he would be willing to be excluded from the Reverse Split and hold illiquid shares as long as the Forward Split was implemented.

On May 25, 2017, the independent members of the Board (without Mr. Hays) convened with Foley & Lardner LLP, the Company’s long-standing outside corporate and securities counsel (“Foley”), to discuss the process the Board would be required to undertake in order to pursue a potential transaction, including whether to form a special committee to evaluate such a potential transaction. After extended discussion, the independent members of the Board concluded there were already sufficient procedural safeguards in place, including, but not limited to, the fact that four of the five members of the Board are independent directors. Please see the section below entitled “– Fairness of the Proposed Transaction – Procedural Fairness” for additional information.

On June 12, 2017, the independent members of the Board convened (without Mr. Hays) and, on June 14, 2017, the full Board convened with Foley to discuss the impact that a potential transaction intended to cash out all unaffiliated holders of our class B common stock would have on the relative voting power and ratable economic interests of our shareholders, as well as various other aspects of a potential transaction.

In early July 2017, we began to negotiate the terms and conditions of a commitment letter and term sheet pursuant to which FNB would commit to provide a credit facility in connection with a potential transaction. Discussions with FNB regarding the Commitment Letter continued throughout July and early August and focused on the relative amounts of the proposed facilities and maintaining customary flexibility to pursue future transactions.


On July 6, 2017, the Board discussed a proposed reverse/forward stock split of the class B common stock at to-be-determined split ratios with the goals of reducing or eliminating public market trading confusion surrounding the two publicly traded classes of our common stock, providing a liquidity event for the non-affiliated holders of class B common stock and achieving those objectives without encumbering our operations or growth prospects with an excessive debt burden. The proposal was a reverse stock split of the class B common stock to cash out all holders (other than Mr. Hays), followed by a forward stock split of the remaining shares held by Mr. Hays to return him to his pre-reverse stock split share ownership of the class B common stock. The Board discussed the proposal including, without limitation, (i) the potential benefits and risks, (ii) the pro forma capital structure, cash flows, and earnings per share accretion, (iii) the pro forma covenant compliance, (iv) the potential impact on our current dividend rates, (v) the proposed timeline for the transaction, (vi) the expected costs to the Company of cashing out fractional shares of the class B common stock in a reverse stock split, (vii) hiring an advisor to assist with valuation alternatives, (viii) shareholder approval requirements for the proposed transaction, (ix) the fiduciary duties of the Board in connection with such a transaction, and (x) potential advantages and disadvantages of the proposed transaction compared to the status quo and the alternative transactions previously considered.

On July 7, 2017, the independent members of the Board (without Mr. Hays) convened with Foley to further discuss the proposal and the matters discussed at the July 6, 2017 Board meeting (as set forth in the immediately preceding paragraph).

On July 15, 2017, the independent members of the Board (with Mr. Hays participating only in the information gathering portion of the meeting) convened with Foley to discuss whether approval by a majority of our unaffiliated shareholders should be used in connection with the Proposed Transaction. After extended discussion, the independent members of the Board concluded any such vote would not provide meaningful additional protection to those unaffiliated shareholders, as shareholders representing disproportionately few shares could unduly influence such a vote, and that allowing a minority of investors to make a determination with respect to the Proposed Transaction alone would not be in the best interests of the Company and our shareholders. Please see the section below entitled “– Fairness of the Proposed Transaction – Procedural Fairness” for additional information. In addition, the independent members of the Board discussed potential fair value considerations for the Cash-Out Price and decided to engage the firm of Emory & Co. to assist with exploring possible alternatives to, and establishing a methodology for determining, the fair value of the class B common stock and, therefore, the Cash-Out Price. The independent members of the Board also considered whether we should make any future commitment to cash out or purchase the post-Proposed Transaction remaining shares of class B common stock held by Mr. Hays and decided against making such a commitment in connection with the Proposed Transaction.

On July 23, 2017, Emory & Co. made a presentation to the independent members of the Board (without Mr. Hays) regarding the Proposed Transaction, the provisions of our Articles relating to the relative rights of the class A and class B common stock and possible alternatives for determining the fair value of the shares of class B common stock to be cashed out pursuant to the Reverse Split. Emory & Co. identified the following valuation alternatives, among others: (i) the closing price of the class B common stock on the day the transaction is announced; (ii) the average of the high and low class B common stock prices on the day of announcement; (iii) the volume weighted average price of the class B common stock on the day of announcement; (iv) the highest trading price of the class B common stock over the previous 52 weeks; (v) an average (weighted average or otherwise) of the sales or closing prices of the class B common stock for a to-be-determined number of recent trading days, in order to give the holders of the class B common stock the benefit of the recent upward trajectory of the quoted price of the class B common stock while also considering fairness to the holders of class A common stock whose shares will not be directly affected by the proposed transaction; (vi) a hybrid of any of the foregoing methods, such as the greater of one or the other; (vii) a discount to recent trading prices or average price of the class B common stock; and (viii) a premium to recent trading prices or average price of the class B common stock. At this meeting, the independent members of the Board requested additional information from Foley regarding the effect that the Proposed Transaction would have on options to purchase class B common stock and restricted shares of class B common stock under our equity incentive plans. The independent members of the Board also discussed whether, in connection with the Proposed Transaction, we should suspend the payment of cash dividends on the class B common stock and the class A common stock for a period of time in order to focus on paying down the indebtedness we would incur to fund the transaction and/or to restore our cash reserves following the Proposed Transaction.


On July 29, 2017, the independent members of the Board (without Mr. Hays) discussed the approvals necessary to effect the Proposed Transaction and the process that would be undertaken by the Company, the Board and the shareholders if the Board recommended the Proposed Transaction. At this meeting, the independent members of the Board also discussed the potential split ratios for the Reverse Split and the Forward Split and the effects that setting such split ratios may have on the transaction and future operational flexibility, including the amount of indebtedness we would need to incur under various scenarios. The independent members of the Board further discussed whether we should change or keep in place our current dividend rates in connection with the Proposed Transaction. Finally, the independent members of the Board discussed whether to accelerate the vesting and cash-out the outstanding stock options and restricted shares tied to the class B common stock as if they were cashed out pursuant to the Reverse Split or to replace those equity awards with class A common stock awards, and the effect of both on associate retention.

On August 1, 2017, we released earnings for the quarter ended June 30, 2017, which reflected increases of 9% and 26% in revenue and net income, respectively, as well as approximately $31.6 million in cash on hand.

Also on August 1, 2017, the Board convened with Foley to further discuss the potential split ratios for the Reverse Split and the Forward Split, the possible accelerated vesting and cashing out of the class B common stock equity awards and whether to change our dividend rates in connection with the Proposed Transaction.

On August 5, 2017, the Board convened with Foley to continue to discuss the potential split ratios for the Reverse Split and the Forward Split and the effects that setting such split ratios may have on the Proposed Transaction and future operational flexibility, including the amount of indebtedness we would need to incur under various scenarios. The Board also continued to discuss accelerated vesting and cashing out of the class B common stock equity awards, as well as the availability of class A common stock under our equity incentive plans. In addition, the Board discussed the reimbursement of certain personal expenses Mr. Hays incurred in connection with exploring strategic alternatives for the Company, including the Proposed Transaction. Finally, the Board discussed whether to increase the number of shares of class A common stock we are authorized to repurchase in light of the Proposed Transaction.

On August 11, 2017, the Audit Committee of the Board convened to review certain expenses incurred by Mr. Hays in connection with exploring strategic alternatives for the Company, including the Proposed Transaction. Based on their review, the Audit Committee approved reimbursing Mr. Hays for approximately $538,000 of such expenses he had personally incurred.

              On August 21, 2017, the Board discussed the Proposed Transaction and the potential split ratios for the Reverse Split and the Forward Split and the effects that setting such split ratios may have on the transaction and our future operational flexibility, including the amount of indebtedness we would need to incur under various scenarios.  The Board further discussed whether we should change or keep in place our current dividend rates in connection with the Proposed Transaction and whether to accelerate the vesting and cash-out the outstanding stock options and restricted shares tied to the class B common stock as if they were cashed out pursuant to the Reverse Split.

On September 15, 2017, the Board and the Compensation Committee of the Board discussed and approved the Proposed Transaction and related matters, including, among other things, the following: (i) setting the ratios for the Reverse Split and the Forward Split and determining the Cash-Out Price for fractional shares of class B common stock following the Reverse Split; (ii) formally presenting the Proposed Transaction to our shareholders for approval at a Special Meeting; (iii) accelerating the vesting of outstanding options to purchase class B common stock and restricted shares of class B common stock and approving the payout of such class B common stock equity awards as if they were cashed out pursuant to the Reverse Split; (iv) approving the Commitment Letter and the borrowing proposed thereunder pursuant to the Credit Facilities; (v) amending the NRC 2006 Equity Incentive Plan and the NRC 2004 Non-Employee Director Stock Plan to remove the class B common stock thereunder; (vi) amending the existing stock repurchase program to remove the class B common stock thereunder; (vii) delisting and deregistering the class B common stock following effectiveness of the Proposed Transaction; and (viii) approving the filing of all required or necessary applications, notices, or other documents with the SEC, Nasdaq, and the State of Wisconsin in connection with the Proposed Transaction. The Board also indicated its current intent to maintain the payment of cash dividends on the Common Stock (with the payment and amount of future dividends, if any, at the discretion of the Board) but to delay the record and payment date for the third quarter dividend until after the Proposed Transaction is consummated. The Board did not make any commitments with respect to future transactions involving the class B common stock still outstanding following the Proposed Transaction.


Reasons for the Proposed Transaction

Because certain desired effects of the 2013 Recapitalization were not ultimately realized, the Board, in consultation with Mr. Hays, began to explore possible transactions to increase liquidity for our shareholders and reduce confusion in the public market surrounding our dual class common stock structure. After discussing various possible alternative transactions, as described below in the section entitled “– Strategic Alternatives Considered By the Board,” the Board has concluded that the Proposed Transaction is fair to, and in the best interests of, all of our shareholders, including those being cashed out pursuant to the terms of the Proposed Transaction. The following discussion of factors considered by the Board is not intended to be exhaustive, but includes the material factors considered by the Board in deciding to proceed with the Proposed Transaction. In light of the variety of factors considered, the Board did not find it practicable to, and did not, quantify or otherwise assign relative weights to the specific factors considered in reaching their respective determinations and recommendations.

Respond to Shareholder Concerns Surrounding Our Dual Class Common Stock Structure

Our Articles contain an “equal status” provision pursuant to which both the class A common stock and the class B common stock receive equal consideration in the event of certain extraordinary transactions, such as a sale of the Company. Our Articles also provide that the shares of class B common stock receives six times the dividends paid on the class A common stock. These provisions, which are somewhat contradictory from a valuation perspective, have resulted in negative commentary from certain of our large shareholders and a disconnect between the market prices of our two classes of publicly traded common stock. In addition, the class A common stock and the class B common stock are both thinly traded with highly concentrated ownership. The Proposed Transaction is expected to reduce or eliminate any confusion in the public market regarding our dual class common stock structure and the relative trading values of the class A common stock and class B common stock. Potential interested investors will no longer have to evaluate their investment decision based on a comparison between the class A common stock and class B common stock. Accordingly, the Board expects the Proposed Transaction will increase the liquidity and diversify the ownership of the class A common stock over time.

Provide Holders of Class B Common Stock with a Liquidity Event While the Class B Common Stock is Trading At or Near An All-Time High

As a result of the Proposed Transaction, holders of less than one share of our class B common stock after giving effect to the Reverse Split will receive cash in exchange for such fractional shares. We will pay to each of these shareholders $53.44 in cash, without interest, for each share of class B common stock held by such shareholders immediately before giving effect to the Reverse Split. Such Cash-Out Price represents approximately 94% of the all-time high closing price for the class B common stock, a premium of approximately 5.3% to the 90-day volume weighted average price of the class B commom stock, and is likely more than any shareholder would be able to obtain by selling their class B common stock holdings into the public market based on the current trading market. We believe this provides holders of less than 1,764,560 shares of class B common stock (before giving effect to the Reverse Split) with a cost-effective way to cash out their investment without experiencing a negative impact of illiquidity on the market price or paying transaction costs such as brokerage fees or service fees. Although such cashed out holders will no longer be holders of our class B common stock, if they desire to maintain an ownership interest in us and to participate in our future earnings or growth, they will have the opportunity to use the cash received pursuant to the Proposed Transaction to invest, subject to availability, in our class A common stock.


Maintain a Moderate Debt Burden and the Flexibility to Fund Future Growth Initiatives and Proposed Transactions and Continue Current Dividends

Structuring the Proposed Transaction so that all current holders of the class B common stock (other than Mr. Hays) will be cashed out as a result of the Reverse Split allows us to achieve our objectives of addressing shareholder concerns with our current dual class common stock structure while maintaining a moderately leveraged capital structure that we expect will allow for future flexibility to fund growth initiatives, continue with our current dividends and fund future business acquisitions and repurchases of class A common stock pursuant to our repurchase program, all as the Board may determine.

Class A Common Stock Earnings Per Share Accretion

We expect that, following the Proposed Transaction, holders of class A common stock will experience substantial accretion to earnings per share of class A common stock. We expect the Proposed Transaction will result in pro forma earnings per share accretion of 24.1% for the class A common stock for the six months ending June 30, 2017. Additionally, holders of class A common stock following the Proposed Transaction will experience a greater percentage of participation in any future dividends, as compared with the existing dual class common stock structure. As a result of the Proposed Transaction, class A common stock will represent 66.4% of any potential dividends from 49.6% before the Proposed Transaction. Please see also the section entitled “Financial Information – Pro Forma Consolidated Financial Statements (Unaudited)” for more information on the anticipated pro forma effect of the Proposed Transaction and the Credit Facilities on our historical financial information.

Increased Liquidity Due to Concentration of Trading and Value Accretion in Class A Common Stock

We expect the Proposed Transaction will decrease uncertainty in the public market as to how to invest in the Company. Shareholders will no longer need to decide between holding class A common stock and class B common stock or attempt to maintain proportionate holdings of each. As a result, the Board expects the Proposed Transaction will increase the liquidity, diversify the ownership and grow the value of the class A common stock over time.

Michael D. Hays Has Agreed to Hold Delisted and Deregistered Class B Common Stock

As the Board discussed and explored various alternative transactions to address negative commentary from shareholders concerning our dual class common stock structure, Mr. Hays indicated that he would be willing to not have his shares of class B common stock be cashed out in the Reverse Split and hold illiquid shares so long as the Forward Split was implemented. This allowed us to address these shareholder concerns while maintaining a moderate debt burden as a result of the Proposed Transaction. The Board viewed the exclusion of Mr. Hays’ shares of class B common stock from the Proposed Transaction as having offsetting benefits and detriments for Mr. Hays. While as result of such exclusion, Mr. Hays will continue to participate in any growth in value through class B common stock, such class B common stock held following the Proposed Transaction will continue to be subject to the “equal status” provision of our Articles, essentially capping the value per share of the class B common stock in any distribution of property, merger, consolidation, purchase or acquisition of property or stock, asset transfer, division, share exchange, recapitalization, reorganization, or similar corporate transaction at the value per share received by holders of class A common stock. Similarly, while Mr. Hays will experience a relative increase in voting power of combined class A common stock and class B common stock due to his continued holdings of class B common stock, Mr. Hays already was able to exercise a controlling influence over our business and the power to elect our directors due to his existing holdings of class A common stock and class B common stock.


Effects of the Proposed Transaction

Rights, Preferences, and Limitations

Our outstanding stock is divided into two classes of common stock: class A common stock and class B common stock, both of which are currently publicly traded. The class B common stock has one vote per share on all matters and the class A common stock has one one-hundredth (1/100th) of one vote per share. As of the Record Date, the class B common stock constituted approximately [●]% of our total voting power. As a result, holders of class B common stock are able to, and following the effectiveness of the Proposed Transaction, will continue to be able to, exercise a controlling influence over our business, have the power to elect our directors and indirectly control business decisions, such as whether to issue additional shares, declare and pay dividends or enter into significant corporate transactions. A majority of the class B common stock is owned by, and following the effectiveness of the Proposed Transaction, will continue to be owned by Mr. Hays. The liquidation rights and rights upon the consummation of certain extraordinary transactions are the same for the holders of class A common stock and class B common stock. Other than share distributions and liquidation rights, the amount of any dividend or other distribution payable on each share of class A common stock is equal to one-sixth (1/6th) of the amount of any such dividend or other distribution payable on each share of class B common stock. The Proposed Transaction does not change the rights associated with our class A common stock or class B common stock. The rights of the holders of class A common stock to be treated equally in the Reverse Split and the Forward Split under our Articles, including, without limitation, Section B(4) of Article 2 of our Articles, will be waived pursuant to the amendments to our Articles giving effect to the Reverse Split and the Forward Split.

If the Proposed Transaction is approved, the interests of the sole remaining holder of our class B common stock, after giving effect to the Proposed Transaction, and the holders of our class A common stock will not change. The repurchased fractional shares would be retired.

If the Proposed Transaction is effected, holders of fewer than 1,764,560 shares of class B common stock before giving effect to the Reverse Split would receive payment of the Cash-Out Price of $53.44 for each share of class B common stock held prior to the Reverse Split and will no longer be holders of class B common stock. If such holders do not hold our class A common stock, they will no longer have any equity interest in the Company in will not participate in our future earnings or growth.

Appraisal or Dissenters Rights

Under Wisconsin law, no appraisal or dissenters’ rights exist with respect to the Proposed Transaction.

Benefits

The Proposed Transaction is expected to result in certain benefits to us, our shareholders cashed out as a result of the Proposed Transaction, and our continued shareholders following the Proposed Transaction (including holders of our class A common stock and the remaining holder of our class B common stock after effecting the Reverse Split), including without limitation the following. Such expectations are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated.

The reduction in number of shares of class B common stock outstanding will reduce the amount of overall dividends paid to holders of class B common stock (an expected savings of approximately $4.26 million per year based on current dividends paid).


There is a relatively illiquid and limited trading market in our class A common stock and class B common stock. Holders of less than 1,764,560 shares of class B common stock prior to the Reverse Split will have the opportunity to obtain cash for their shares at approximately 94% of the all-time high closing price for the class B common stock, without incurring brokerage commissions or service fees.

We expect that the liquidity of the class A common stock will be positively affected by the Proposed Transaction over time due to the elimination of confusion in the public market regarding our current dual class common stock structure.

The reduction in the number of holders of class B common stock to one could result in cost savings to us, as we will reduce the costs of administering the current number of accounts with respect to shares of class B common stock, which cost savings may be offset if the number of holders of our class A common stock increases after the Proposed Transaction.

Our business and operations are expected to continue substantially as presently conducted.

It is currently envisioned that the Board will maintain our current cash dividends but, in light of the Proposed Transaction, the Board has decided to delay the record and payment date for the third quarter dividend until after the Proposed Transaction is consummated. As always, the payment and amount of future dividends, if any, is at the discretion of the Board and will depend on our future earnings, financial condition, general business conditions, alternative uses of our earnings, and other factors.

The percentage of our future earnings, cash flows and shareholders’ equity attributable to our class A common stock, as opposed to our class B common stock, will increase compared to the current percentage.

Please see the section entitled “ – Reasons for the Proposed Transaction” for a more detailed discussion of the reasons for and expected benefits of the Proposed Transaction.

Detriments

The Proposed Transaction is expected to result in certain detriments to us, our shareholders cashed out as a result of the Proposed Transaction and our continued shareholders following the Proposed Transaction (including holders of our class A common stock and the remaining holder of our class B common stock after effecting the Reverse Split), including without limitation the following. Such expectations are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those currently anticipated.

If the Proposed Transaction is approved, it is estimated that holders of class B common stock owning in the aggregate approximately 1,775,684 shares of class B common stock will no longer be holders of class B common stock. If such holders do not hold our class A common stock, they will cease to be shareholders of the Company, will no longer hold an equity interest in the Company, and, therefore, will not share in any future increases in the Company’s stock price or participate in the Company’s future earnings or growth, if any, and will no longer have the right to vote on any corporate matter. However, such cashed out holders will have the opportunity to use the cash received pursuant to the Proposed Transaction to invest, subject to availability, in our class A common stock.


If the Proposed Transaction is approved, holders of less than 1,764,560 shares of class B common stock prior to the Reverse Split will be required to involuntarily surrender their shares in exchange for cash, rather than at a time and for a price of their choosing.

Mr. Hays, as the sole remaining holder of 1,764,560 or more shares of class B common stock prior to the Reverse Split, will not be entitled to receive any cash payment for his shares in the Reverse Split and will continue as a class B common stock shareholder of the Company. Mr. Hays will, however, receive approximately $208,000 as a result of the cashing out of his class B common stock options in connection with the Proposed Transaction.

The Proposed Transaction may be taxable for cashed out holders of our class B common stock.

The Proposed Transaction will result in an increase in the relative voting power of Mr. Hays, compared to the remaining holders of class A common stock, following the Proposed Transaction, as shown in the table below under the section entitled “– Effects of the Proposed Transaction – Effect on Affiliated Holders of 1,764,560 or More Shares of Class B Common Stock and Remaining Holders of Class A Common Stock and Class B Common Stock Generally.”

We will incur costs associated with the Proposed Transaction.

Mr. Hays, as the sole remaining holder of our class B common stock following the Proposed Transaction, will face an illiquid market for his class B common stock, which will likely negatively affect the price of the class B common stock after the Proposed Transaction.

Our increased level of indebtedness could adversely affect our financial condition and results of operations. We will be required to dedicate a portion of our cash flows from operations to repayment of debt, limiting the availability of cash for other purposes, and our flexibility in planning for, or reacting to, changes in our business and industry will be more limited. Furthermore, our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions, or other purposes may be limited.

The Proposed Transaction will result in us having, on a pro forma basis, a negative amount of shareholders’ equity.

As of the Record Date, approximately [●]% of the issued and outstanding shares of our class A common stock and [●]% of the issued and outstanding shares of our class B common stock, collectively representing [●]% of the total voting power of shareholders entitled to vote on the Proposed Transaction, was held collectively by our directors, executive officers and affiliates, including Mr. Hays and the Grandchildren’s Trust. Our directors, executive officers and affiliates, including Mr. Hays and the Grandchildren’s Trust, have indicated that they intend to vote all of their shares of class A common stock and class B common stock (approximately [●]% of the issued and outstanding shares eligible to vote at the Special Meeting) “FOR” the Proposed Transaction. Accordingly, approval of the Proposed Transaction is expected, regardless of whether or not the minority, unaffiliated shareholders vote in favor of the Proposed Transaction.

As part of the Reverse Split and the Forward Split, the rights of the holders of class A common stock to participate in the Proposed Transaction pursuant to Section B(4) of Article 2 of our Articles will be waived.


Reduction in the Number of Holders of Class B Common Stock

We expect that, as a result of the Proposed Transaction, the number of holders of record of the class B common stock, as defined by Exchange Act rules, will be reduced to one (Mr. Hays).

Termination of Class B Common Stock Exchange Act Registration

Shares of class B common stock are currently registered under the Exchange Act. Applicable rules permit such registration to be terminated upon application to the SEC if there are fewer than 300 holders of record of the class B common stock. We intend to terminate the registration of the class B common stock under the Exchange Act as soon as practicable after the Proposed Transaction, if approved, is effected.

Delisting from Nasdaq and Effect on Market for Class B Common Stock

We intend to delist the class B common stock from Nasdaq immediately upon effecting the Proposed Transaction. Following such delisting, the class B common stock will no longer be quoted on Nasdaq and trades in such shares would only be possible through privately negotiated transactions. There can be no assurance that any trading will occur in the class B common stock after we terminate the listing of the class B common stock on Nasdaq.

Effect on the Company

We estimate that the Proposed Transaction would reduce the number of outstanding shares of class B common stock by approximately 1,775,684 shares (approximately 50.2% of the current outstanding class B shares) with a cash requirement to us (including expenses) of approximately $102.175 million. Please see the section entitled “Additional Information Regarding the Proposed Transaction – Source and Amount of Funds and Expenses” for a detailed discussion of the expected costs of the Proposed Transaction. The repurchased fractional shares would be retired. The Proposed Transaction would also reduce the number of holders of the class B common stock to one (Mr. Hays).

In connection with the Proposed Transaction, we intend to enter into the Credit Facilities. Please see the section entitled “Additional Information Regarding the Proposed Transaction – Source and Amount of Funds and Expenses” for a description of material terms of the proposed Credit Facilities. Our entry into the Credit Facilities is conditioned on this Proposed Transaction being approved and effected. Please see also the section entitled “Financial Information – Pro Forma Consolidated Financial Statements (Unaudited)” for more information on the anticipated pro forma effect of the Proposed Transaction and the Credit Facilities on our historical financial information.

The directors and officers of the Company immediately prior to the Proposed Transaction will remain the directors and officers of the Company immediately following the effectiveness of the Proposed Transaction. In connection with the Proposed Transaction, we will accelerate the vesting of the outstanding options to purchase class B common stock and restricted shares of class B common stock and such class B common stock equity awards will be paid out as if they were cashed out pursuant to the Reverse Split. This will account for approximately $7.5 million of the expected costs of the Proposed Transaction. Please see the section entitled “Additional Information Regarding the Proposed Transaction – Source and Amount of Funds and Expenses” for more information on the expected costs of the Proposed Transaction.


Effects on Affiliated and Unaffiliated Holders of Fewer than 1,764,560 Shares of Class B Common Stock

Following the Proposed Transaction, holders of fewer than 1,764,560 shares of class B common stock before giving effect to the Reverse Split would receive payment of the Cash-Out Price of $53.44 for each share of class B common stock held prior to the Reverse Split. If such persons are not holders of our class A common stock, they would cease to be shareholders of the Company and will no longer participate in any of our future earnings or growth. They would have no further interest in the Company with respect to any cashed out shares and would only have a right to receive cash for such shares. We believe this provides such holders with a cost-effective way to cash out their investment without experiencing a negative impact of illiquidity on the market price or paying transaction costs such as brokerage fees or service fees. However, the Proposed Transaction will require holders of fewer than 1,764,560 shares of class B common stock before giving effect to the Reverse Split to involuntarily surrender their shares of class B common stock in exchange for cash, rather than selecting the timing of and price received for disposing of their shares of our class B common stock. Holders of our class B common stock in certificated form who are cashed out in the Proposed Transaction will receive a letter of transmittal as soon as practicable after the Proposed Transaction is consummated with instructions on how to surrender existing certificates in exchange for cash payment. Holders of our class B common stock in electronic, book-entry form who are cashed out in the Proposed Transaction will receive their cash payment directly from our transfer agent, without having to take any action.

We intend to permit those who hold our class B common stock in street name through a nominee (such as a bank or broker) to be treated in the Proposed Transaction in the same manner as holders of class B common stock whose shares are registered in their names and will instruct nominees to effect the Proposed Transaction for their beneficial holders. However, nominees may have different procedures and those who hold class B common stock in street name should contact their nominees to instruct the nominee as to how the beneficial shareholder wishes to proceed. The Proposed Transaction structure will focus on the number of shares held by record holders. We and our transfer agent will not have the necessary information to compare the record holdings of any shareholder with “street name” holdings in a brokerage account. In addition, we will lack the information to compare holdings across multiple brokerage firms. If you are in this situation, we recommend that you consolidate your holdings into one brokerage account or record holder position prior to the Effective Date.

The Proposed Transaction may be taxable for cashed out holders of our class B common stock. Please see the section entitled “Additional Information Regarding the Proposed Transaction – Material U.S. Federal Income Tax Consequences” for further information.

Effect on Unaffiliated Holders of 1,764,560 or More Shares of Class B Common Stock

Currently, there are no unaffiliated holders of 1,764,560 or more shares of class B common stock. Accordingly, we do not expect any unaffiliated holders of class B common stock to remain after giving effect to the Proposed Transaction.

Effect on Holders of Class A Common Stock

Our class A common stock is not and will not be directly affected by the Proposed Transaction. The class A common stock will continue to be traded on Nasdaq and we will continue to have reporting obligations under the Exchange Act with respect to our class A common stock. The Proposed Transaction will have no impact on the number of shares of class A common stock outstanding. Holders of class A common stock prior to the Proposed Transaction will continue to have an equity interest in the Company and, therefore, will continue to participate in our future earnings. The percentage of our future earnings, cash flows and shareholders’ equity attributable to our class A common stock, as opposed to our class B common stock, will increase compared to the current percentage. This increase is expected to positively impact holders of our class A common stock. The rights of the holders of class A common stock to be treated equally in the Reverse Split and the Forward Split under our Articles, including, without limitation, Section B(4) of Article 2 of our Articles, will be waived pursuant to the amendments to our Articles giving effect to the Reverse Split and the Forward Split.


Please see the sections entitled “– Effects of the Proposed Transaction – Effect on Affiliated Holders of 1,764,560 or More Shares of Class B Common Stock and Remaining Holders of Class A Common Stock and Class B Common Stock Generally” below, and “– Effects of the Proposed Transaction – Rights, Preferences, and Limitations” above, for further information on how the Proposed Transaction is expected to impact holders of class A common stock.

Effect on Affiliated Holders of 1,764,560 or More Shares of Class B Common Stock and Remaining Holders of Class A Common Stock and Class B Common Stock Generally

We expect that only Mr. Hays will continue to hold shares of class B common stock immediately after the Proposed Transaction and the percentage of ownership of the class B common stock Mr. Hays holds would increase from approximately 56% of the outstanding shares of class B common stock to 100% of the outstanding shares of class B common stock.

The Proposed Transaction will result in an increase in the interest of Mr. Hays in our net book value and net earnings (losses), relative to the remaining holders of class A common stock following the Proposed Transaction, as shown in the following table (shown using the two-class earnings per share method):

  

At December 31, 2016

   

At June 30, 2017

 
  

Net Earnings/(Loss)

 

Percentage Interest

  

Net Book Value

 

Percentage Interest

  

Net Earnings/(Loss)

 

Percentage Interest

 

Total

 $20,518,000  100.0% $

3.59

  100.0% $

12,272,000

  100.0%

Mr. Hays interest in:

                     

Pre-Proposed Transaction

 $

8,380,000

 

40.8

% $

1.08

 

30.1

% $

5,012,000

 40.8%

Post-Proposed Transaction

 $

10,639,000

 

51.9

% $1.19 

33.1

% $6,363,000 

51.9

%

The Proposed Transaction will also result in an increase in the relative voting power of Mr. Hays compared to the remaining holders of class A common stock following the Proposed Transaction, as shown in the following table:

Pre-Proposed Transaction Voting Power

Post-Proposed Transaction Voting Power

Mr. Hays

     53,890 A votes

1,973,205 B votes

54.1%

     57,607 A votes

1,764,560 B votes

92.3%

Other shareholders

   155,538 A votes

1,567,039 B votes

45.9%

151,821 A votes

           - B votes

7.7%

Please see the section entitled “Additional Information Regarding the Proposed Transaction – Special Interests of the Affiliated Persons” for further discussion of interests in the Proposed Transaction that certain affiliated persons have that are in addition to, or different from, our shareholders generally.

Additionally, following the Proposed Transaction Mr. Hays will be deprived of the ability to dispose of shares of class B common stock pursuant to Rule 144 under the Securities Act of 1933, as amended (the “Securities Act”). Because the class B common stock will no longer be quoted on Nasdaq after giving effect to the Proposed Transaction, trades in such shares would only be possible through privately negotiated transactions. Accordingly, following the Proposed Transaction Mr. Hays is expected to face an illiquid market for his class B common stock.


Strategic Alternatives Considered By the Board

In making the determination to proceed with the Proposed Transaction, the Board evaluated other strategic alternatives. As discussed below, the Board ultimately rejected the alternatives to the Proposed Transaction because the Board believed that the Proposed Transaction would be the fairest, simplest and most cost-efficient approach to address shareholder concerns surrounding our dual class common stock structure. The Board considered the following alternative strategies:

Convert One Class of Common Stock into the Other Class

The Board originally considered converting one class of the Company’s common stock into the other class of common stock. This alternative was quickly dismissed, however, since Nasdaq, when approving the 2013 Recapitalization under its “voting rights rule,” expressly provided that one class of the Company’s common stock could not be converted into the other class of common stock.

Sale of the Company

The Board briefly considered a sale of the Company. This alternative was dismissed after Mr. Hays stated that he, as well as the Grandchildren’s Trust and other family affiliates, would not participate in, or vote in favor of, a sale transaction. Moreover, the disparate trading prices of the class A common stock and class B common stock, along with the “equal status” provision under our Articles, created hurdles to any sale transaction.

Complete Going Private Transaction of Both Class A Common Stock and Class B Common Stock

The Board considered both a negotiated transaction and a tender offer as part of a complete “going private” transaction subject to Rule 13e-3 of the Exchange Act. In addition to potential issues with transaction structure, such as uncertain and unpredictable results of either undertaking, both potential transactions would be considerably more expensive than the Proposed Transaction and, if attempted, would burden the Company with a highly leveraged capital structure that could negatively impact future performance and impair our operational flexibility. In addition, Mr. Hays informed the Board that he, as well as the Grandchildren’s Trust and other family affiliates, would not support a sale of control, a private equity investment or a highly leveraged capital structure.

Tender Offer for all Shares of Class B Common Stock (with Mr. Hays Agreeing to Sit-out)

The Board considered an issuer tender offer (either a fixed price or a “dutch auction”) to repurchase shares of our outstanding class B common stock, other than those shares held by Mr. Hays. The results of an issuer tender offer would be unpredictable, however, due to its voluntary nature. The Board was uncertain as to whether this alternative would result in shares being tendered by a sufficient number of record shareholders so as to permit the Company to delist and deregister the class B common stock. In addition, even if the class B common stock could be delisted and deregistered, the Board determined it was not in the Company’s best interests to leave unaffiliated holders of class B common stock who chose not to tender pursuant to the tender offer with no market for the class B common stock following the completion of any such tender offer.

Cash-Out of All Class A Common Stock or Class B Common Stock

The Board considered a cash-out of all class A common stock outstanding or, alternatively, all class B common stock outstanding, in a transaction with a similar structure to the Proposed Transaction. As with other potential alternatives, the Board was concerned that either alternative would be considerably more expensive than the Proposed Transaction and, if attempted, would burden the Company with a highly leveraged capital structure that could negatively impact future performance and impair operational flexibility.


Continuing As-Is

The Board considered taking no action to address the shareholder concerns over the dual class common stock structure. However, given the recent trading price behavior of the class A common stock and class B common stock and the access to favorable financing terms (see the section entitled “Additional Information Regarding the Proposed Transaction – Source and Amount of Funds and Expenses for more information on the proposed Credit Facilities with which we expect to fund the costs of the Proposed Transaction), the Board believed that the current conditions presented an opportunity to address shareholder concerns and provide the holders of class B common stock with a favorable liquidity event.

How the Board Will Determine Whether to Effect the Proposed Transaction

The shareholders will consider and vote on the Reverse Split and the Forward Split. If the shareholders approve each of the stock splits, then the Board, at its discretion, may elect to either effect or abandon the Proposed Transaction. If the Board elects to abandon the Proposed Transaction, then no funds will be paid to cash out fractional shares of the class B common stock and the total transaction costs will consist solely of the expenses incurred to that date in Officeconnection with the Proposed Transaction. These expenses are estimated at approximately $1.175 million. A number of factors or situations could cause the Board to decide to abandon the Proposed Transaction, even if approved by the shareholders. These factors or situations include:

The Board may decide to abandon or delay the Proposed Transaction if the economic conditions or the financial condition of the Company, or their outlook, at the time the Proposed Transaction is to be effected are such that in the judgment of the Board it is no longer advisable to use the Company’s cash resources or incur debt to effect the Proposed Transaction.

In the event the Company has insufficient cash and/or is unable to close on the Credit Facilities or otherwise secure debt on terms satisfactory to the Company necessary to complete the Proposed Transaction, the Board would abandon or postpone the Proposed Transaction.

In the event the Board determines that it is in the Company’s best interest to enter into a strategic transaction that may arise in the future, such as an asset or stock sale or a business combination transaction, the Board may elect to abandon the Proposed Transaction as a result of such strategic transaction.

Please see the information under the sections entitled “Proposals – Reverse Split and Forward Split” and “Special Factors —Effects of the Proposed Transaction” for a discussion of what will occur if the Board decides to proceed with the Proposed Transaction.

Immediately following the Special Meeting, the Board intends to decide whether to effect the Proposed Transaction or to abandon or delay it. If the Board decides to effect the Proposed Transaction, we expect that management, at the discretion of the Board, will effect the Proposed Transaction on the date of the Special Meeting or soon as reasonably practicable thereafter by filing Articles of Amendment to our Articles (one amendment effecting the Reverse Split and a second amendment effecting the Forward Split) with the State of Wisconsin.


Fairness of the Proposed Transaction

The Board has fully reviewed and considered the terms, purpose, alternatives and effects of the Proposed Transaction and has determined that the Proposed Transaction is in the best interests of the Company and all of our shareholders, including those being cashed out pursuant to the terms of the Proposed Transaction, and is substantively and procedurally fair to the affiliated and unaffiliated shareholders of the Company, including the holders of our class A common stock, the holders of class B common stock who will receive cash in lieu of fractional shares and Mr. Hays, who will remain as the sole class B common stock shareholder of the Company following the Proposed Transaction. After studying the Proposed Transaction and its anticipated effects on our shareholders, the Board unanimously approved the Proposed Transaction and deemed it procedurally and substantively fair to all of the Company’s affiliated and unaffiliated shareholders and to the Company.

Fairness of the Substance of the Proposed Transaction

In determining the fairness of the Proposed Transaction, the Board considered the factors discussed below, in addition to the strategic alternatives discussed above in the section entitled “— Strategic Alternatives Considered By the Board.” The Board believes that the Proposed Transaction is substantively fair to the Company’s unaffiliated shareholders in light of these factors. The Board did not assign specific weight to the factors set forth below in a formulaic fashion, and except as described below, the factors below are not subject to quantification. Moreover, in its consideration, individual directors may have given differing weights to different factors. However, the Board did place special emphasis on eliminating confusion in the public market surrounding our dual class common stock structure, responding to shareholder concerns regarding the dual class common stock structure and providing and/or increasing liquidity for our shareholders, as described in the section entitled “—Reasons for the Proposed Transaction.” The discussion below is not meant to be exhaustive, but the Company believes it includes the material factors considered by the Board in reaching their determinations.

Material Factors Considered by the Board

 

Terms expiringAddress Shareholder Concerns and Reduce or Eliminate Confusion Regarding Dual Class Common Stock Structure. If the Proposed Transaction is completed, we expect shareholder concerns and market confusion regarding the dual class common stock structure of the Company will be reduced or eliminated. Please see the sections above entitled “— Purpose of the Proposed Transaction” and “— Reasons for the Proposed Transaction.”

Opportunity to Provide a Liquidity Event for Class B Common Stock. The Board considered the opportunity for the holders of the Company’s class B common stock to have a liquidity event while the class B common stock is at or near an all-time high, without paying any brokerage or service fees, commissions or other fees. In turn, holders of our class B common stock who receive a cash payment for their class B common stock pursuant to the Reverse Split will have the opportunity to use the cash received to invest, subject to availability, in our class A common stock, which will remain listed with Nasdaq. The Board did not quantify the consideration of brokerage and service fees, commissions and other fees paid for a share purchase or saved by the Proposed Transaction since such fees vary significantly depending upon the method used to acquire or dispose of shares. Please see the section entitled “— Reasons for the Proposed Transaction” for more information.

Current and Historical Market Prices. The Board considered recent and historical trading prices of the Company’s class B common stock. The class B common stock has traded on Nasdaq since May 24, 2013 and this market has represented the principal outlet for shareholders who wished to dispose of shares of class B common stock. The Board viewed Nasdaq as a good indicator of what a willing buyer would pay to a willing seller, neither one of whom is under any compulsion to buy or sell, after considering such factors as their estimate of the Company’s value as a whole, its earnings and performance history, its prospects, the prospects of the industry as a whole, an assessment of the control parties and management of the Company, and other factors that typically bear on a common stock purchase or sale decision. Accordingly, the Board determined that a Cash-Out Price based on the historical trading prices of the Company’s class B common stock would be the most accurate method of determining the fair value of shares of class B common stock being cashed out in the Proposed Transaction. In determining the Cash-Out Price based on historical trading prices in the class B common stock, the Board determined that either the volume weighted average price of the class B common stock on a specified date or, in light of the limited trading market of the class B common stock (as described in the section entitled “— Reasons for the Proposed Transaction”), a volume weighted average trading price of the class B common stock over a recent period of time would most accurately represent the current value of the class B common stock. Accordingly, the Board determined to calculate the Cash-Out Price as a price equal to the greater of (i) the volume weighted average price of the class B common stock on the trading day immediately preceding the announcement of the Proposed Transaction and (ii) the volume weighted average price of the class B common stock during the 20 trading days immediately preceding the announcement of the Proposed Transaction. The Board determined that a Cash-Out Price of $53.44 was a fair price for the class B common stock being cashed out in the Proposed Transaction in light of the factors considered by the Board as described herein.


Liquidity of Class B Common Stock and Class A Common StockThe Board discussed the lack of an active trading market for the class B common stock and, to a lesser extent, the class A common stock. Since our shareholders are not currently able to trade their class B common stock in a liquid market, the Board considered the ability to offer holders of our class B common stock, other than Mr. Hays, with a cost-effective liquidity event (without experiencing any negative impact of illiquidity on the market price) to be an additional indication of fairness to the holders of class B common stock to be cashed out. In turn, the Board believes class A common stock shareholders will, over time, experience increased liquidity and diversification of ownership as a result of the Proposed Transaction (and class B common stock shareholders who are cashed out will have the opportunity to invest, subject to availability, in class A common stock if they desire). Please see the section above entitled “— Reasons for the Proposed Transaction” for more information.

Class A Common Stock Earnings Per Share Accretion. By cashing out holders of fewer than 1,764,560 shares of class B common stock, we expect that holders of class A common stock, which will remain publicly traded, will experience substantial accretion to earnings per share in their holdings of our class A common stock. Furthermore, holders of the class A common stock will experience a greater percentage of participation in any future dividends, as compared to the Company’s current dual class common stock structure. Please see the section above entitled “— Reasons for the Proposed Transaction” for more information.

Moderate Debt Burden While Maintaining Flexibility For Future Growth. Given that every holder of our class B common stock, other than Mr. Hays, will be cashed out as a result of the Reverse Split, the Company can address shareholder concerns with the dual class common stock structure while maintaining a moderately leveraged capital structure on favorable financing terms that allows the Company current and future flexibility to fund growth initiatives, continue with our current dividends and fund future business acquisitions and repurchases of class A common stock, all as the Board may determine. Please see the section above entitled “— Reasons for the Proposed Transaction” for more information.

Dividend Savings. The Board also considered that the Company would save approximately $4.26 million in dividend costs per year (assuming the current dividend rates remain constant) as a result of the reduction in the number of shares of class B common stock outstanding after consummation of the Proposed Transaction. Please see the sections above entitled “— Purpose of the Proposed Transaction” and “— Reasons for the Proposed Transaction.

Equal Treatment of Affiliated and Unaffiliated Holders of Less Than 1,764,560 Shares ofClass B Common StockThe Proposed Transaction will not affect holders of class B common stock differently on the basis of affiliate status. The sole determining factor in whether a shareholder will be cashed out or will continue as a holder of class B common stock as a result of the Proposed Transaction is the number of shares of class B common stock held by the shareholder immediately prior to the Proposed Transaction. As a result of the Proposed Transaction, we expect Mr. Hays to be the sole remaining holder of our class B common stock. Structuring the Proposed Transaction in this manner allowed us to address shareholder concerns with our dual class common structure while maintaining a moderate debt burden as a result of the Proposed Transaction. The Board viewed the exclusion of Mr. Hays’ shares of class B common stock from the Proposed Transaction as having offsetting benefits and detriments for Mr. Hays. While as result of such exclusion, Mr. Hays will continue to participate in any growth in value through class B common stock, such class B common stock held following the Proposed Transaction will continue to be subject to the “equal status” provision of our Articles, essentially capping the value per share of the class B common stock in any distribution of property, merger, consolidation, purchase or acquisition of property or stock, asset transfer, division, share exchange, recapitalization, reorganization, or similar corporate transaction at the 2018value per share received by holders of class A common stock. Similarly, while Mr. Hays will experience a relative increase in voting power of combined class A common stock and class B common stock due to his continued holdings of class B common stock, Mr. Hays already was able to exercise a controlling influence over our business and the power to elect our directors due to his existing holdings of class A common stock and class B common stock.


Possible Disadvantages of Effecting the Proposed Transaction

The Board also considered the following possible disadvantages of effecting the Proposed Transaction:

Cashed Out Holders of Class B Common Stock will not Participate in Future Increases in the Value of the Company Stock or Payments of Dividends. Following the Proposed Transaction, cashed out holders of class B common stock will have no further financial interest in the Company and will not have the opportunity to participate in the potential appreciation in the value of, or the payment of dividends on, the class B common stock. Further, such holders of our class B common stock will be required to involuntarily surrender their shares in exchange for cash, rather than at a time and for a price of their choosing. The Board also considered the fact that the Proposed Transaction may be taxable for cashed out holders of our class B common stock. However, holders of our class B common stock who will be cashed out in the Proposed Transaction will have the opportunity to invest, subject to availability, in our class A common stock, which will remain publicly traded following the Proposed Transaction and participate in the potential appreciation in the value of, or the payment of dividends on, the class A common stock. Please see the section above entitled “— Reasons for the Proposed Transaction” for more information.

Reduced Cash on Hand and Increased Level of IndebtednessThe Company estimates that the cost of payment to holders of class B common stock who are cashed out in the Reverse Split, the cost of payment to the holders of options to purchase class B common stock and restricted shares of class B common stock who are being cashed out in connection with the Proposed Transaction, professional fees, transfer agent costs and other expenses of the Proposed Transaction will total approximately $102.175 million. As a result, immediately after the Proposed Transaction, the Company’s cash balances on hand will be reduced by approximately $31 million. Further, our increased level of indebtedness as a result of entering into the Credit Facilities could adversely affect our financial condition and results of operations.

Mr. Hays Treated Unequally Under the Proposed Transaction. Mr. Hays, as the sole remaining holder of 1,764,560 or more shares of class B common stock prior to the Reverse Split will receive unequal treatment under the Proposed Transaction. Mr. Hays will not be entitled to receive any payment for his shares of class B common stock (other than the cash out of his class B common stock options) and will continue as a class B common stock shareholder of the Company. As a result, Mr. Hays will face an illiquid market for his class B common stock which will likely negatively affect the price of the class B common stock after the Proposed Transaction. However, the Proposed Transaction will also result in an increase in the relative voting power of Mr. Hays compared to the remaining holders of class A common stock, following the Proposed Transaction.


No Appraisal or Dissenters’ RightsUnder Wisconsin law, no appraisal or dissenters’ rights are available to shareholders in connection with the Proposed Transaction.

Valuation Methods Not Applicable to the Company

Although potentially relevant to a determination of fairness of the Proposed Transaction, the factors listed below, for the reasons given, were determined by the Board to not be applicable to the Company and were not considered or were not given any weight by the Board.

Net Book Value. The Board did not view net book value to be a reliable measure of fair value. Net book value is based on the historical cost of a company’s assets and does not take into account the value of a company if the company does not have the necessary access to capital and/or liquidity to continue to operate. In addition, the Board determined that net book value does not take into account the other considerations that might be part of the “willing buyer/willing seller” evaluation discussed above under the subsection “— Current and Historical Market Prices.”

Going Concern Valuation. An indicator of going concern value is the discounted future cash receipts approach, which uses future cash receipt projections and discounts them at a rate which incorporates both the time value of money and the uncertainty of future cash receipts to arrive at a present valuation estimate. Given the other considerations discussed herein, the Board did not pursue this approach due to the significance of the subjective assumptions that would be involved in such an approach, as well as the significant advisor, investment bank and financial modeling expenses associated with the approach.

Liquidation Value. The Board viewed the liquidation value of the Company to be an inappropriate measure for the purpose of evaluating the cash price to be paid for fractional shares. There is no present intention of liquidating the Company or selling a substantial portion of its assets in the near term. Further, the Proposed Transaction will only result in the termination of an equity interest by the class B common stock shareholders reduced to fractional shares as a result of the Proposed Transaction. A liquidation process would also involve additional legal fees, costs of sale and other expenses that would reduce any amounts that shareholders might receive upon liquidation. Given these and the other factors considered by the Board as described in this proxy statement, the Board did not pursue a liquidation value approach.

Conclusion

The Board believes that all of the factors mentioned above, both favorable and unfavorable, when viewed together support a conclusion that the Proposed Transaction is substantively fair to all the Company shareholders, including the unaffiliated holders of our class B common stock cashed out as a result of the Reverse Split and continuing holders of our class A common stock and class B common stock following the Proposed Transaction. Based on the factors described above, the Board set the Cash-Out Price at $53.44.

Procedural Fairness

In addition to the fairness of the substance of the Proposed Transaction, the Board believes that the process by which decisions were made regarding the Proposed Transaction is fair to unaffiliated holders of our class B common stock, who will be cashed out pursuant to the Proposed Transaction, and to the continuing holders of our Common Stock following the effectiveness of the Proposed Transaction.

The Board noted that shareholders who are cashed out can invest, subject to availability, in shares of the Company’s class A common stock, which will remain listed on Nasdaq after the Effective Date of the Proposed Transaction.


No special committee composed of the independent members of the Board was formed to appraise or negotiate the Proposed Transaction. The independent members of the Board considered whether to form such a committee and concluded that there were already sufficient procedural safeguards so as to make such a committee unnecessary, including that the Board is comprised of well over a majority of independent directors (constituting four of the five directors). The independent directors who were involved in the deliberations and decisions regarding the Proposed Transaction include Donald M. Berwick, JoAnn M. Martin, Barbara J. Mowry and John N. Nunnelly. None of the independent directors are employees of the Company nor are they otherwise controlled by, or under common control with, the Company. Each is an experienced and knowledgeable business person and is deemed to be independent under the listing standards of Nasdaq, including the heightened standards for members of audit committees and compensation committees. With regard to shares of class B common stock beneficially owned by the independent directors, none of such directors have any agreement with the Company or Mr. Hays, as controlling shareholder, regarding such shares. In addition, each of the independent directors will be treated identically in the Proposed Transaction with (i) the unaffiliated shareholders of the Company in the Reverse Split, with respect to class B common stock currently held by such independent directors, and (ii) all Company associates who have options to purchase class B common stock or restricted shares of class B common stock which will, immediately prior to the Effective Date, vest in full and be paid out as if they were cashed out pursuant to the Reverse Split.

The independent directors did, however, meet six times without Mr. Hays being present to discuss the Proposed Transaction amongst themselves and with representatives of Foley, the Company’s outside corporate and securities counsel. They also discussed the Proposed Transaction with Mr. Hays (as the full Board) on numerous occasions since they comprised a majority of the Board, viewed Mr. Hays’ participation in, and contributions to, Board meetings to be valuable to their decision-making process and did not consider their collective or individual independence to be jeopardized in any respect. Based on the factors described above, the independent members of the Board concluded that they had the independence and experience to fairly represent the interests of the unaffiliated shareholders and had a sufficient opportunity to discuss and form their own conclusions as to the fairness of the Proposed Transaction without the necessity of forming a special committee. The independent members of the Board unanimously voted in favor of the Proposed Transaction on the terms and conditions described in this proxy statement.

The Company did not receive a report, opinion or appraisal from an outside party as to the fairness of the Proposed Transaction to holders of our class A common stock, holders of our class B common stock who will be cashed out as a result of the Proposed Transaction or Mr. Hays, who will remain as the sole holder of class B common stock following the Proposed Transaction, or as to the value of the class B common stock. The independent members of the Board concluded that there were already sufficient procedural safeguards without the expense of retaining an independent fairness advisor. As discussed in “—Background of the Proposed Transaction” above, the independent members of the Board did, however, retain Emory & Co. to assist them with exploring the possible alternatives for determining the fair value of the class B common stock to be cashed out in the Reverse Split.

No representative or advisor was retained by the independent members of the Board on behalf of the unaffiliated shareholders to prepare a fairness evaluation or otherwise appraise or negotiate the Proposed Transaction. The independent members of the Board concluded that there were already sufficient procedural safeguards without the expense of retaining an external representative or advisor to negotiate the Proposed Transaction, particularly since unaffiliated and affiliated shareholders would be treated the same in the Proposed Transaction.

The Board determined not to condition the approval of the Proposed Transaction on approval by a majority of our unaffiliated shareholders because the Board believed that any such vote would not provide meaningful additional protection to those unaffiliated shareholders. In addition, based on information available to us, as of the Record Date, approximately [●]% of our outstanding class B common stock is held by non-affiliates. The Board did not believe it was in our best interest or the best interest of our shareholders to incur the increased costs associated with allowing a minority of investors, voting alone, to make a determination with respect to the Proposed Transaction, and the Board was also concerned that if the Proposed Transaction were structured to require the approval of a majority of the unaffiliated shareholders, that shareholders representing disproportionately few shares could unduly influence the vote, especially if minority shareholder participation in the voting was minimal. Finally, the Board noted that the vote of a majority of unaffiliated shareholders was not required under Wisconsin law.


The Board has not granted unaffiliated shareholders access to our corporate files, except as required by Wisconsin law, nor has it extended the right to retain counsel or appraisal services at our expense. With respect to unaffiliated shareholders’ access to our corporate files, the Board believes that this proxy statement, together with our other filings with the SEC, provide adequate information for unaffiliated shareholders. The Board also considered the fact that under Wisconsin law, and subject to specified conditions set forth under Wisconsin law, shareholders have the right to review our relevant books and records of account.

ADDITIONAL INFORMATION REGARDING THE PROPOSED TRANSACTION

Special Interests of the Affiliated Persons

In considering the recommendation of the Board with respect to the Proposed Transaction, shareholders should be aware that the Company’s executive officers and directors, including Michael D. Hays, its founder, controlling shareholder, chief executive officer and a director, have interests in the Proposed Transaction that are in addition to, or different from, the shareholders generally. These interests may create potential conflicts of interest and include the following:

Mr. Hays holds 1,973,205 shares of the Company’s class B common stock as of the Record Date and will, after the Swap with the Grandchildren’s Trust and immediately before consummation of the Reverse Split, hold 1,764,560 shares of class B common stock. Mr. Hays will be the only shareholder to retain shares of class B common stock after giving effect to the Proposed Transaction.

Mr. Hays will increase his percentage ownership interest in the Company and his total voting power because an estimated 1,775,684 shares of the outstanding class B common stock will be retired as a result of the Proposed Transaction. For example, assuming the Proposed Transaction is implemented and based on information and estimates of record ownership, shares outstanding and other ownership information and assumptions as of the Record Date, Mr. Hays’ beneficial ownership percentage will increase from approximately 30% to approximately 33% and Mr. Hays’ voting power will increase from approximately 54% to approximately 92%.

Mr. Hays has had a role in electing to pursue the Proposed Transaction and structuring its terms.

Our directors and executive officers, as well as other Company associates (i.e., employees), will have their unvested stock options and/or restricted stock tied to the class B common stock vested immediately prior to the Effective Date of the Proposed Transaction and then will have all of their outstanding options to purchase class B common stock and restricted shares of class B common stock paid out as if they were cashed out pursuant to the Reverse Split. This is estimated to account for approximately $7.5 million of the total estimated costs of the Proposed Transaction.

The Grandchildren’s Trust, which was originally established by and received all of its shares of Common Stock from Mr. Hays, held approximately 28% of our class A common stock and 125,355 shares, or approximately 3.5%, of our class B common stock as of the Record Date. Prior to the Effective Date of the Proposed Transaction, Mr. Hays and the Grandchildren’s Trust will effect the Swap, which will result in the Grandchildren’s Trust receiving a larger payment from the Company in the Reverse Split since it will own 208,645 more shares of class B common stock after the Swap that will be cashed out pursuant to the Reverse Split.


Mr. Hays, our other executive officers and directors and the Grandchildren’s Trust have indicated to the Company that they will vote all of their shares of Common Stock in favor of the Proposed Transaction. Accordingly, the Proposed Transaction is expected to be approved.

Shareholder Approval

Under Wisconsin law and the Company’s Articles, the following three “voting groups” must approve both the Reverse Split and the Forward Split: (1) the holders of the class A common stock and the class B common stock, voting together as a single class; (2) the holders of the class A common stock, voting separately as an independent voting group; and (3) the holders of the class B common stock, voting separately as an independent voting group.

Assuming a quorum of each voting group is present at the Special Meeting, the number of votes cast within each voting group for approval of each of the Reverse Split and the Forward Split must exceed the number of votes cast against it. The Reverse Split is conditioned upon the approval by the Company’s shareholders of the Forward Split, and vice versa. If the shareholders do not approve either the Reverse Split or the Forward Split, then the Proposed Transaction will fail and will not be consummated, even if one of the two stock splits received enough votes to pass independently.

As a result of his stock holdings, Mr. Hays has the power to approve, on behalf of both (i) the holders of the class B common stock and (ii) the holders of the class A and class B common stock, voting together as a single class, both the Reverse Split and the Forward Split, without the affirmative vote of any other shareholder. In addition, Mr. Hays and the Grandchildren’s Trust, as a result of their collective stock holdings, have the power to approve, on behalf of the holders of the class A common stock, both the Reverse Split and the Forward Split, without the affirmative vote of any other shareholder. Mr. Hays and the Grandchildren’s Trust have indicated to us that they intend to vote “FOR” both the Reverse Split and the Forward Split. Accordingly, we expect the Proposed Transaction to be approved.

Effective Date

The Proposed Transaction will become effective as of the date that the State of Wisconsin accepts for filing Articles of Amendment to our Articles (one amendment effecting the Reverse Split and a second amendment effecting the Forward Split), or on any later date that we may specify in the Articles of Amendment to our Articles. We intend to effect the Proposed Transaction through the filing of such Articles of Amendment on the day the Proposed Transaction is approved by our shareholders or as soon as practicable thereafter.

On or following the Effective Date, Nasdaq will file a Form 25 with the SEC, and we will file a Form 15 with the SEC, in each case to terminate the registration of the class B common stock under the Exchange Act and to delist our class B common stock from trading on Nasdaq.

The Company’s class A common stock will continue to be registered with the SEC under the Exchange Act and continue to be traded on Nasdaq following the consummation of the Proposed Transaction. Accordingly, the Company will continue to be subject to the filing of periodic reports and other documents under the Exchange Act, just as it is today.


Payment for Fractional Shares 

The Company’s transfer agent, American Stock Transfer & Trust Company (the “Transfer Agent”), will act as the Company’s agent for purposes of paying for fractional shares of class B common stock in connection with the Proposed Transaction.

Shareholders owning less than 1,764,560 shares of class B common stock at the Effective Date will receive $53.44 in cash, without interest, for each share of class B common stock owned by such holder immediately prior to the Reverse Split. Mr. Hays is the only shareholder of the Company who is expected to own 1,764,560 or more shares of class B common stock at the Effective Date and, therefore, will not receive any cash as a result of the Reverse Split. The Forward Split that will immediately follow the Reverse Split will reconvert Mr. Hays’ shares of class B common stock back into the same number of shares of class B common stock he held immediately before the Effective Date. As a result, the total number of shares of class B common stock held by Mr. Hays will not change after completion of the Proposed Transaction.

Shareholders owning less than 1,764,560 shares of class B common stock at the Effective Date who hold their shares in certificated form will receive a letter of transmittal as soon as practicable after the Proposed Transaction is consummated with instructions on how to surrender existing certificates in exchange for cash payment. As soon as practicable after the Transfer Agent receives surrendered certificates from any such shareholder, together with a duly completed and executed letter of transmittal with respect thereto, and such other documents as the Company may require, the Transfer Agent will deliver to such shareholder cash in an amount equal to $53.44 in cash, without interest, for each share of class B common stock owned by such holder immediately prior to the Reverse Split. Shareholders owning less than 1,764,560 shares of class B common stock at the Effective Date who hold their shares electronically in book-entry form with the Transfer Agent do not need to take any action to receive $53.44 in cash, without interest, for each share of class B common stock owned by such holder immediately prior to the Reverse Split.    The Transfer Agent will deliver to such shareholders cash in an amount equal to $53.44 in cash, without interest, for each share of class B common stock owned by such holder immediately prior to the Reverse Split.

For purposes of determining ownership of shares of class B common stock on the Effective Date, such shares will be considered held by the person in whose name such shares are registered on the records of the Company or, in the case of shares held by a broker, bank or other third party (“Participants”) in “street name” on behalf of its client, in the name of the person whose account such shares are held in by such Participants on the Effective Date, regardless of the beneficial ownership of those shares. Upon effecting the Proposed Transaction, the Company intends to treat shareholders holding class B common stock in “street name” in the same manner as registered shareholders whose shares are registered in their names. Prior to the Effective Date, the Company will conduct an inquiry of all the Participants that hold shares of class B common stock in “street name.” These Participants will be instructed to effect the Proposed Transaction for their beneficial holders holding class B common stock in “street name.” These Participants will provide the Company with information on how many fractional shares will be cashed out.

Unavailability of Appraisal or Dissenters’ Rights

No appraisal or dissenters’ rights are available under Wisconsin law to holders of class A common stock or class B common stock in connection with the Proposed Transaction.


Source and Amount of Funds and Expenses

Based on estimates of the record ownership of our class B common stock, the expected number of shares of our class B common stock outstanding, the expected number of outstanding stock options and restricted shares tied to our class B common stock, and other information as of the Record Date, and assuming that approximately 1,775,684 shares of our class B common stock (before giving effect to the Reverse Split) are cashed out pursuant to the Proposed Transaction, we estimate that the total funds required to consummate the Proposed Transaction, including expenses, will be approximately $102.175 million. Approximately $101 million of this amount will be used to pay the consideration to holders of class B common stock entitled to receive cash for their fractional shares in the Reverse Split and to cash out the holders of outstanding options to purchase class B common stock and restricted shares of class B common stock in connection with the Proposed Transaction, and approximately $1.175 million will be used to pay the costs of the Proposed Transaction:

Cash Consideration to Holders of class B common stock (including holders of outstanding options to purchase class B common stock and restricted shares of class B common stock)

 $101,000,000 

Legal fees

 $500,000 

Accounting fees

 $175,000 

Advisor fees

 $50,000 

Printing, solicitation, mailing, transfer agent, exchange agent, and related costs

 $30,000 

SEC and Nasdaq fees

 $30,000 

Miscellaneous fees and expenses

 $190,000 

Bank fees and expenses

 $200,000 

Total Estimated Costs and Expenses

 $102,175,000 

The expected costs described above include approximately $538,000 of fees and expenses incurred by Mr. Hays in connection with exploring strategic alternatives, including the Proposed Transaction, for which we have reimbursed Mr. Hays.

Final costs of the Proposed Transaction may be more or less than the estimates shown above. We expect to pay the costs of the Proposed Transaction, including the amounts to be paid to holders of class B common stock for their fractional shares and payments to cash out outstanding options to purchase class B common stock and restricted shares of class B common stock, from cash on hand and through borrowings under the Term Loan. However, we do not currently have any definitive agreements with FNB to loan funds to us to fund the costs of the Proposed Transaction. Accordingly, any loans by FNB to fund the costs of the Proposed Transaction will be subject to the negotiation and execution by us and FNB of appropriate definitive agreements. We do not currently have any alternative financing arrangement or alternative financing plans in the event borrowings from FNB are not available. Should we enter into definitive documentation with FNB to borrow funds to fund the costs of the Proposed Transaction, we intend to make repayments under each of the proposed Credit Facilities in the normal course of business from ordinary cash flow generated from operations.

On September 18, 2017, we entered into the Commitment Letter with FNB, which expires on December 29, 2017, to provide (i) a Term Loan of $70 million, (ii) a Delayed Draw Term Loan facility of $20 million, and (iii) a Line of Credit in an amount equal to $10 million, in each case subject to the terms and conditions set forth in the Commitment Letter. Should we enter into definitive documentation relating to the Credit Facilities with FNB, we will use (A) the Term Loan to fund, in part, the Reverse Split, the cashing out of outstanding stock options and restricted shares tied to the class B common stock and the costs of the Proposed Transaction, (B) the Delayed Draw Term Loan, if used, is designated to fund any future business acquisitions or repurchasing of class A common stock (we do not presently have plans for any acquisitions or class A common stock repurchases) and (C) the Line of Credit to fund ongoing working capital needs and for other general corporate purposes. Under the proposed terms of the Credit Facilities, we will be the borrower under the Term Loan, the Delayed Draw Term Loan (if any), and the Line of Credit. The following is a description of the anticipated terms of the Credit Facilities, although the final terms of definitive documentation may be different from those set forth below.


Principal, interest rate, and fees

Principal and accrued interest amounts outstanding under the Term Loan are due and payable monthly during the term of the Term Loan, which shall expire on the fifth anniversary of the closing date of the Term Loan. The Term Loan will bear interest at a fixed rate of the five (5) year London Interbank Offered Rate (“LIBOR”) swap index rate plus a spread (i.e., as of September 13, 2017, this fixed rate would have been 4.16%).

In the event that the Delayed Draw Term Loan is used, interest only payments will be due through the calendar year in which the Delayed Draw Term Loan is drawn upon. After that, amortization will occur at the then current Term Loan rate and schedule with principal and accrued interest amounts outstanding under the Delayed Draw Term Loan due and payable monthly during the term of the Delayed Draw Term Loan, which shall expire on the fifth anniversary of the closing date of the Term Loan. The Delayed Draw Term Loan (if drawn upon) will bear interest at a floating rate equal to the thirty (30) day LIBOR index, plus 225 basis points.

Principal amounts outstanding under the Line of Credit are due and payable in full at maturity, which shall be the third anniversary of the closing date of the Line of Credit. The Line of Credit will bear interest (which shall accrue and be due on a monthly basis during the term of the Line of Credit) at a floating rate equal to the thirty (30) day LIBOR index, plus 225 basis points.

In addition to paying interest on outstanding principal under the Credit Facilities, we will be required to pay at the closing of the Credit Facilities a one-time fee equal to 0.25% of the amount borrowed under the Term Loan. We will also be obligated to pay ongoing unused commitment fees quarterly in arrears pursuant to the Line of Credit and the Delayed Draw Term Loan facility at a rate of 0.20% per annum based on the actual daily unused portions of the Line of Credit and the Delayed Draw Term Loan facility, respectively.

Guarantee and security

All obligations under the Credit Facilities will be guaranteed by each of our direct and indirect active, wholly owned, material domestic subsidiaries, as determined by FNB in its reasonable discretion (each, a “guarantor”).

The Credit Facilities will each be secured, subject to permitted liens and other agreed upon exceptions, by a first-priority lien on and perfected security interest in substantially all of our and the guarantors’ present and future assets (including, without limitation, fee-owned real property, and limited, in the case of the equity interests of foreign subsidiaries, to 65% of the outstanding equity interests of such subsidiaries).

Certain covenants and other terms

The Credit Facilities will contain customary representations and warranties and customary events of default. The Credit Facilities will also contain certain affirmative and negative covenants, including, but not limited to, restrictions, subject to certain exceptions, on our ability to:

create, incur, assume, or permit to exist any additional indebtedness;

effect repurchases of class A common stock in excess of certain maximum allowances;

enter into certain acquisition transactions;

create, incur, assume, or permit to exist any liens upon any assets;

enter into any transactions the effect of which would be a change of control;

purchase, make, incur, assume, or permit to exist any investment, loan, or advance to or in any other person; and

enter into any transactions with affiliates.


The Credit Facilities will also contain certain financial covenants with respect to minimum fixed charge coverage ratio and maximum cash flow leverage ratio. Pursuant to the Credit Facilities, we will be required to maintain a minimum fixed charge coverage ratio of 1.10x for all testing periods throughout the term(s) of the Credit Facilities. The Commitment Letter defines “fixed charge coverage ratio” as follows: free cash flow (pre-tax net income plus interest plus depreciation plus amortization plus non-cash compensation expense minus distributions/dividends (subject to certain permitted stock repurchase exclusions) minus cash tax expense minus unfinanced capital expenditures (subject to certain permitted acquisition exclusions)) divided by contractual minimum debt service (contractual principal and interest loan payments plus contractual capital lease payments). Pursuant to the Credit Facilities, we will also be required to maintain a cash flow leverage ratio of 3.00x or less for all testing periods throughout the term(s) of the Credit Facilities. The Commitment Letter defines “cash flow leverage” as follows: funded senior debt (total outstanding principal balances on all loans less contractually subordinated debt plus outstanding capital lease obligations) divided by earnings before interest, taxes, depreciation, and amortization (pre-tax net income plus interest plus depreciation plus amortization plus non-cash compensation expense).

Conditions to closing and FNB’s funding of the proposed Credit Facilities include, without limitation: (i) definitive documentation in respect of the Proposed Transaction in a form acceptable to FNB and consummation of the Proposed Transaction substantially concurrently with initial borrowings under the Term Loan, (ii) the execution and delivery by the applicable parties (including FNB, the Company, and the guarantors) of definitive agreements with respect to the Credit Facilities and other credit documentation, in each case consistent with the terms provided in the Commitment Letter, (iii) receipt by FNB of satisfactory documentation and information about us and our subsidiaries, sufficient for FNB to complete its diligence process, (iv) the payment of fees and expenses due to FNB under the terms of the Commitment Letter required to be paid on the closing date of the Credit Facilities, (v) the absence of any “Material Adverse Effect,” as such term is defined in the Commitment Letter, and (vi) the Company migrating and maintaining its primary banking relationship with FNB post-closing.

Material U.S. Federal Income Tax Consequences

For purposes of this discussion, a “U.S. Holder” means, for United States federal income tax purposes, an individual who is a citizen or resident alien of the U.S., a corporation or other entity taxable for U.S. federal income tax purposes as a corporation created or organized in or under the laws of the U.S., any state thereof or the District of Columbia, or an estate or trust treated as a U.S. person under Section 7701(a)(30) of the Internal Revenue Code of 1986, as amended (the “Code”). This summary is limited to U.S. persons that hold our class B common stock as capital assets within the meaning of Section 1221 of the Code for federal income tax purposes (generally, assets held for investment).

The discussion is based upon the Code and regulations, rulings, judicial decisions, and administrative pronouncements and interpretations thereunder as of the date of this proxy statement. These authorities may be repealed, revoked or modified, perhaps with retroactive effect, so as to produce U.S. federal income tax consequences different from those discussed below. No ruling has been or will be sought from the Internal Revenue Service regarding the income or other tax consequences of the Proposed Transaction, and no assurance can be given that the Internal Revenue Service will not challenge the conclusions stated below or will not assert, or that a court will not sustain, a position contrary to any of the income tax consequences described below.


This summary does not purport to be a complete analysis of all of the potential U.S. federal income tax effects and does not address all of the tax consequences that may be relevant to a particular shareholder in light of his, her or its individual circumstances. Without limiting the generality of the foregoing, this summary does not address the effect of any special rules applicable to certain types of holders, including, without limitation, financial institutions, regulated investment companies, mutual funds, retirement plans, tax-exempt organizations, insurance companies, dealers or traders in securities, holders that received their stock pursuant to the exercise of employee stock options or otherwise as compensation, holders who hold their stock as part of a hedge, straddle, conversion, constructive sale, or other arrangement involving more than one position or other risk reduction, or other integrated transaction, non-U.S. holders, holders who functional currency is not the U.S. dollar, or investors in pass-through entities and the applicable pass-through entity, including a partnership or other entity or arrangement treated as a partnership for U.S. federal income tax purposes and Subchapter S corporations.

This summary is of a general nature and is included herein solely for information purposes. This summary is not intended to be, and should not be construed to be, legal or tax advice. Because U.S. tax consequences may differ from one holder to the next, the discussion set out below does not purport to describe all of the tax considerations that may be relevant to you and your particular situation. Accordingly, you are advised to consult your own tax advisor as to the U.S. federal, state, local and other tax consequences of the Proposed Transaction. The statements of U.S. tax law set out below are based on the laws and interpretations in force as of the date of this proxy statement, and are subject to any changes occurring after that date. Any statement herein regarding any U.S. federal tax is not intended or written to be used, and cannot be used, by any taxpayer for the purpose of avoiding any penalties that may be imposed under the Code. You should seek advice based on your particular circumstances from an independent tax advisor.

Tax Consequences of Proposed Transaction to a U.S. Holder

The following is a summary of material U.S. federal income tax consequences of the Proposed Transaction to the Company’s unaffiliated holders of our class B common stock who are U.S. Holders. A U.S. Holder’s receipt of cash in exchange for the fraction of a share of class B common stock resulting from the Reverse Split will be a taxable transaction to such holder for U.S. federal income tax purposes. If the receipt of cash qualifies as a sale or exchange of the U.S. Holder’s stock under Section 302 of the Code, the U.S. Holder generally should recognize gain or loss equal to the difference between the amount of cash received by such holder and such holder’s adjusted tax basis in the class B common stock exchanged in the Proposed Transaction. Any such gain or loss will constitute capital gain or loss and will be long-term capital gain or loss if the U.S. Holder has held the class B common stock for more than one year. In general, long-term capital gains of a non-corporate U.S. Holder are taxed at lower rates than those applicable to ordinary income. The deductibility of capital losses is subject to certain limitations.

The Proposed Transaction will generally be treated as a sale or exchange of such stock if the exchange (1) results in the complete redemption of the holder’s interest in the Company, (2) is “substantially disproportionate” with respect to such holder, or (3) is “not essentially equivalent to a dividend” under the specific facts and circumstances. The tests are not only applied to the stock owned directly by a holder, but also to the stock that the holder owns indirectly based on certain attribution rules under Section 318 of the Code. Under Section 318 of the Code, a U.S. Holder will generally be considered to own stock that is owned (and, in some cases, constructively owned) by some members of such holder’s family and by entities in which such holder, a member of such holder’s family, or a related entity has an interest.

Complete Termination. A U.S. Holder’s exchange of class B common stock for cash in the Proposed Transaction generally will result in a complete termination of such holder’s interest in the Company if, following the Proposed Transaction, (i) the holder no longer owns (directly or indirectly) any stock (including class A common stock) of the Company or (ii) the holder no longer directly owns any stock of the Company and is eligible to waive (and does in fact waive) constructive ownership of stock such holder is considered to own under Section 318 of the Code.


Substantial Disproportionate Redemption. A U.S. Holder’s exchange of class B common stock for cash in the Proposed Transaction generally will meet the “substantially disproportionate test” if, after the Proposed Transaction, (i) the holder owns (directly or indirectly) less than 50% of the voting power of the Company, and (ii) the ratio of voting stock owned (directly or indirectly) by the holder to all outstanding voting stock of the Company after the transaction is less than 80% of the ratio of voting stock owned (directly or indirectly) by the holder to all outstanding voting stock of the Company before the transaction.

Not Essentially Equivalent to a Dividend. For the Proposed Transaction to meet the “not essentially equivalent to a dividend test,” a U.S. Holder must experience a “meaningful reduction” in its proportionate interest in the Company as a result of the exchange, taking into account the constructive ownership rules described above. Whether a “meaningful reduction” takes place with respect to a particular holder depends on each holder’s individual facts and circumstances. In some instances, the Internal Revenue Service has ruled that even a small reduction in the proportionate interest of a minority stockholder in a publicly held corporation who exercises no control over the corporate affairs of the company may constitute a “meaningful reduction.” See, e.g., Rev. Rul. 76-385, 1976-2 C.B. 92.

Each U.S. Holder is urged to consult its own tax advisor as to the application of the Section 302 tests to such holder under its particular circumstances.

In 2013, the Company undertook the 2013 Recapitalization, which was a reclassification of its common stock into class A common stock and class B common stock. At the time, the Company stated it did not believe that either the class A common stock or class B common stock would constitute “Section 306 stock” within the meaning of Section 306(c) of the Code. The Company continues to believe that the class B common stock does not constitute “Section 306 stock.” However, if the class B common stock is determined to constitute Section 306 stock, a U.S. Holder may be deemed to realize ordinary income as opposed to capital gain as a result of the Proposed Transaction. The rules of Section 306 of the Code are complex, and each U.S. Holder is urged to consult its own tax advisor as to the application of Section 306 to such holder under its particular circumstances.

Backup Withholding and Information Reporting

In general, information reporting requirements will apply to cash received in the Proposed Transaction by a U.S. Holder. Additionally, backup withholding, currently at a rate of 28%, will apply to such payments if a U.S. Holder fails to furnish a taxpayer identification number, furnishes an incorrect taxpayer identification number, fails to report interest or dividends properly or otherwise fails to comply with applicable requirements of the backup withholding rules. Exempt recipients that are not subject to backup withholding and do not provide an IRS Form W-9 may nonetheless be treated as foreign payees subject to withholding under the Foreign Account Tax Compliance Act, and may be withheld upon at the 30% rate. Any amounts withheld under the backup withholding rules will be allowed as a credit against the U.S. Holder’s U.S. federal income tax liability and may entitle the U.S. Holder to a refund, provided that the required information is timely furnished to the Internal Revenue Service. The Company cannot refund amounts once they are withheld.

Escheat Laws

The unclaimed property and escheat laws of each state provide that, under circumstances defined in that state’s statutes, holders of unclaimed or abandoned property must surrender that property to the state. Persons whose shares of class B common stock are cashed out pursuant to the Reverse Split and whose addresses are unknown to us generally will have a period of years from the Effective Date in which to claim the cash payment payable to them. For example, with respect to class B common stock shareholders whose last known addresses are in Wisconsin, as shown by our records, the period is five years. Following the expiration of that five-year period, Wisconsin escheat laws would likely cause the cash payments to escheat to the State of Wisconsin. For class B common stock shareholders who reside in other states or whose last known addresses, as shown by our records, are in states other than Wisconsin, such states may have abandoned property laws which call for such state to obtain either (i) custodial possession of property that has been unclaimed until the owner reclaims it; or (ii) escheat of such property to the state. Under the laws of such other jurisdictions, the “holding period” or the time period which must elapse before the property is deemed to be abandoned may be shorter or longer than five years. If we do not have an address for the holder of record of the shares of class B common stock, then unclaimed cash-out payments would be turned over to our state of incorporation, the State of Wisconsin, in accordance with its escheat laws.


Accounting Treatment

We anticipate that we will account for the Proposed Transaction by treating the fractional shares of class B common stock repurchased as cancelled shares. The effective vesting of outstanding equity awards tied to the class B common stock will result in a nonrecurring charge to the income statement, with an increase to additional paid in capital. The repurchase of fractional shares of class B common stock in the Reverse Split, the cashing out of the outstanding equity awards tied to class B common stock and the retirement of treasury shares will result in a reduction to total shareholders’ equity. Additional borrowings to fund the Proposed Transaction will result in increased liabilities and decreased net income for increased interest expense, net of tax. Tax expense will decrease in the period of the Proposed Transaction due to the charges for share based compensation as well as the additional tax benefit for the excess of the payment price to settle the class B common stock equity awards over the original value of the awards. However, additional taxes will be incurred, resulting in a one-time decrease to net income for the repatriation of cash from our Canadian subsidiary. Earnings per share will increase as a result of there being fewer shares of our Common Stock outstanding after the Proposed Transaction.

Regulatory Approvals

The Company is not aware of any material governmental or regulatory approval required for the consummation of the Proposed Transaction, other than compliance with the applicable federal and state securities laws, Nasdaq rules and Wisconsin corporate laws.

MEETING AND VOTING INFORMATION

Time and Place

The Special Meeting will be held on [●], November [●], 2017 at [●], local time, at our corporate offices located at 1245 Q Street, Lincoln Nebraska 68508.

Who May Vote

Only holders of record of the Company’s class A common stock and class B common stock at the close of business on the Record Date (i.e., October [●], 2017) are entitled to vote at the Special Meeting. On that date, the Company had outstanding and entitled to vote: (a) [●] shares of class A common stock, each of which is entitled to one-one-hundredth (1/100th) of one vote per share, with an aggregate of [●] votes; and (b) [●] shares of class B common stock, each of which is entitled to one vote per share, with an aggregate of [●] votes.


Voting

If a broker, bank or other nominee holds your shares, you will receive instructions from them that you must follow in order to have your shares voted. If a bank, broker or other nominee holds your shares and you wish to attend the Special Meeting and vote in person, you must obtain a “legal proxy” from the record holder of the shares giving you the right to vote the shares.

If you hold your shares in your own name as a holder of record, you may instruct the proxy holders how to vote your shares of Common Stock by completing, signing and dating the enclosed proxy card where indicated and by mailing or otherwise returning the card to us before the Special Meeting. This proxy statement, including Appendix A and Appendix B hereto, the proxy card and any other proxy solicitations materials will be available on the Internet at https://www.rdgir.com/national-research-corporation. The proxy holders will vote your shares in accordance with your instructions. If you sign and return a proxy card without giving specific voting instructions, your shares will be voted ‘FOR” the Reverse Split and “FOR” the Forward Split. Of course, you may also choose to attend the meeting and vote your shares in person.

Revoking Your Voting Instructions to Your Proxy Holders

If you are a holder of record and you vote by proxy, you may later revoke your proxy instructions by:

sending a written statement to that effect to Kevin R. Karas, Secretary, National Research Corporation, 1245 Q Street, Lincoln, Nebraska 68508;

submitting a proxy card with a later date and signed as your name appears on the shareholder account; or

voting in person at the Special Meeting (although attendance at the meeting will not, by itself, revoke a proxy).

If a broker, bank or other nominee holds your shares and you vote by proxy, you may later revoke your proxy instructions by informing your broker, bank or other nominee in accordance with that entity’s procedures.

Voting Groups; Required Votes; Quorum; Abstentions; Broker Non-Votes

Under Wisconsin law and the Company’s Articles, the following three “voting groups” must approve both the Reverse Split and the Forward Split: (1) the holders of the class A common stock and the class B common stock, voting together as a single class; (2) the holders of the class A common stock, voting separately as an independent voting group; and (3) the holders of the class B common stock, voting separately as an independent voting group.

Assuming a quorum of each voting group is present at the Special Meeting, the number of votes cast within the voting group for approval of each of the Reverse Split and the Forward Split must exceed the number of votes cast against it. The Reverse Split is conditioned upon the approval by the Company’s shareholders of the Forward Split, and vice versa. If the shareholders do not approve either the Reverse Split or the Forward Split, then the Proposed Transaction will fail and will not be consummated, even if one of the two stock splits received enough votes to pass independently.

The presence of a majority of the votes entitled to be cast by each voting group constitutes a quorum for the purpose of transacting business at the Special Meeting.


Abstentions and broker non-votes will be counted as present in determining whether there is a quorum; however, they will not constitute a vote “for” or “against” each of the Reverse Split and the Forward Split and will be disregarded in the calculation of votes cast. A broker non-vote occurs when a broker submits a proxy card with respect to shares that the broker holds on behalf of another person but declines to vote on a particular matter, either because the broker elects not to exercise its discretionary authority to vote on the matter or does not have authority to vote on the matter.

INFORMATION ABOUT THE COMPANY

The Company is a leading provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers and other healthcare organizations. The Company’s solutions enable its clients to understand the voice of the customer with greater clarity, immediacy and depth. The Company’s heritage, proprietary methods, and holistic approach enable its partners to better understand the people they care for and design experiences that inspire loyalty and trust, while also facilitating regulatory compliance and the shift to population-based health management. The Company’s ability to measure what matters most and systematically capture, analyze and deliver insights based on self-reported information from patients, families and consumers is critical in today’s healthcare market. The Company believes that access to and analysis of its extensive consumer-driven information is becoming more valuable as healthcare providers increasingly need to more deeply understand and engage patients and consumers in an effort towards effective population-based health management.

The Company’s expertise includes the efficient capture, interpretation, transmittal and benchmarking of critical data elements from millions of healthcare consumers. Using its portfolio of solutions through internet-based business intelligence tools, the Company’s clients gain insights into what people think and feel about their organizations in real-time, allowing them to build on their strengths and resolve service issues with greater speed and personalization. The Company’s clients are also able to access networking groups, on-line education and an extensive library of performance improvement material that can be tailored to each of their unique needs.

The Company’s portfolio of subscription-based solutions provide actionable information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement. The Company partners with clients across the continuum of healthcare services. The Company’s clients range from integrated health systems and post-acute providers, such as home health, long term care and hospice, to numerous payer organizations. The Company believes this cross-continuum positioning is a unique and an increasingly important capability as evolving payment models drive healthcare providers and payers towards a more collaborative and integrated service model.

The Company has achieved a market leadership position through its more than 35 years of industry innovation and experience, as well as its long-term, recurring revenue relationships (solutions that are used or required by a client each year) with many of the healthcare industry’s largest organizations. Since its founding in 1981, the Company has focused on meeting the evolving information needs of the healthcare industry through internal product development, as well as select acquisitions.

The principal executive offices of the Company are located at 1245 Q Street, Lincoln, Nebraska 68508 and its telephone number is (402) 475-2525.


MARKET PRICE OF COMMON STOCK

Market Information

The Company’s class A common stock and class B common stock are traded on Nasdaq under the symbols “NRCIA” and “NRCIB,” respectively. The closing price of our class A common stock and class B common stock as of September 15, 2017 (the trading day prior to the announcement of the Proposed Transaction) was $34.25 and $53.42, respectively, and the closing price as of the Record Date was $[●] and $[●], respectively.

The following table sets forth the range of high and low sales prices for, and dividends declared on the class A common stock and class B common stock for the period from July 1, 2015, through June 30, 2017:

  

Class A

  

Class B

 
  

High

  

Low

  

Dividends

Declared Per

Common Share

  

High

  

Low

  

Dividends

Declared Per

Common Share

 

2015 Quarter Ended:

                        

September 30

 $15.21  $10.72  $0.06  $35.50  $27.54  $0.36 

December 31

 $17.42  $11.32  $0.44  $38.22  $31.88  $2.64 
                         

2016 Quarter Ended:

                        

March 31

 $16.10  $13.70  $0.08  $36.87  $32.99  $0.48 

June 30

 $16.67  $12.53  $0.08  $44.60  $33.19  $0.48 

September 30

 $17.14  $13.26  $0.08  $38.50  $32.18  $0.48 

December 31

 $20.00  $14.35  $0.10  $46.37  $32.57  $0.60 
                         

2017 Quarter Ended:

                        

March 31

 $20.92  $16.50  $0.10  $41.73  $38.76  $0.60 

June 30

 $28.75  $19.15  $0.10  $49.29  $39.00  $0.60 

The payment and amount of future dividends, if any, is at the discretion of the Board and will depend on the Company’s future earnings, financial condition, general business conditions, alternative uses of the Company’s earnings and other factors.

Shareholders

As of the Record Date, there were approximately [●] shareholders of record and approximately [●] beneficial owners of the class A common stock and approximately [●] shareholders of record and approximately [●] beneficial owners of the class B common stock.

Common Stock Repurchase Information

In February 2006, and as amended in connection with the 2013 Recapitalization (which created the two classes of Common Stock), the Board authorized the repurchase of 2,250,000 shares of class A common stock and 375,000 shares of class B common stock in the open market or in privately negotiated transactions. Unless terminated earlier by resolution of the Board, the repurchase program will expire when the Company has repurchased all shares authorized for repurchase thereunder. During the quarter ended September 30, 2015, the Company repurchased 111,549 shares of class A common stock for an average purchase price of $11.56 per share and between a range of $11.30 to $13.31, and repurchased 300 shares of class B common stock at a purchase price of $32.75 per share. Other than during the quarter ended September 30, 2015, the Company has not purchased any shares of either class A common stock or class B common stock during the last two years. The remaining shares that may be purchased under this authorization are 280,491 shares of class A common stock and 69,491 shares of class B common stock.


In connection with approving the Proposed Transaction, the Board further amended the foregoing stock repurchase authorization to provide that, immediately after the consummation of the Proposed Transaction, no shares of class B common stock shall be eligible to be repurchased.

Purchases/Sales of Class B Common Stock by Directors and Executive Officers

None of the directors or executive officers of the Company have engaged in any transaction in our class B common stock during the past 60 days. In connection with the Proposed Transaction, Mr. Hays and the Grandchildren’s Trust will effect the Swap.

FINANCIAL INFORMATION

Pro Forma Consolidated Financial Statements (Unaudited)

The following unaudited pro forma consolidated balance sheet as of June 30, 2017 and the unaudited pro forma consolidated statements of income for the fiscal year ended December 31, 2016 and for the six months ended June 30, 2017 are condensed and unaudited and should be read in conjunction with our historical consolidated financial statements and accompanying notes, which are incorporated by reference into this proxy statement. The pro forma financial information is intended to illustrate what the approximate effects of the estimated cash payments for the fractional shares resulting from the Reverse Split, the cashing out of all outstanding options to purchase class B common stock and restricted shares of class B common stock, the new term loan to fund the Proposed Transaction and the related expense of the Proposed Transaction would have had on the Company’s financial condition and results of operations if completed at an earlier date. Adjustments to the pro forma consolidated balance sheet are computed as if the Reverse Split occurred on June 30, 2017, while the pro forma adjustments related to the consolidated statements of income are computed as if the Reverse Split had occurred on January 1, 2016. The pro forma financial information is based on the assumptions stated in the notes to the pro forma financial statements, which should be carefully considered. The pro forma financial information is not necessarily indicative of the results that would have occurred had the Proposed Transaction actually taken place in the respective periods nor do they purport to project the results of operations for any future period. The historical amounts as of and for the six months ending June 30, 2017 were derived from the Company’s unaudited consolidated financial statements that were included in the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2017. The historical amounts for the fiscal year ended December 31, 2016 were derived from the Company’s audited consolidated financial statements that were included in the Company’s Annual MeetingReport on Form 10-K for the fiscal year ended December 31, 2016.


NATIONAL RESEARCH CORPORATION AND SUBSIDIARY
CONDENSED CONSOLIDATED BALANCE SHEET-PRO FORMA

(In thousands, except share amounts and par value)

  

Actual
June 30, 2017

  

Pro Forma Adjustments

   

Pro Forma
June 30, 2017

 

Assets

             

Current assets:

             

Cash and cash equivalents

 $31,628  $(25,522)

(A)

    
       (6,106)

(B)

  - 

Trade accounts receivable, net of allowance for doubtful accounts

  13,138        13,138 

Unbilled revenue

  1,644        1,644 

Prepaid expenses

  3,378        3,378 

Income tax receivable

  1,172   2,733 

(D)

  3,905 

Other current assets

  23        23 

Total current assets

  50,983   (28,895)   22,088 
              

Property and equipment, net

  12,138        12,138 

Intangible assets, net

  2,830        2,830 

Goodwill

  57,942        57,942 

Other

  683        683 

Total assets

 $124,576  $(28,895)  $95,681 
              

Liabilities and Shareholders Equity

             

Current liabilities:

             

Line of Credit

 $-  $2,653 

(A)

 $2,653 

Current portion of notes payable

  2,107   4,391 

(A)

  6,498 

Accounts payable and accrued expenses

  7,791        7,791 

Income taxes payable

  -   1,250 

(C)

  1,250 

Dividends payable

  4,218        4,218 

Deferred revenue

  16,735        16,735 

Total current liabilities

  30,851   8,294    39,145 
              

Notes payable, net of current portion

  -   63,302 

(A)

  63,302 

Deferred income taxes

  5,057   527 

(D)

  5,584 

Other long term liabilities

  838        838 

Total liabilities

  36,746   72,123    108,869 
              

Shareholders’ equity:

             

Preferred stock

  -        - 

Class A Common stock

  26        26 

Class B Common stock

  4   (3)

(A)

  1 
              

Additional paid-in capital

  49,620   (9,708)

(A)

    
       (5,490)

(B)

  34,422 
              

Retained earnings/accumulated deficit

  75,343   (101,482)

(A)

    
       (616)

(B)

    
       (1,250)

(C)

    
       2,206 

(D)

  (25,799)

Accumulated other comprehensive loss

  (2,127)       (2,127)

Treasury stock, at cost

  (35,036)  15,325 

(A)

  (19,711)

Total shareholders’ equity

  87,830   (101,018)   (13,188)

Total liabilities and shareholders’ equity

 $124,576   (28,895)  $95,681 
              

Book Value per share (See Note H)

 $3.59       $(0.58)


NATIONAL RESEARCH CORPORATION AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENT OF INCOME-PRO FORMA

(In thousands, except share amounts and par value)

  

For the six months ending June 30, 2017

 
  

 

 

Actual
June 30, 2017

  

Pro Forma Adjustments

   

Pro Forma
June 30, 2017

 

Revenues:

             

Revenue

 $58,710  $-   $58,710 
              

Operating expense:

             

Direct

  24,439        24,439 

Selling, general and administrative

  13,591        13,591 

Depreciation and amortization

  2,244        2,244 

Total operating expenses

  40,274   -    40,274 
              

Operating Income

  18,436   -    18,436 
              

Other income (expense)

             

Interest income and other, net

  64        64 

Interest expense

  (50)  (1,271)

(E)

  (1,321)

Total other income (expense)

  14   (1,271)   (1,257)
              

Income before income taxes

  18,450   (1,271)   17,179 
              

Provision for income taxes

  6,178   (464)

(F)

  5,714 
              

Net Income

 $12,272  $(807)  $11,465 
              
              

Earnings Per Share of Common Stock:

             

Basic Earnings Per Share

             

Class A

 $0.29  $0.07 

(G)

 $0.36 

Class B

 $1.75  $0.43 

(G)

 $2.18 
              

Diluted Earnings Per Share

             

Class A

 $0.28  $0.07 

(G)

 $0.35 

Class B

 $1.71  $0.47 

(G)

 $2.18 
              

Weighted average shares and shares equivalents outstanding:

             

Class A - basic

  20,745        20,745 

Class B - basic

  3,514   (1,749)

(G)

  1,765 

Class A - diluted

  21,404        21,404 

Class B - diluted

  3,584   (1,819)

(G)

  1,765 


NATIONAL RESEARCH CORPORATION AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENT OF INCOME-PRO FORMA

(In thousands, except share amounts and par value)

  For the twelve months ending December 31, 2016 
  

 

 

Actual
December 31, 2016

  

Pro Forma Adjustments

   

Pro Forma
December 31, 2016

 

Revenues:

             

Revenue

 $109,384  $-   $109,384 
              

Operating expense:

             

Direct

  45,577        45,577 

Selling, general and administrative

  28,385        28,385 

Depreciation and amortization

  4,225        4,225 

Total operating expenses

  78,187   -    78,187 
              

Operating Income

  31,197   -    31,197 
              

Other income (expense)

             

Interest income and other, net

  349        349 

Interest expense

  (190)  (2,703)

(E)

  (2,893)

Total other income (expense)

  159   (2,703)   (2,544)
              

Income before income taxes

  31,356   (2,703)   28,653 
              

Provision for income taxes

  10,838   (987)

(F)

  9,851 
              

Net Income

 $20,518  $(1,716)  $18,802 
              
              

Earnings Per Share of Common Stock:

             

Basic Earnings Per Share

             

Class A

 $0.49  $0.11 

(G)

 $0.60 

Class B

 $2.93  $0.58 

(G)

 $3.51 
              

Diluted Earnings Per Share

             

Class A

 $0.48  $0.11 

(G)

 $0.59 

Class B

 $2.88  $0.63 

(G)

 $3.51 
              
              

Weighted average shares and shares equivalents outstanding:

             

Class A - basic

  20,713        20,713 

Class B - basic

  3,505   (1,740)

(G)

  1,765 

Class A - diluted

  21,037        21,037 

Class B - diluted

  3,560   (1,795)

(G)

  1,765 


Notes to Pro Forma Financial Statements (Unaudited)

Pro Forma Adjustments

The following pro forma adjustments are based on preliminary estimates and assumptions, which may change as additional information is obtained, and as a result, actual results may differ materially:

(A)

Adjustment to give effect to the Proposed Transaction and the repurchase and retirement of all fractional shares of class B common stock, representing 1,775,684 shares of class B common stock at a price of $53.44 per share (an aggregate of $94,893,000) and nonrecurring expected transaction costs of $975,000. The Proposed Transaction is to be funded through the use of existing cash on hand and a new debt facility (new term debt of $70,000,000 with debt origination fees of $200,000 less existing $2,107,000 debt required to be repaid) and borrowings on the line of credit.

(B)

Adjustment to give effect to the $6,106,000 cash settlement of class B common share options at $53.44 per option and nonrecurring charges of $616,000 associated with the accelerated vesting of class B common share options and restricted stock awards, which will be subject to the Reverse Split upon vesting and included in the repurchase of the fractional shares of class B common stock. We have not reflected an adjustment to the historical stock compensation expense recorded in our statements of income related to our class B common share awards which total $472,000 and $148,000 for the year ended December 31, 2016 and the six months ended June 30, 2017, respectively.

(C)

Adjustment to give effect to the estimated tax liability of $1,250,000 related to the repatriation of cash from our Canadian subsidiary assumed to be used to fund a portion of the repurchase of the fractional shares of class B common stock.

(D)

Adjustment to give effect to the $2,733,000 tax benefit related to the accelerated vesting and settlement of class B share awards, based on a 36.5% income tax rate and the reversal of deferred tax assets of $527,000 related to the awards.

(E)

Adjustment to reflect the incremental interest expense related to our new credit facility at an assumed interest rate of 4.16% and amortization of loan origination fee, partially offset by interest expense on the $2,107,000 of existing debt required to be repaid.

(F)

Adjustment to give effect to the income taxes related to the pro forma income statement adjustments at an assumed income tax rate of 36.5%.

(G)

Adjustment to give effect to the repurchase of the fractional class B shares. Net income per share of class A common stock and class B common stock is computed using the two-class method. The liquidation rights and the rights upon the consummation of an extraordinary transaction are the same for the holders of class A common stock and class B common stock. Other than share distributions and liquidation rights, the amount of any dividend or other distribution payable on each share of class A common stock will be equal to one-sixth (1/6th) of the amount of any such dividend or other distribution payable on each share of class B common stock. As a result, the undistributed earnings for each period are allocated based on the contractual participation rights of the class A and class B common stock as if the earnings for the period had been distributed. Accordingly for purposes of computing earnings per share, pro forma net income for the six months ended June 30, 2017 of $7,613,000 has been allocated to the class A common stock shareholders and $3,852,000 to the class B common stock shareholders. For the year ended December 31, 2016, pro forma net income of $12,607,000 has been allocated to the class A common stock shareholders and $6,195,000 to the class B common stock shareholders in computing earnings per share.

(H)

Book Value per share, calculated as total shareholders’ equity divided by total shares outstanding which include both class A and class B common shares.

Historical Financial Statements

Historical financial statements and their related financial footnotes of the Company are incorporated herein by reference to (i) Part I, Item 1 of the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2017, filed with the SEC on August 4, 2017 and (ii) Part II, Item 8 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, filed with the SEC on March 3, 2017.


EXECUTIVE OFFICERS AND DIRECTORS

The following table sets forth the ages as of the Record Date and present positions for each of our executive officers and directors:

Name

Age

Position

Michael D. Hays

62

Chief Executive Officer and Director

Steven D. Jackson

42

President

Kevin R. Karas

59

Senior Vice President Finance, Chief Financial Officer, Treasurer and Secretary

Donald M. Berwick (3) (4) (5)

71

Director

JoAnn M. Martin (1) (4) (5)

63

Director

Barbara J. Mowry (1) (2) (3) (4)

69

Director

John N. Nunnelly (1) (2) (3) (4) (5)

64

Director

______________________
(1) Member of the Audit Committee

(2) Member of the Compensation Committee

(3) Member of the Nominating Committee

(4) Member of the Strategic Planning Committee

(5) Member of the Leadership Development Committee

The following is a brief description of the professional experience and background of our directors and executive officers:

 

Michael D. Hays, 62, has served as Chief Executive Officer and a director since he founded the Company in 1981. He also served as President of the Company from 1981 to 2004 and from July 2008 to July 2011. Prior to founding the Company, Mr. Hays served for seven years as a Vice President and a director of SRI Research Center, Inc. (n/k/a the Gallup Organization). Mr. Hays’ background as founder of the Company, and his long and successful tenure as Chief Executive Officer and a director, led to the conclusion that he should serve as a director of the Company.

 

John N. NunnellySteven D. Jackson , 64, has served as a directorPresident of the Company since December 1997. Mr. Nunnelly is a retiredOctober 2015. He served as Group President from McKesson Corporation,October 2014 until September 2015, during which time he oversaw the Company’s Market Insights, Transparency, and Predictive Analytics business units. Prior to joining the Company, Mr. Jackson served as Chief Strategy Officer for Vocera Communications where he was employed from 2007 to 2014. He also served as Chief Operating Officer for ExperiaHealth, a leadersubsidiary of Vocera. Earlier in pharmaceutical distributionhis career, Mr. Jackson held positions of increasing responsibility at The Advisory Board Company, Neoforma, and healthcare information technology. During his 28-year career at McKesson, Mr. NunnellyStockamp & Associates.

Kevin R. Karas has served as Chief Financial Officer, Treasurer and Secretary of the Company since September 2011, and as Senior Vice President Finance since he joined the Company in a variety of other positions including,December 2010. From 2005 to 2010, he served as Vice President of Strategic PlanningFinance for Lifetouch Portrait Studios, Inc., a national retail photography company.  Mr. Karas also previously served as Chief Financial Officer at CARSTAR, Inc., an automobile collision repair franchise business, from 2000 to 2005, Chief Financial Officer at Rehab Designs of America, Inc., a provider of orthotic and Business Development,prosthetic services, from 1993 to 2000, and as a regional Vice President and General Manager of the Amherst Product GroupFinance and Vice President of Sales-Decision Support. These responsibilities included leading several business units, including one with over $360 million in annual revenue. In addition, he was involved in managingOperations at Novacare, Inc., a numberprovider of mergers and acquisitions. Mr. Nunnelly also serves as an adjunct professor at the University of Massachusetts, School of Nursing, advising students and faculty on matters pertainingphysical rehabilitation services, from 1988 to healthcare information technology. These experiences and Mr. Nunnelly’s expertise1993.  He began his career as a professional and educator in the field of healthcare information technology led to the conclusion that he should serve as a director of the Company.

Terms expiringCertified Public Accountant at the 2019 Annual MeetingErnst & Young.

 

Donald M. Berwick, 70, has served as a director of the Company since October 2015. Dr. Berwick is the former President and Chief Executive Officer of the Institute for Healthcare Improvement, which he co-founded and led for almost 20 years, and where he now serves as President Emeritus and Senior Fellow. He is also currently a Lecturer in the Department of Health Care Policy at Harvard Medical School. From July 2010 to December 2011, Dr. Berwick served as the Administrator of the Centers for Medicare and Medicaid Services as an appointee of President Barack Obama. Dr. Berwick previously served on the faculty of the Harvard Medical School and the Harvard School of Public Health (from 1974 to 2010). He was also vice chair of the U.S. Preventive Services Task Force (from 1990 to 1995), the first “Independent Member” of the Board of Trustees of the American Hospital Association (from 1996 to 1999) and the chair of the National Advisory Council of the Agency for Healthcare Research and Quality (from 1995 to 1999). Dr. Berwick’s expertise as a professional, administrator, lecturer and educator in the field of healthcare led to the conclusion that he should serve as a director of the Company.

 


Gail L. WardenJoAnn M. Martin, 78, has served as a director of the Company since January 2005. Mr. Warden is currently President Emeritus of Detroit-based Henry Ford Health System, where he served as President and Chief Executive Officer from 1988 until 2003. Prior to this role, Mr. Warden served as President and Chief Executive Officer of Group Health Cooperative of Puget Sound, as well as Executive Vice President of the American Hospital Association. Mr. Warden serves as Chairman to several national healthcare committees and as a board member to many other healthcare related committees and institutions. Mr. Warden’s extensive experience in the healthcare industry and the many leadership roles he has held with healthcare enterprises, including serving as the president and chief executive officer of a large integrated health system for 15 years, and industry organizations led to the conclusion that he should serve as a director of the Company.


CORPORATE GOVERNANCE

Independent Directors and Annual Meeting Attendance

Of the six directors currently serving on the Board, the Board has determined that Donald M. Berwick, JoAnn M. Martin, Barbara J. Mowry, John N. Nunnelly and Gail L. Warden are “independent directors” as that term is defined in the listing standards of The NASDAQ Stock Market.

Directors are expected to attend the Company’s annual meeting of shareholders each year. Other than Dr. Berwick, each of the directors attended the Company’s 2016 annual meeting of shareholders.

Currently, the Company does not have a chairman and the Board does not have a policy on whether the roles of chief executive officer and chairman should be separate. The Board has, however, designated a lead director since 2007, withJune 2001. Ms. Martin serving as the lead director from 2007 until May 2012 and Mr. Nunnelly serving as the lead director since May 2012. The Board believes its current leadership structure is appropriate at this time since it establishes the Company’s chief executive officer as the primary executive leader with one vision and eliminates ambiguity as to who has primary responsibility for the Company’s performance.

The lead director is an independent director who is appointed by the independent directors and who works closely with the chief executive officer. In addition to serving as the principal liaison between the independent directors and the chief executive officer in matters relating to the Board as a whole, the primary responsibilities of the lead director are as follows:

Preside at all meetings of the Board at which the chief executive officer is not present, including any executive sessions of the independent directors, and establish agendas for such executive sessions in consultation with the other directors and the chief executive officer;

Advise the chief executive officer as to the quality, quantity, and timeliness of the flow of information from management that is necessary for the independent directors to effectively perform their duties;

Have the authority to call meetings of the independent directors as appropriate; and

Be available to act as the spokesperson for the Company if the chief executive officer is unable to act as the spokesperson.

Committees

The Board held four meetings in 2016. During 2016, each of the directors, other than Mr. Warden, attended all of the meetings of the Board and all of the meetings held by all committees of the Board on which such director served during 2016.

The Board has a standing Audit Committee, Compensation Committee, Nominating Committee, Strategic Planning Committee and Leadership Development Committee. Each of these committees has the responsibilities set forth in formal written charters adopted by the Board. The Company makes available copies of each of these charters free of charge on its website located at www.nrchealth.com. Other than the text of the charters, the Company is not including the information contained on or available through its website as a part of, or incorporating such information by reference into, this proxy statement.

The Audit Committee’s primary function is to assist the Board in fulfilling its oversight responsibilities by overseeing the Company’s systems of internal controls regarding finance, accounting, legal compliance and ethics that management and the Board have established; the Company’s accounting and financial reporting processes; and the audits of the financial statements of the Company. The Audit Committee presently consists of JoAnn M. Martin (Chairperson), Barbara J. Mowry, John N. Nunnelly and Gail L. Warden, each of whom meets the independence standards of the NASDAQ Stock Market and the Securities and Exchange Commission for audit committee members. The Board has determined that JoAnn M. Martin qualifies as an “audit committee financial expert,” as that term is defined by the Securities and Exchange Commission, because she has the requisite attributes through, among other things, education and experience as a president, chief financial officer and certified public accountant. The Audit Committee held five meetings in 2016.


The Compensation Committee determines compensation programs for the Company’s executive officers, reviews management’s recommendations as to the compensation to be paid to other key personnel and administers the Company’s equity-based compensation plans. The Compensation Committee presently consists of Barbara J. Mowry (Chairperson), John N. Nunnelly and Gail L. Warden, each of whom meets the independence standards of the NASDAQ Stock Market and the Securities and Exchange Commission for compensation committee members. The Compensation Committee held four meetings in 2016. In 2015, management of the Company engaged Aon Hewitt, a nationally recognized compensation consultant, to assist the Company in its review of its compensation and benefits programs, including the competitiveness of pay levels, executive compensation design issues, market trends and technical considerations.

The Nominating Committee presently consists of Donald M. Berwick (Chairperson), Barbara J. Mowry, John N. Nunnelly and Gail L. Warden, each of whom meets the independence standards of The NASDAQ Stock Market for nominating committee members. The Nominating Committee’s primary functions are to: (1) recommend persons to be selected by the Board as nominees for election as directors and (2) recommend persons to bewas elected to fill any vacancies on the Board. The Nominating Committee did not hold any meetings in 2016.

The Strategic Planning Committee assists the Board in reviewing and, as necessary, altering, the Company’s strategic plan, reviewing industry trends and their effects, if any, on the Company and assessing the Company’s products, services and offerings and the viability of such portfolio in meeting the needs of the markets that the Company serves. John N. Nunnelly (Chairperson), Donald M. Berwick, JoAnn M. Martin, Barbara J. Mowry and Gail L. Warden are the current members of the Strategic Planning Committee. The Strategic Planning Committee held one meeting in 2016.

The Leadership Development Committee assists the Board in reviewing the Company’s strategy to attract, develop and retain its associates. The Leadership Development Committee presently consists of Gail L. Warden (Chairperson), Donald M. Berwick, JoAnn M. Martin and John N. Nunnelly. The Leadership Development Committee did not hold any meetings in 2016.

Board Oversight of Risk

The full Board is responsible for the oversight of the Company’s operational and strategic risk management process. The Board relies on its Audit Committee to address significant financial risk exposures facing the Company and the steps management has taken to monitor, control and report such exposures, with appropriate reporting of these risks to be made to the full Board. The Board relies on its Compensation Committee to address significant risk exposures facing the Company with respect to compensation, with appropriate reporting of these risks to be made to the full Board. The Board’s role in the Company’s risk oversight has not affected the Board’s leadership structure.


Nominations of Directors

The Nominating Committee will consider persons recommended by shareholders to become nominees for election as directors. Recommendations for consideration by the Nominating Committee should be sent to the Secretary of the Company in writing together with appropriate biographical information concerning each proposed nominee. The Company’s By-Laws also set forth certain requirements for shareholders wishing to nominate director candidates directly for consideration by the shareholders. With respect to an election of directors to be held at an annual meeting, a shareholder must, among other things, give notice of intent to make such a nomination to the Secretary of the Company not less than 60 days or more than 90 days prior to the second Wednesday in the month of April.

In identifying and evaluating nominees for director, the Nominating Committee seeks to ensure that the Board possesses, in the aggregate, the strategic, managerial and financial skills and experience necessary to fulfill its duties and to achieve its objectives, and seeks to ensure that the Board is comprised of directors who have broad and diverse backgrounds, possessing knowledge in areas that are of importance to the Company. The Nominating Committee looks at each nominee on a case-by-case basis regardless of who recommended the nominee. In looking at the qualifications of each candidate to determine if their election would further the goals described above, the Nominating Committee takes into account all factors it considers appropriate, which may include strength of character, mature judgment, career specialization, relevant technical skills or financial acumen, diversity of viewpoint and industry knowledge. In addition, the Board and the Nominating Committee believe that the following specific qualities and skills are necessary for all directors to possess:

A director must display high personal and professional ethics, integrity and values.

A director must have the ability to exercise sound business judgment.

A director must be accomplished in his or her respective field, with broad experience at the administrative and/or policy-making level in business, government, education, technology or public interest.

A director must have relevant expertise and experience, and be able to offer advice and guidance based on that expertise and experience.

A director must be independent of any particular constituency, be able to represent all shareholders of the Company and be committed to enhancing long-term shareholder value.

A director must have sufficient time available to devote to activities of the Board and to enhance his or her knowledge of the Company’s business.

The Board also believes the following qualities or skills are necessary for one or more directors to possess:

At least one independent director must have the requisite experience and expertise to be designated as an “audit committee financial expert,” as defined by applicable rules of the Securities and Exchange Commission, and have past employment experience in finance or accounting, requisite professional certification in accounting, or any other comparable experience or background which results in the member’s financial sophistication, as required by the rules of NASDAQ.


One or more of the directors generally must be active or former executive officers of public or private companies or leaders of major complex organizations, including commercial, scientific, government, educational and other similar institutions.

As noted above, in identifying and evaluating nominees for director, the Nominating Committee seeks to ensure that, among other things, the Board is comprised of directors who have broad and diverse backgrounds, because the Board believes that directors should be selected so that the Board is a diverse body. The Nominating Committee implements this policy by considering how potential directors’ backgrounds would contribute to the diversity of the Board. As part of its annual self-evaluation, the Nominating Committee assesses the effectiveness of its efforts to attain diversity by considering whether it has an appropriate process for identifying and selecting director candidates.

Transactions with Related Persons

Except as otherwise disclosed in this section, we had no related person transactions during 2016, and none are currently proposed, in which we were a participant and in which any related person had a direct or indirect material interest. Our Board has adopted written policies and procedures regarding related person transactions. For purposes of these policies and procedures:

A “related person” means any of our directors, executive officers, nominees for director, any holder of 5% or more of the common stock or any of their immediate family members; and

A “related person transaction” generally is a transaction (including any indebtedness or a guarantee of indebtedness) in which we were or are to be a participant and the amount involved exceeds $120,000, and in which a related person had or will have a direct or indirect material interest.

Each of our executive officers, directors or nominees for director is required to disclose to the Audit Committee certain information relating to related person transactions for review, approval or ratification by the Audit Committee. Disclosure to the Audit Committee should occur before, if possible, or as soon as practicable after the related person transaction is effected, but in any event as soon as practicable after the executive officer, director or nominee for director becomes aware of the related person transaction. The Audit Committee’s decision whether or not to approve or ratify a related person transaction is to be made in light of the Audit Committee’s determination that consummation of the transaction is not or was not contrary to our best interests. Any related person transaction must be disclosed to the full Board.

Ms. Martin, a director of the Company, serves as President and Chief Executive Officer of Ameritas Life Insurance Corp. In connection with the Company’s regular assessment of its insurance-based associate benefits, an insurance and the costs associated therewith, which is conducted by an independent insurance broker,financial services company, in 2007 the Company began purchasing dental insurance for certain of its associates fromJuly 2005. From April 2003 to July 2005, she served Ameritas Life Insurance Corp. as President and inChief Operating Officer. Prior thereto, Ms. Martin served as Senior Vice President and Chief Financial Officer of Ameritas for more than the last five years. In April 2009, Ms. Martin was elected President and Chief Executive Officer of Ameritas Holding Company and Ameritas Mutual Holding Company (previously named UNIFI Mutual Holding Company), where she had served as Executive Vice President and Chief Financial Officer for more than the Companylast five years. Ms. Martin has served as an officer of Ameritas and/or its affiliates since 1988. Ms. Martin also began purchasing vision insurance for certainserves as a director of its associates from Ameritas Life Insurance Corp. The total value of these purchases, which were conducted in arms’ length transactions and approved by the Audit Committee pursuant to our related person transaction policies and procedures, were $232,000 in 2016 and $227,000 in 2015.Separate Accounts (since 2003).

 

Mr. Hays,Barbara J. Mowry has served as a director of the Company since May 2014. Ms. Mowry founded, and is currently the Chief Executive Officer majority shareholderof, GoreCreek Advisors, a management consulting firm. Prior to founding GoreCreek Advisors, Ms. Mowry served as Senior Vice President - Data Integration of Oracle Corporation, an industry leading software, hardware and services company, from January 2010 through March 2011, and as President and Chief Executive Officer of Silver Creek Systems, Inc., a data quality solutions software company, from January 2003 to December 2009. Ms. Mowry served as a director of Axion Health (from 2012 to 2014) and the Federal Reserve Bank of Kansas City (from 2012 to 2014) where she was Chair of the Board from 2013 to 2014. Ms. Mowry also serves as a director of IMA Financial Group (since May 2017), a privately held diversified financial services company, and as a director of several not-for-profit organizations, including the Kauffman Foundation (since 2013), the University of Minnesota Executive Committee, Carlson School of Management and the Board of Overseers (since 2004), the Colorado Innovation Network (since 2013) and the National Association of Corporate Directors Colorado Chapter where she is a Leadership Fellow. Ms. Mowry previously served as a director of Gaiam, Inc. (from 1999 to 2013), Real Goods Solar, Inc. (from 2008 to 2013) and the Denver Branch of the Federal Reserve Bank of Kansas City (from 2008 to 2011).

John N. Nunnelly has served as a director of the Company since December 1997. Mr. Nunnelly is an ownera retired Group President from McKesson Corporation, a leader in pharmaceutical distribution and healthcare information technology. During his 28-year career at McKesson, Mr. Nunnelly served in a variety of 14%other positions including, Vice President of Strategic Planning and Business Development, Vice President and General Manager of the equity interestAmherst Product Group and Vice President of Nebraska Global Investment Company LLC (“Nebraska Global”). The Company, directly or indirectly through its former subsidiary Customer-Connect LLC, purchased certain services from Nebraska Global, primarily consistingSales-Decision Support. These responsibilities included leading several business units, including one with over $360 million in annual revenue. In addition, he was involved in managing a number of software development services. The total valuemergers and acquisitions. Mr. Nunnelly also serves as an adjunct professor at the University of these purchases, which were conducted in arms’ length transactionsMassachusetts, School of Nursing, advising students and approved by the Audit Committee pursuantfaculty on matters pertaining to our related person transaction policies and procedures, were $488,000 in 2016 and $440,000 in 2015.healthcare information technology.

 

Communications withThere are no family relationships between any of the Board of Directors

Shareholders may communicate with the Board by writing to NRC Health, Board of Directors (or, at the shareholder’s option, to a specific director), c/o Kevin R. Karas, Secretary, 1245 Q Street, Lincoln, Nebraska 68508. The Secretary will ensure that the communication is delivered to the Boarddirectors or the specified director, as the case may be.


2016 DIRECTOR COMPENSATION

Directors who are executive officers of the Company.

Each director and executive officer is a United States citizen. Neither the Company, receive no compensation for service as membersnor, to our knowledge, any of either the Boarddirectors or committees thereof. From January 1, 2016 to June 30, 2016, directors who were not executive officers, has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or has been a party to any judicial or administrative proceeding (except for matters that were dismissed without sanction or settlement) that resulted in a judgment, decree, or final order enjoining future violations of, or prohibiting activities subject to, federal or state securities laws, or a finding of any violation of federal or state securities laws.

The executive officers and directors of the Company, were compensated as follows: an annual retainer of $50,000well as the Grandchildren’s Trust, intend to vote for the lead directorProposed Transaction and $25,000 for eachrecommend to the other director, a fee of $1,000 for each Board meeting attended, a fee of $1,000 for each Audit Committee meeting attended ($1,500 per meeting for the chairperson of the Audit Committee) and a fee of $750 for each Compensation Committee, Nominating Committee and/or Strategic Planning Committee meeting attended ($1,000 per meeting for the chairperson of each such committee). Based on, among other things, a review of best practices in director compensation, the Board modified the director compensation structure from a meeting-based structure to a fixed-fee based structure effective July 1, 2016. Accordingly, from and after July 1, 2016, directors who are not executive officersshareholders of the Company are compensated as follows: an annual fixed fee of $75,000that they support for the lead director and $50,000 for each other director. Directors are also reimbursed for out-of-pocket expenses associated with attending meetings of the Board and committees thereof. Ms. Martin served as the Company’s lead director from 2007 to May 2012, and Mr. Nunnelly has served as the Company’s lead director since May 2012.

Pursuant to the National Research Corporation 2004 Non-Employee Director Stock Plan, each director who is not an associate (i.e., employee) of the Company also receives an annual grant of an option to purchase 36,000 shares of our class A common stock and 6,000 shares of our class B common stock on the date of each annual meeting of shareholders. The options have an exercise price equal to the fair market value of the class A common stock and class B common stock, as applicable, on the date of grant and vest one year after the grant date.

The following table sets forth information regarding the compensation received by each of the Company’s directors during 2016:

Name

 

Fees Earned or

Paid in Cash

  

Option Awards(1)

  

Total

 
             

Donald M. Berwick

 $41,000  $138,240  $179,240 
             

JoAnn M. Martin

 $47,000  $138,240  $185,240 
             

Barbara J. Mowry

 $46,750  $138,240  $184,990 
             

John N. Nunnelly

 $71,500  $138,240  $209,740 
             

Gail L. Warden

 $45,250  $138,240  $183,490 

_______________________

1 Represents the aggregate grant date fair value of option awards granted during the year, computed in accordance with FASB ASC Topic 718.  See Note 7 to the Company’s Consolidated Financial Statements included in its Annual Report on Form 10-KProposed Transaction for the years ended December 31, 2016, December 31, 2015, and December 31, 2014, for a discussion of assumptions made in the valuation of share-based compensation.   As of December 31, 2016, the outstanding option awards for each director were as follows:  Dr. Berwick – 72,000 options for class A common stock and 12,000 options for class B common stock; Ms. Martin – 229,800 options for class A common stock and 30,000 options for class B common stock; Ms. Mowry – 144,000 options for class A common stock and 24,000 options for class B common stock; Mr. Nunnelly – 288,000 options for class A common stock and 42,000 options for class B common stock; Mr. Warden – 324,000 options for class A common stock and 54,000 options for class B common stock.


REPORT OF THE AUDIT COMMITTEE

In accordance with its written charter, the Audit Committee’s primary function is to assist the Board in fulfilling its oversight responsibilities by overseeing the Company’s systems of internal controls regarding finance, accounting, legal compliance and ethics that management and the Board have established; the Company’s accounting and financial reporting processes; and the audits of the financial statements of the Company.

In fulfilling its responsibilities, the Audit Committee has reviewed and discussed the audited financial statements contained in the 2016 Annual Report on Form 10-K with the Company’s management and independent registered public accounting firm. Management is responsible for the financial statements and the reporting process, including the system of internal controls. The independent registered public accounting firm is responsible for expressing an opinion on the audited financial statements in conformity with U.S. generally accepted accounting principles and assessing the effectiveness of the Company’s internal control over financial reporting.

The Audit Committee discussed with the independent registered public accounting firm matters required to be discussed by Public Company Accounting Oversight Board Auditing Standard No. 16, “Communications with Audit Committees; Related Amendments to PCAOB Standards; and Transitional Amendments to AU Sec. 380.” In addition, the Company’s independent registered public accounting firm provided to the Audit Committee the written disclosures and the letter required by applicable requirements of the Public Company Accounting Oversight Board regarding the independent registered public accounting firm’s communications with the Audit Committee concerning independence, and the Audit Committee discussed with the independent registered public accounting firm the firm’s independence. The Audit Committee pre-approves all audit and permissible non-audit services provided by the independent registered public accounting firm on a case-by-case basis. The Audit Committee has considered whether the provision of the services relating to the Audit-Related Fees, Tax Fees and All Other Feesreasons set forth in “Miscellaneous – Independent Registered Public Accounting Firm” was compatible with maintaining the independence of the independent registered public accounting firm and determined that such services did not adversely affect the independence of the firm.

In reliance on the reviews and discussions referred to above, the Audit Committee recommended to the Board (and the Board has approved) that the audited financial statements be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016, for filing with the Securities and Exchange Commission.

This report shall not be deemed incorporated by reference by any general statement incorporating by reference this proxy statement, into any filingincluding under the Securities Act of 1933, as amended, orsection entitled “Special Factors — Reasons for the Securities Exchange Act of 1934, as amended, and shall not otherwiseProposed Transaction.” Accordingly, we expect the Proposed Transaction to be deemed filed under such Acts.

AUDIT COMMITTEE

JoAnn M. Martin, Chairperson

Barbara J. Mowry

John N. Nunnelly

Gail L. Wardenapproved.

 


 

PRINCIPAL SHAREHOLDERS

 

The following table sets forth certain information regarding the beneficial ownership of the Company’s class A common stock and class B common stock as of the Record Date (i.e., March 14,October [●], 2017) by: (1) each director and director nominee; (2)(a) each of theour directors and named executive officers named in the Summary Compensation Table; (3)officers; (b) all of the directors director nominees and executive officers as a group; and (4)(c) each person or entity known to the Company to be the beneficial owner of more than 5% of either class of the Common Stock. Except as otherwise indicated in the footnotes, each of the holders listed below has sole voting and investment power over the shares beneficially owned. As of the Record Date, there were 20,913,343[●] shares of class A common stock and 3,543,463[●] shares of class B common stock outstanding.

 

 Shares Beneficially Owned Shares Beneficially Owned 
 Class A Common Stock  Class B Common Stock Class A Common Stock Class B Common Stock 

Name of Beneficial Owner

 

Shares

  

%

  

Shares

  

%

 

Shares

 

%

 

Shares

 

%

 

Directors and Executive Officers(1)

                        
           

Michael D. Hays (1)

  5,489,916(2)(4)  26.1%  1,975,833(3)(5)  55.7%

Michael D. Hays (6)

5,489,916

(2)(4)

26.1

%

1,975,833

(3)(5)

55.8

%

Steven D. Jackson

  125,983(4)  *   20,997(5)  * 

125,983
 

(4)

*

 

20,997
 

(5)

*

 

Kevin R. Karas

  40,208(4)  *   6,755(5)  * 

40,208

(4)

*

 

6,755

(5)

*

 

Donald M. Berwick

  72,000(4)  *   12,000(5)  * 

72,000

(4)

*

 

12,000

(5)

*

 

JoAnn M. Martin

  396,048(4)  1.9%  61,733(5)  1.7%

391,276

(4)

1.8

%

61,733

(5)

1.7

%

Barbara J. Mowry

  144,000(4)  *   24,000(5)  * 

144,000

(4)

*

 

24,000

(5)

*

 

John N. Nunnelly

  316,700(4)  1.5%  45,900(5)  1.3%

265,784

(4)

1.3

%

45,900

(5)

1.3

%

Gail L. Warden

  384,671(4)  1.8%  64,263(5)  1.8%

All directors, nominees and executive officers as a group (eight persons)

  6,969,526(4)  31.5%  2,211,481(5)  59.6%

All directors, nominees and executive officers as a group (seven persons)

6,529,167

(4)

29.5

%

2,147,218

(5)

57.8

%
                        

Other Holders

                      

 

 
           

Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009 and Kent E. Endacott, as the Special Holdings Direction Advisor under this Trust (6)

  5,765,900   27.6%  125,355   3.5%
            

Conestoga Capital Advisors LLC (7)

  0   *   232,953   6.6%
            

Kayne Anderson Rudnick Investment Management LLC (8)

  1,350,222   6.5%  0   * 

Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009 and Kent E. Endacott, as the Special Holdings Direction Advisor under this Trust (6) (7)

5,765,900 

 

27.5

%

125,355 

 

3.5

%

Conestoga Capital Advisors LLC (8)

0 

 

*

 

232,953

 

6.6

%

Kayne Anderson Rudnick Investment Management LLC (9)

1,350,222

 

6.4

%

0

 

*

 

_______________________

* Denotes less than 1%.

 

(1)

The address of Mr. Haysall directors and officers is 1245 Q Street, Lincoln, Nebraska 68508.

(2)

Includes 5,850,871 shares of class A common pledged as security and 139,045 shares of class A common stock held by Mr. Hays’ wife.  Mr. Hays disclaims beneficial ownership of the shares held by his wife.

(3)

Includes 1,975,696 shares of class B common stock pledged as security and 137 shares of class B common stock held by Mr. Hays’ wife.  Mr. Hays disclaims beneficial ownership of the shares held by his wife.

(4)

Includes shares of class A common stock that may be purchased under stock options which are currently exercisable or exercisable within 60 days of March 14, 2017,the Record Date, as follows:  Dr. Berwick, 72,000 shares; Mr. Hays, 100,917 shares; Mr. Jackson, 0 shares; Mr. Karas, 26,403 shares; Ms. Martin, 229,800216,000 shares; Mr. Nunnelly, 288,000 shares; Mr. Warden, 324,000237,084 shares; Ms. Mowry, 144,000 shares; and all directors nominees and executive officers as a group, 1,185,120796,440 shares.


(5)

Includes shares of class B common stock that may be purchased under stock options which are currently exercisable or exercisable within 60 days of March 14, 2017,the Record Date, as follows:  Dr. Berwick, 12,000 shares; Mr. Hays, 2,491 shares; Mr. Jackson, 0 shares; Mr. Karas, 4,400 shares; Ms. Martin, 30,000 shares; Mr. Nunnelly, 42,000 shares; Mr. Warden, 54,000 shares; Ms. Mowry, 24,000 shares; and all directors nominees and executive officers as a group, 168,891114,891 shares.

(6)

Prior to the Proposed Transaction, the Grandchildren’s Trust and Mr. Hays will effect the Swap pursuant to which the Grandchildren’s Trust will receive 208,645 shares of class B common stock from Mr. Hays in return for the Grandchildren’s Trust transferring to Mr. Hays an equivalent value amount of shares of class A common stock.

(7)

The trustee of this Trust is Bessemer Trust Company of Delaware, N.A. and its address is 1007 N. Orange Street, Suite 1450, Wilmington, Delaware 19801. The address of the Special Holdings Direction Advisor for this Trust is c/o Woods & Aitken LLP, 301 South 13th Street, Suite 500, Lincoln, Nebraska 68508.

(7)(8)

The number of shares owned set forth above in the table is as of or about December 31, 2016 as reported by Conestoga Capital Advisors LLC in its amended Schedule 13G filed with the Securities and Exchange Commission. The address for this shareholder is 550 E. Swedesford Rd. Suite 120 Wayne, Pennsylvania 19087. This shareholder reports sole dispositive power with respect to all of these shares but sole voting power only over 205,773 of these shares.

(89)

The number of shares owned set forth above in the table is as of or about December 31, 2016 as reported by Kayne Anderson Rudnick Investment Management LLC in its Schedule 13G filed with the Securities and Exchange Commission. The address for this shareholder is 1800 Avenue of the Stars, 2nd Floor, Los Angeles, California 90067. This shareholder reports sole voting and dispositive power with respect to 303,508 of these shares and shared voting and dispositive power with respect to 1,046,714 of these shares.

 
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Securities Exchange Act of 1934 requires the Company’s directors, executive officers and any owner of greater than 10% of the Company’s Common Stock to file reports with the Securities and Exchange Commission concerning their ownership of the Company’s Common Stock. Based solely upon information provided to the Company by individual directors and executive officers, the Company believes that, during the fiscal year ended December 31, 2016, all of its directors and executive officers and owners of greater than 10% of the Company’s Common Stock complied with the Section 16(a) filing requirements.


 

RATIFICATION OF THE APPOINTMENT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
TRANSACTIONS WITH RELATED PERSONS

 

The Audit CommitteeExcept as otherwise disclosed in this section, we had no related person transactions to-date in 2017 or during 2015-2016, and none are currently proposed, in which we were a participant and in which any related person had a direct or indirect material interest. Our Board has appointed KPMG LLP to serve as our independent registered public accounting firm for the year ending December 31, 2017.

We are asking our shareholders to ratify the appointment of KPMG LLP as our independent registered public accounting firm. Although ratification is not required, our Board is submitting the appointment of KPMG LLP to our shareholders for ratification because we value our shareholders’ views on our independent auditorsadopted written policies and as a matter of good corporate practice. In the event that our shareholders fail to ratify the appointment, the Audit Committee will consider it as a direction to consider the appointment of a different firm. Even if the appointment is ratified, the Audit Committee in its discretion may select a different independent auditor at any time if it determines that such a change would be in the best interests of the Company and our shareholders.

Representatives of KPMG LLP are expected to be present at the Annual Meeting with the opportunity to make a statement if they so desire. Such representatives are also expected to be available to respond to appropriate questions.

Assuming a quorum is present at the Annual Meeting, the number of votes cast for the ratification of the Audit Committee’s appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2017 must exceed the number of votes cast against it. Abstentions and broker non-votes will be counted as present in determining whether there is a quorum; however, they will not constitute a vote “for” or “against” ratification and will be disregarded in the calculation of votes cast. A broker non-vote occurs when a broker submits a proxy card with respect to shares that the broker holds on behalf of anotherprocedures regarding related person but declines to vote on a particular matter, either because the broker elects not to exercise its discretionary authority to vote on the matter or does not have authority to vote on the matter. Shares of the Company’s class A common stock and class B common stock vote together as a single class on this matter.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR RATIFICATION OF THE APPOINTMENT OF KPMG LLPAS OUR INDEPENDENT REGISTEREDPUBLIC ACCOUNTING FIRM.SHARES OF THE COMPANY’S COMMON STOCK REPRESENTED BY EXECUTED BUT UNMARKED PROXIES WILL BE VOTED “FOR” RATIFICATION OF THE APPOINTMENT OF KPMG LLPAS OUR INDEPENDENT REGISTEREDPUBLIC ACCOUNTING FIRM.


COMPENSATION DISCUSSION AND ANALYSIS

The following discussion and analysis relates to the compensation of the individuals named in the Summary Compensation Table, a group we refer to as our “named executive officers.” In this discussion, the terms “we,” “our,” “us” or similar terms refer to the Company.

Overview of Executive Compensation Philosophy

We recognize the importance of maintaining sound principles for the development and administration of our executive compensation and benefit programs. Specifically, we design our executive compensation and benefit programs to advance the following core principles:

We strive to compensate our executive officers at competitive levels to ensure that we attract and retain a highly competent, committed management team.

We provide our executive officers with the opportunity to earn competitive pay as measured against comparable companies.

We link our executive officers’ compensation, particularly annual cash bonuses, to established Company financial performance goals.

We believe that a focus on these principles will benefit us and, ultimately, our shareholders in the long term by ensuring that we can attract and retain highly-qualified executive officers who are committed to our long-term success.

Role of the Compensation Committee

The Board appoints the Compensation Committee, which consists entirely of directors who are “outside directors” fortransactions. For purposes of Section 162(m) of the Internal Revenue Codethese policies and “non-employee directors” for purposes of the Securities Exchange Act of 1934. The following individuals are members of the Compensation Committee:procedures:

 

 

Barbara J. Mowry (Chairperson)

John N. Nunnelly

Gail L. Warden

The Compensation Committee determines compensation programs for our executive officers or recommends such programs to the full Board for approval. The Committee also reviews management’s recommendations as to the compensation to be paid to other key personnel and administers our equity-based compensation plans. Periodically, the Compensation Committee reviews and determines our compensation and benefit programs, with the objective of ensuring the executive compensation and benefits programs are consistent with our compensation philosophy. At the time of such reviews, our management has engaged a nationally recognized compensation consultant.

Consistent with this practice, in late 2015, when determining compensation for 2016, the Compensation Committee engaged Aon Hewitt to review our compensation and benefit programs before determining compensation for 2016. Prior to its engagement of Aon Hewitt in connection with its determination of 2016 compensation, our most recent review of our compensation and benefit programs had been conducted in October 2011. In connection with its engagement of Aon Hewitt in 2015, the Compensation Committee evaluated the independence from management of Aon Hewitt and the individual representatives of Aon Hewitt who served as the Compensation Committee’s consultants in light of the factors required by the NASDAQ Stock Market. As part of its evaluation, the Compensation Committee considered the fact that management had separately engaged Aon Hewitt to provide certain risk and benefits consulting services in 2015, but the Compensation Committee concluded that, due to Aon Hewitt’s policies and procedures ensuring independence and the small amount of Aon Hewitt’s revenues represented by its engagement, Aon Hewitt’s work did not raise a conflict of interest impairing Aon Hewitt’s ability to provide independent advice to the Compensation Committee regarding executive compensation matters.


Our management instructed Aon Hewitt to conduct a comprehensive review of our total compensation program for our named executive officers, benchmarking the base salary, target annual cash incentive compensation, long-term incentive compensation, and total target direct compensation that we offer our named executive officers. Aon Hewitt worked with our management to update the group of companies that we had used during the previous major review of our compensation and benefit programs in 2011 to ensure that the companies included in the group in 2015 were of comparable size, industry and type to our company or were companies with which we compete. Annual revenues of the comparison companies ranged from approximately $28.5 million to approximately $752.6 million, with median revenues of approximately $199.3 million.

The companies selected for our review of compensation in 2015 were the following:

Advisory Board CompanyHealthstream, Inc.
Athenahealth, Inc.Hooper Holmes, Inc.
Bio Telemetry, Inc.Landauer, Inc.
Castlight Health, Inc.Mattersight Corp.
Cartesian, Inc. (f/k/a The Management Network Group, Inc.)Medidata Solutions, Inc.
Computer Programs & Systems, Inc.Merge Healthcare, Inc.
Forrester Research, Inc.Press Ganey Holdings, Inc.
Franklin Covey Co.RCM Technologies, Inc.


We refer to these companies as “comparable companies.” In determining compensation levels for our named executive officers in 2016, our Compensation Committee reviewed the comparable company data to the extent the data reflected positions similar to those held by our named executive officers. Our Compensation Committee considered these data and other information provided by Aon Hewitt to assess our competitive position with respect to the following components of compensation:

Base salary;

Annual cash incentive compensation; and

Long-term equity incentive compensation.

The Compensation Committee did not engage Aon Hewitt orA “related person” means any other compensation consultant to provide advice concerning executive officer or director compensation during 2016.

One objective of the Compensation Committee in setting compensation for our executive officers other than our Chief Executive Officer is to establish base salary at a competitive level compared with comparable companies to attract and retain highly-qualified individuals. The Compensation Committee’s considerations in setting our Chief Executive Officer’s base salary are described below. For our executive officers other than our Chief Executive Officer, we consider base salary to be at a “competitive level” if it is within 20% above or below the median level paid by comparable companies to similarly situated executives. However, the Compensation Committee may pay base salaries that are more than 20% above or below the median level paid by comparable companies based on its evaluation of individual factors relative to a named executive officer. The Compensation Committee also considers individual performance, level of responsibility, skills and experience, and internal comparisons among executive officers in determining base salary levels. Based on comparable company information and these other considerations, the Compensation Committee resets executive salary levels at the time of each significant compensation review, which levels are then generally adjusted only to reflect changes in responsibilities or comparable company data.

The Compensation Committee administers our annual cash incentive program and long-term equity incentive plans and approves all awards made under the program and plans. For annual and long-term incentives, the Compensation Committee considers internal comparisons and other existing compensation awards or arrangements in making compensation decisions and recommendations. In its decision-making process, the Compensation Committee receives and considers the recommendations of our Chief Executive Officer as to executive compensation programs for all of the other officers. In its decision-making process for the long-term incentives for our executive officers, the Compensation Committee considers relevant factors, including our performance and relative shareholder return and the awards given to the executive officer in past years. The Compensation Committee makes its decisions regarding general program adjustments to future base salaries, annual incentives and long-term incentives concurrently with its assessment of the executive officers’ performance. Adjustments generally become effective in January of each year.

In fulfilling its objectives as described above, the Compensation Committee took the following steps in determining 2016 compensation levels for our named executive officers:

Referred to the comparative company data provided in 2015 by Aon Hewitt;

Reviewed the performance of our Chief Executive Officer and determined his total compensation;

Reviewed the performance of our otherdirectors, executive officers, and other key associates (i.e., employees) with assistance from our Chief Executive Officer; and

Determined total compensationnominees for our named executive officers based on the 2015 compensation review, recommendations by our Chief Executive Officer (as to the other officers) and the Compensation Committee’s reviewdirector, any holder of 5% or more of the officers’ performance.


2016 Say on Pay Vote

In May 2016 (after the 2016 executive compensation actions described in this Compensation DiscussionCommon Stock or any of their immediate family members; and Analysis had taken place), we held our annual advisory shareholder vote on the compensation of our named executive officers at our annual shareholders’ meeting, and, consistent with the recommendation of the Board, our shareholders approved our executive compensation, with more than 99% of votes cast in favor. Consistent with this strong vote of shareholder approval, we have not undertaken any material changes to our executive compensation programs in response to the outcome of the vote.

Total Compensation

We intend to continue our strategy of compensating our executive officers at competitive levels through programs that emphasize performance-based incentive compensation in the form of cash and equity-based awards. To that end, we have structured total executive compensation to ensure that there is an appropriate balance between a focus on our long-term versus short-term performance. We believe that the total compensation paid or awarded to the executive officers during 2016 was consistent with our financial performance and the individual performance of each of our executive officers. We also believe that this total compensation was reasonable in its totality and is consistent with our compensation philosophies described above.

CEO Compensation

The Compensation Committee reviews annually the salary and total compensation levels of Michael D. Hays, our Chief Executive Officer. Based on the comparative company data that Aon Hewitt provided as part of our compensation review completed in 2015, Mr. Hays’ salary and overall compensation are significantly below the median level paid to chief executive officers of comparable companies. Due to Mr. Hays’ large holding of our stock and his desire to materially align his compensation with the interests of our other shareholders, he requested that his base salary and targeted overall compensation remain unchanged. The Compensation Committee has not proposed an increase in his salary or overall compensation since 2005.

Elements of Compensation

Base Salary

The objective of the Compensation Committee is to establish base salary at a competitive level compared with comparable companies, with the exception of Mr. Hays’ salary, as noted above. Within the framework of offering competitive base salaries, we have historically attempted to minimize base salary increases in order to limit our exposure if we do not meet our objectives for financial growth under our incentive compensation program. Accordingly, based on comparable company information and the other factors noted above, the Compensation Committee generally resets executive salary levels at the time of each significant compensation review and generally does not subsequently make adjustments except to reflect changes in responsibilities. Following its 2015 review of compensation, the Compensation Committee left Mr. Hays’ and Mr. Jackson’s base salaries unchanged from 2015. In the case of Mr. Hays, the decision was based on his request, described above, that his salary not be increased. In the case of Mr. Jackson, the decision was based the comparable company data showing that Mr. Jackson’s salary was at a competitive level. In the case of Mr. Karas, the Compensation Committee increased his base salary by 16%, to $285,000 per annum, to bring his salary level closer to the median level of the comparable company data.


Base salaries paid to Messrs. Hays, Karas and Jackson represented the following percentages of their total compensation (as calculated for purposes of the Summary Compensation Table).

Base Salary as a Percentage
of Total Compensation

Michael D. Hays

51%

Kevin R. Karas

51%

Steven D. Jackson

31%

Annual Cash Incentive

Our executive officers are eligible for annual cash incentive awards under our incentive compensation program. Please note that, while we may refer to annual cash incentive awards as bonuses in this discussion, the award amounts are reported in the Summary Compensation Table under the column titled “Non-Equity Incentive Plan Compensation” pursuant to the Securities and Exchange Commission’s regulations.

We intend for our incentive compensation program to provide an incentive to meet and exceed our financial goals, and to promote a superior level of performance. Within the overall context of our pay philosophy and culture, the program:

Provides competitive levels of total cash compensation;

Aligns pay with organizational performance;

Focuses executive attention on key business metrics; and

Provides a significant incentive for achieving and exceeding performance goals.

Under our incentive compensation program, the Compensation Committee establishes performance measures for our named executive officers at the beginning of each year. For 2016, the Compensation Committee used our overall revenue and net income as performance measures because the Compensation Committee believes these are key measures of our ability to deliver value to our shareholders for which our named executive officers have primary responsibility. The Compensation Committee weighted the two performance measures equally in determining bonus payouts. The Compensation Committee structured the incentive compensation program so that our named executive officers would receive a bonus based on the percentage of growth in overall revenue and net income in 2016 over 2015, starting from “dollar one” of such growth. Consistent with past years, the Compensation Committee structured the incentive compensation program for our named executive officers to require performance representing growth in revenue or net income for any payout to be received.

The Compensation Committee structured the incentive compensation program to permit payouts to be earned for any growth in revenue and net income because it believed that providing an incentive to achieve growth in these measures would provide an effective incentive to the executive officers in 2016. The Compensation Committee determined that the bonuses under the incentive compensation program would be equal to the following (subject to a maximum of 200% of base salary): the product of the executive officer’s base salary (i) multiplied by the sum of the percentage year over year increase, if any, in overall revenue plus the percentage year over year increase, if any, in overall net income (ii) multiplied by 2.5.

In determining the potential bonus amounts for our named executive officers described above, the Compensation Committee considered the comparative company data and Aon Hewitt’s recommendations in connection with the 2015 compensation review, and concluded that that payouts determined by these formulas were likely to produce results consistent with our past practice of setting annual target payouts at 50% of base salary, and would continue to provide competitive compensation consistent with our goals for annual incentive awards.


The following table shows amounts actually earned by our named executive officers for 2016, along with the percentages of their total compensation (as calculated for purposes of the Summary Compensation Table) that these amounts represent.

Name

2016 Actual Bonus

Percentage of
Total Compensation

2016 Actual

Bonus Amount

Michael D. Hays

30%

74,656

   

Kevin R. Karas

30%

167,010

   

Steven D. Jackson

18%

175,800

Long-Term Equity Incentive

The general purpose of our current equity-based plans is to promote the achievement of our long-range strategic goals and enhance shareholder value. The Compensation Committee may from time to time approve discretionary awards, however, we generally grant equity-based awards in the following circumstances:

Annual Awards. To provide an additional performance incentive for our executive officers and other key management personnel, our executive compensation package generally includes annual grants of stock options. In each year following our 2013 recapitalization pursuant to which we established two classes of common stock (class A common stock and class B common stock), we have granted options to purchase both class A common stock and class B common stock.

 

 

A New Hire“related person transaction” generally is a transaction (including any indebtedness or Promotion Awards. We also award restricted stock grantsa guarantee of indebtedness) in which we were or are to newly hiredbe a participant and the amount involved exceeds $120,000, and in which a related person had or promoted executive officers during their first year of participation in our equity incentive program to provide greater alignment between the officers’ interests and those of our shareholders, and to assist in retention.will have a direct or indirect material interest.

 

OptionsEach of our executive officers, directors or nominees for director is required to purchase sharesdisclose to the Audit Committee of common stock are typically granted with a per-share exercise price of 100%our Board (the “Audit Committee”) certain information relating to related person transactions for review, approval or ratification by the Audit Committee. Disclosure to the Audit Committee should occur before, if possible, or as soon as practicable after the related person transaction is effected, but in any event as soon as practicable after the executive officer, director or nominee for director becomes aware of the fair marketrelated person transaction. The Audit Committee’s decision whether or not to approve or ratify a related person transaction is to be made in light of the Audit Committee’s determination that consummation of the transaction is not or was not contrary to our best interests. Any related person transaction must be disclosed to the full Board.

Ms. Martin, a director of the Company, serves as President and Chief Executive Officer of Ameritas Life Insurance Corp. In connection with the Company’s regular assessment of its insurance-based associate benefits and the costs associated therewith, which is conducted by an independent insurance broker, in 2007 the Company began purchasing dental insurance for certain of its associates from Ameritas Life Insurance Corp. and, in 2009, the Company also began purchasing vision insurance for certain of its associates from Ameritas Life Insurance Corp. The total value of a sharethese purchases, which were conducted in arms’ length transactions and approved by the Audit Committee pursuant to our related person transaction policies and procedures, were $120,000 for the six-month period ended June 30, 2017, $232,000 in 2016 and $227,000 in 2015.

Mr. Hays, the founder, chief executive officer, majority shareholder and director of the classCompany, is an owner of common stock subject14% of the equity interest of Nebraska Global Investment Company LLC (“Nebraska Global”). The Company, directly or indirectly through its former subsidiary Customer-Connect LLC, purchased certain services from Nebraska Global, primarily consisting of software development services. The total value of these purchases, which were conducted in arms’ length transactions and approved by the Audit Committee pursuant to our related person transaction policies and procedures, were $488,000 in 2016 and $440,000 in 2015. There were no purchases from Nebraska Global in 2017. In addition, in 2015 the Company purchased 25% of the equity units of Customer-Connect LLC, from Nebraska Global for approximately $1.7 million.

AVAILABLE INFORMATION

The Company has filed the Schedule 13E-3 with the SEC in connection with the Proposed Transaction. As permitted by the rules and regulations of the SEC, this proxy statement does not contain all of the information set forth in the Schedule 13E-3. The Company is currently required to file reports and other information with the SEC under the Exchange Act. Copies of these reports and other information, including the Schedule 13E-3, are available at the SEC’s public reference facilities at 100 F Street, N.E., Washington, D.C. 20549. Copies of such materials can also be obtained at prescribed rates by writing to the option on the date of grant. The valuePublic Reference Section of the option willSEC at 100 F Street, N.E., Washington, D.C. 20549. These filing can also be dependent onviewed at the future market value of the common stock, which we believe helps to align the economic interests of our key management personnel with the interests of our shareholders. To encourage our key management personnel to continue in employment with us, when we grant restricted stock under the 2006 Equity Incentive Plan to executive officers, we generally impose a 5-year restriction period on the grant.

In determining equity incentive awards for 2016, the Compensation Committee considered the comparative company data and Aon Hewitt’s recommendations resulting from the 2015 compensation review, and concluded that setting annual target equity awards for our named executive officersSEC’s website at approximately 50% of their respective then-current base salaries would provide competitive compensation consistent with our goals for equity awards. The Compensation Committee generally grants stock options effective on a date in the first week of January. Accordingly, effective January 5, 2016, the Compensation Committee granted options to each of our named executive officers. To determine the number and class of options approximately equal to 50% of an executive officer’s base salary, the Compensation Committee allocated the target equity award amount between class A options and class B options using a six-to-one ratio and divided the applicable portion of the annual target equity award amount by the closing price per share of the applicable class of stock on the day prior to the date of grant. The number of options granted to our named executive officers is shown in the Grants of Plan-Based Awards Table.http://www.sec.gov.

 


 

Our Compensation Committee may condition awards onINCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

The SEC allows the achievementCompany to “incorporate by reference” the information it files with the SEC into this proxy statement. This permits the Company to disclose important information to you by referring to these filed documents. The information incorporated by reference is an important part of various performance goals, includingthis proxy statement. The following documents that the following:Company has filed with the SEC are incorporated by reference in this proxy statement:

 

 

Return on equity;

Pre-tax profits;

Return on investment;

Net earnings;

Return on net assets;

Net earnings per share;

Shareholder value added;

Working capital as a percent of net cash provided by operating activities;

Earnings from operations;

Market price for our common stock; and

Total shareholder return.

In conjunction with selecting the applicable performance goal or goals, the Compensation Committee will also fix the relevant performance level or levels that must be achieved with respect to the goal or goals in order for key associates to earn the performance-based awards. For 2016, no performance-based awards were granted to our named executive officers.

Other Benefits

To assist our associates in preparing financially for retirement, we maintain a 401(k) plan for all associates over 21 years of age, including our executive officers. Pursuant to the 401(k) plan, we match 25% of the first 6% of compensation contributed by our associates up to allowable Internal Revenue Service limitations. We also maintain group life, health, dental and vision insurance programs for all of our salaried associates, and our named executive officers are eligible to participate in these programs on the same basis as all other eligible associates. In 2016, we provided Mr. Jackson with relocation assistance in connection with his move to our headquarters and made an additional cash payment to him to make him whole for such assistance on an after-tax basis. The cost of this relocation assistance and the make-whole payment are disclosed below in the All Other Compensation column of the Summary Compensation Table.

Agreements with Officers

We do not have employment, retention, severance, change of control or similar agreements with any of our executive officers. While we enter into award agreements with our executive officers and other participants under our long-term equity award plans, these agreements and plans do not provide for acceleration of vesting or other benefits upon a change of control or termination.


2016 SUMMARY COMPENSATION TABLE

Set forth below is information regarding compensation earned by or paid or awarded to the following executive officers: Michael D. Hays, our Chief Executive Officer; Kevin R. Karas, our Senior Vice President Finance, Chief Financial Officer, Treasurer and Secretary; and Steven D. Jackson, our President and Chief Operating Officer. We had no other executive officers, as defined in Rule 3b-7 of the Securities Exchange Act of 1934, whose total compensation exceeded $100,000 during 2016. The identification of such named executive officers is determined based on the individual’s total compensation for 2016, as reported below in the Summary Compensation Table, other than amounts reported as above-market earnings on deferred compensation and the actuarial increase in pension benefit accruals.

The following table sets forth for our named executive officers with respect to 2016, 2015 and 2014 (or, in the case of Mr. Jackson, 2016 and 2015 only because 2015 was the first year with respect to which he was a named executive officer): (1) the dollar value of base salary earned during the year; (2) the aggregate grant date fair value of stock and option awards granted during the year, computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, Compensation-Stock Compensation (“FASB ASC Topic 718”); (3) the dollar value of earnings for services pursuant to awards granted during the year under non-equity incentive plans; (4) all other compensation for the year; and (5) the dollar value of total compensation for the year.

Name and

Principal Position

 

Year

 

Salary

  

Bonus

  

Stock

Awards(1)

  

Option Awards(1)

  

Non-Equity

Incentive Plan

Compensation

  

All Other

Compensation(2)

  

Total

 
                               

Michael D. Hays

 

2016

 $127,400   --   --  $44,261  $74,656  $2,079  $248,396 

Chief Executive Officer

 

2015

 $127,400   --   --  $47,633  $11,211  $3,178  $189,422 
  

2014

 $127,400   --   --  $19,019  $84,466  $2,644  $233,529 
                               

Kevin R. Karas

 

2016

 $283,640   --   --  $99,018  $167,010  $4,727  $554,395 

Senior Vice President

 

2015

 $245,700   --   --  $91,866  $21,622  $2,862  $362,050 

Finance, Chief

 

2014

 $234,000   --   --  $34,937  $155,142  $3,253  $439,032 

Financial Officer, Treasurer and Secretary

                              
                               

Steven D. Jackson

 

2016

 $300,000   --   --  $104,229  $175,800  $400,838  $980,867 

President(3)

 

2015

 $300,000   --  $1,050,067   --  $26,400  $3,900  $1,380,367 

_______________________

(1)

Represents the aggregate grant date fair value of the stock or option awards, as indicated, granted during the year, computed in accordance with FASB ASC Topic 718. See Note 9 to the Company’s Consolidated Financial Statements included in itsOur Annual Report on Form 10-K for the year ended December 31, 2016 for a discussion of assumptions made in, filed with the valuation of share-based compensation.

(2)

Represents, for each of our named executive officers, the amount of our 401(k) matching contributions; for Messrs. KarasSEC on March 3, 2017; and Jackson, the amount of a technology allowance; and for Mr. Jackson, relocation assistance in the amount of $258,075 and a related tax gross-up of $137,801.

(3)

Mr. Jackson became our President on October 1, 2015.


GRANTS OF PLAN-BASED AWARDS IN 2016

We maintain the 2006 Equity Incentive Plan and the 2001 Equity Incentive Plan pursuant to which grants may be made to our executive officers. The following table sets forth information regarding all such incentive plan awards that were made to the named executive officers in 2016.

      

Estimated Possible Payouts
Under Non-Equity

Incentive Plan Awards(1)

                     

Name

 

Grant

Date

 

Date of Committee Action

 

Threshold

  

Target

  

Maximum

  

All Other Stock Awards: No. of Shares of Stock or

Units(2)

  

All Other Option Awards: No. of Securities Underlying Options(2)

  

Exercise or Base Price of Option Awards(2)

  

Closing Price on Date of Grant

  

Grant Date Fair Value of Stock and Option Awards

 
                                     

Michael D. Hays

 

1/05/2016

 

11/9/2015

                  9,145(3) $15.23  $15.39  $38,683 
  

1/05/2016

 

11/9/2015

                  1,524(5) $34.00  $34.00  $5,578 
       -(4)  $63,700  $254,800                     
                                     

Kevin R. Karas

 

1/05/2016

 

11/9/2015

                  20,458(3) $15.23  $15.39  $86,537 
  

1/05/2016

 

11/9/2015

                  3,410(5) $34.00  $34.00  $12,481 
       -(4)  $141,820  $567,280                     
                                     

Steven D. Jackson

 

1/05/2016

 

11/9/2015

                  21,535(3) $15.23  $15.39  $91,093 
  

1/05/2016

 

11/9/2015

                  3,589(5) $34.00  $34.00  $13,136 
       -(4)  $150,000  $600,000                     

_______________________

(1)

These amounts represent only potential payments under the 2016 incentive plan awards; the actual amounts received (if any) are shown in the Summary Compensation Table above.

(2)

The restricted stock and stock option awards were granted under the 2006 Equity Incentive Plan. The exercise price of the stock option awards was equal to the closing stock price on January 4, 2016, the day immediately prior to the grant date.

(3)

Options to purchase shares of class A common stock.

(4)

There were no thresholds for payments under these 2016 incentive plan awards; payments below target would be made for any year-over-year increase in any of the applicable performance measures.

(5)

Options to purchase shares of class B common stock.


OUTSTANDING EQUITY AWARDS AT DECEMBER 31, 2016

The following table sets forth information on outstanding option and stock awards held by the named executive officers at December 31, 2016, including the number of shares underlying both exercisable and unexercisable portions of each stock option, the exercise price and expiration date of each outstanding option, the number of shares of stock that have not vested and the market value of such shares.

  Option Awards      Stock Awards       

Name

 

No. of Securities Underlying Unexercised Options
(
Exercisable)

  

No. of Securities Underlying Unexercised Options
(Unexercisable)

  

Option Exercise
Price

 

Option Expiration

Date

 

No. of Shares or Units of
Stock That

Have Not Vested

  

Market Value of Shares or Units of Stock That Have Not Vested

  

Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that have Not Vested

  

Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights that have Not Vested

 
                              

Michael D. Hays

  25,068(1)(2)  -  $6.62 

01/05/17

  -   -   -   - 
   21,633(1)(3)  -  $7.59 

01/04/18

  -   -   -   - 
   20,109(1)(4)  -  $8.12 

01/05/19

  -   -   -   - 
   26,481(1)(5)     $6.30 

01/05/20

  -   -   -   - 
   17,745(1)(6)     $9.14 

01/05/21

  -   -   -   - 
       14,949(1)(7) $10.75 

01/05/22

  -   -   -   - 
       2,491(7)(8) $21.50 

01/05/22

  -   -   -   - 
   -   10,938(1)(9) $14.50 

01/07/23

  -   -   -   - 
   -   1,823(8)(9) $27.13 

01/07/23

  -   -   -   - 
   -   2,904(1)(10) $18.80 

01/07/24

  -   -   -   - 
   -   266(8)(10) $34.15 

01/07/24

  -   -   -   - 
   -   10,014(1)(11) $13.17 

01/06/25

  -   -   -   - 
   -   1,669(8)(11) $35.48 

01/06/25

  -   -   -   - 
   -   9,145(1)(12) $15.23 

01/05/26

  -   -   -   - 
   -   1,524(8)(12) $34.00 

01/05/26

  -   -   -   - 
                              

Kevin R. Karas

      26,403(1)(7) $10.75 

01/05/22

  -   -   -   - 
       4,400(7)(8) $21.50 

01/05/22

  -   -   -   - 
   -   20,088(1)(9) $14.50 

01/07/23

  -   -   -   - 
   -   3,348(8)(9) $27.13 

01/07/23

  -   -   -   - 
   -   5,334(1)(10) $18.80 

01/07/24

  -   -   -   - 
   -   489(8)(10) $34.15 

01/07/24

  -   -   -   - 
   -   19,313(1)(11) $13.17 

01/06/25

  -   -   -   - 
   -   3,219(8)(11) $35.48 

01/06/25

  -   -   -   - 
   -   20,458(1)(12) $15.23 

01/05/26

  -   -   -   - 
   -   3,410(8)(12) $34.00 

01/05/26

  -   -   -   - 
                              

Steven D. Jackson

  -   21,535(1)(12) $15.23 

01/05/26

  52,477(13) $997,063(13)  73,506(15) $1,396,614(15)
   -   3,589(8)(12) $34.00 

01/05/26

  8,746(14) $364,446(14)  12,251(16) $510,499(16)


_______________________

(1)

Option to purchase shares of class A common stock.

(2)

Options vest in full on the fifth anniversary of the grant date. These options vested on January 5, 2012.

(3)

Options vest in full on the fifth anniversary of the grant date. These options vested on January 4, 2013.

(4)

Options vest in full on the fifth anniversary of the grant date. These options vested on January 5, 2014.

(5)

Options vest in full on the fifth anniversary of the grant date. These options vested on January 5, 2015.

(6)

Options vest in full on the fifth anniversary of the grant date. These options vested on January 5, 2016.

(7)

Options vest in full on the fifth anniversary of the grant date. These options will vest on January 5, 2017.

(8)

Option to purchase shares of class B common stock.

(9)

Options vest in full on the fifth anniversary of the grant date. These options will vest on January 7, 2018.

(10)

Options vest in full on the fifth anniversary of the grant date. These options will vest on January 7, 2019.

(11)

Options vest in full on the fifth anniversary of the grant date. These options will vest on January 6, 2020.

(12)

Options vest in full on the fifth anniversary of the grant date. These options will vest on January 5, 2021.

(13)

Restricted shares of class A common stock that become fully vested on the fifth anniversary of the grant date, which occurred in 2015. The market value is based on the $19.00 per share closing price of our class A common stock on the NASDAQ Stock Market on December 31, 2016.

(14)

Restricted shares of class B common stock that become fully vested on the fifth anniversary of the grant date, which occurred in 2015. The market value is based on the $41.67 per share closing price of our class B common stock on the NASDAQ Stock Market on December 31, 2016.

(15)

Restricted shares of class A common stock granted in 2014 that become vested on the earlier of the achievement of performance goals established prior to the executive’s appointment as an executive officer or the fifth anniversary of the grant date. The market value is based on the $19.00 per share closing price of our class A common stock on the NASDAQ Stock Market on December 31, 2016.

(16)

Restricted shares of class B common stock granted in 2014 that become vested on the earlier of the achievement of performance goals established prior to the executive’s appointment as an executive officer or the fifth anniversary of the grant date. The market value is based on the $41.67 per share closing price of our class B common stock on the NASDAQ Stock Market on December 31, 2016.


Option Exercises and Stock Vested in 2016

    

Option Awards

  

Stock Awards

 

Name

 

Number of
Shares
Acquired
on Exercise
(#)

  

Value
Realized on
Exercise
($)
(1)

  

Number of

Shares

Acquired on

Vesting
(#)

  

Value

Realized on

Vesting
($)

 

Michael D. Hays

  33,234(2) $335,996   --   -- 
     24,043(3) $435,448   --   -- 
                   

Kevin R. Karas

  --   --   20,892(2) $321,528 
     --   --   3,482(3) $118,388 
                   

Steven D. Jackson

  --   --   --   -- 
     --   --   --   -- 

(1)

Amounts represent the product of the number of shares acquired on exercise multiplied by the excess of the closing market price per share on the date of exercise over the exercise price per share.

(2)

Shares of class A common stock.

(3)

Shares of class B common stock.

Risk Assessment of Compensation Policies and Practices

The Board relies on the Compensation Committee to address risk exposures facing the Company with respect to compensation, with appropriate reporting of these risks to be made to the full Board. The Committee, as part of its periodic review of compensation and benefit programs, assesses the potential risks arising from the Company’s compensation policies and practices and considers safeguards against incentives to take excessive risks. Based on its most recent review, the Compensation Committee has concluded that the risks arising from the Company’s compensation policies and practices for its associates are not reasonably likely to have a material adverse effect on the Company.


COMPENSATION committee report

The Compensation Committee has reviewed and discussed the preceding Compensation Discussion and Analysis with management and, based on such review and discussion, has recommended to the Board of Directors that the Compensation Discussion and Analysis be included in the Company’s proxy statement.

Barbara J. Mowry, Chairperson

John N. Nunnelly

Gail L. Warden


advisory vote on executive COMPENSATION

This proposal provides our shareholders with the opportunity to cast a vote either for or against a non-binding, advisory resolution to approve the compensation of our named executive officers as disclosed in the Compensation Discussion and Analysis section and the accompanying compensation tables and narrative discussion in this proxy statement. We are required to hold this vote by Section 14A of the Securities Exchange Act of 1934.  As discussed in the Compensation Discussion and Analysis above, beginning on page 16, we have designed our executive compensation and benefit programs for our executive officers, including our named executive officers, to advance the following core principles:

We strive to compensate our executive officers at competitive levels to ensure that we attract and retain a highly competent, committed management team.

 

 

We provide our executive officersOur Quarterly Report on Form 10-Q for the quarter ended June 30, 2017, filed with the opportunity to earn competitive pay as measured against comparable companies.SEC on August 4, 2017.

Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this proxy statement to the extent that a statement contained herein or in any other subsequently filed document that is also or is deemed to be incorporated by reference herein modifies or supersedes such statement. Please note that any forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, in our Annual Report on Form 10-K for the year ended December 31, 2016 and our Quarterly Report on Form 10-Q for the quarter ended June 30, 2017 incorporated by reference herein are specifically excluded from the safe harbor for forward-looking statements provided by Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, for purposes of the Proposed Transaction.

If you are a beneficial owner of the Company’s Common Stock and would like a copy of any of the information incorporated by reference in this proxy statement (other than exhibits to such information, unless such exhibits are specifically incorporated by reference into such information), the Company will provide it to you without charge. If you would like to receive any of this information, please call (402) 475-2525 or write the Company at Kevin R. Karas, Secretary, National Research Corporation, 1245 Q Street, Lincoln, Nebraska 68508.

FORWARD-LOOKING STATEMENTS

This proxy statement and other reports that the Company files with the SEC contain forward-looking statements about the Proposed Transaction and the Company’s business. For this purpose, any statements that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are based on management’s current expectations, and generally can be identified by the use of words such as “believes,” “contemplates,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “can,” “will,” “may,” and other similar expressions. These forward-looking statements include, but are not limited to, statements concerning the following:

the completion of the Proposed Transaction;

 

 

We link our executive officers’ compensation, particularly annual cash incentives, to established Company financial performance goals.the effects, including expected benefits and tax consequences, of the Proposed Transaction;

 

We believe that a focus on these principles will benefit us and, ultimately, our shareholders in the long term by ensuring that we can attract and retain highly-qualified executive officers who are committed to our long-term success.

the estimated number of shares of class B common stock to be cashed out in the Reverse Split;

 

The Board invites you to review carefully the Compensation Discussion and Analysis beginning on page 16 and the tabular and other disclosures on compensation beginning on page 23, and cast an advisory vote either for or against the following resolution:

Resolved, that shareholders approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Compensation Discussion and Analysis section and the compensation tables and narrative discussion contained in this Proxy Statement.”

While the vote does not bind the Board to any particular action, the Board values the input of our shareholders, and will take into account the outcome of this vote in considering future compensation arrangements. 

Assuming a quorum is present at the Annual Meeting, the number of votes cast for the non-binding resolution to approve the Company’s executive compensation program must exceed the number of votes cast against it. Abstentions and broker non-votes will be counted as present in determining whether there is a quorum; however, they will not constitute a vote “for” or “against” the non-binding resolution and will be disregarded in the calculation of votes cast. A broker non-vote occurs when a broker submits a proxy card with respect to shares that the broker holds on behalf of another person but declines to vote on a particular matter, either because the broker elects not to exercise its discretionary authority to vote on the matter or does not have authority to vote on the matter. Shares of the Company’s class A common stock and class B common stock vote together as a single class on this advisory vote.

When we hold our next advisory vote on the compensation of our named executive officers will depend on the results of Proposal 4, “Advisory Vote on the Frequency of Shareholder Votes on Executive Compensation,” and our Board’s determination based on those results.

THE BOARD RECOMMENDS A VOTE FOR APPROVAL OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THIS PROXY STATEMENT. SHARES OF THE COMPANY’S COMMON STOCK REPRESENTED BY EXECUTED BUT UNMARKED PROXIES WILL BE VOTED FORAPPROVAL OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THIS PROXY STATEMENT.

the expected cost of the Proposed Transaction, including the estimated amount to be paid to cash out the holders of fewer than 1,764,560 shares of class B common stock in the Reverse Split and the estimated amount to be paid to cash out the holders of options to purchase class B common stock and restricted shares of class B common stock;

 


 

advisory vote on the frequency of shareholder votes
on executive COMPENSATION

The amount and terms of any indebtedness incurred in connections with the Proposed Transaction; and

 

As discussed above, the Board values the input of our shareholders regarding the Company’s compensation program for its named executive officers. As required by Section 14A of the Securities Exchange Act of 1934, shareholders are invited to express their view on a non-binding, advisory basis as to how frequently shareholders will vote on a non-binding, advisory resolution to approve the compensation of our named executive officers. Shareholders can advise the Board on whether such vote should occur every year, every two years or every three years.

This is an advisory vote, and as such is not binding on the Board. However, the Board will take the results of the vote into account when deciding when to call for the next vote on a non-binding resolution to approve the Company’s compensation program for its named executive officers. A scheduling vote similar to this will occur at least once every six years.

The Board recommends that a vote on a non-binding resolution to approve our compensation program for our named executive officers be held every year, because it believes that an annual vote will promote best governance practices and facilitate our Compensation Committee’s and our management’s consideration of the views of our shareholders in structuring our compensation programs for our named executive officers. We believe than an annual vote will provide our Compensation Committee and our management with more direct input on, and reactions to, our current compensation practices, and better allow our Compensation Committee and our management to measure how they respond to the prior year’s vote.

When voting on this advisory vote, shareholders should understand that they are not voting “for” or “against” the Board’s recommendation to hold the advisory vote every year. Rather, shareholders have the option to recommend that such advisory vote on the compensation of our named executive officers be held every one, two or three years, or to abstain entirely from voting on the proposal. Please mark on the enclosed proxy your preference as to how frequently shareholders will vote on a non-binding resolution to approve our compensation program for our named executive officers, as either every year, every two years or every three years, or you may abstain from voting.

Assuming a quorum is present at the Annual Meeting, the advisory vote as to how frequently shareholders will vote on a non-binding resolution to approve our compensation program for our named executive officers requires a plurality of the votes cast for the three options presented at the annual meeting. The frequency option that receives the most votes of all the votes cast in person or by proxy at the meeting is the one that will be deemed approved by the shareholders. Abstentions and broker non-votes will be counted as present in determining whether there is a quorum; however, they will have no effect in determining whether any frequency option has been approved and will be disregarded in the calculation of votes cast. A broker non-vote occurs when a broker submits a proxy card with respect to shares that the broker holds on behalf of another person but declines to vote on a particular matter, either because the broker elects not to exercise its discretionary authority to vote on the matter or does not have authority to vote on the matter.

We intend to hold our next advisory vote on the frequency of shareholder votes on executive compensation at our annual meeting in 2023.

THE BOARD RECOMMENDS A VOTE FOR HOLDING A NON-BINDING VOTE TO APPROVE THE COMPANYS COMPENSATION PROGRAM FOR ITS NAMED EXECUTIVE OFFICERS EVERY YEAR. SHARES OF COMMON STOCK REPRESENTED BY EXECUTED BUT UNMARKED PROXIES WILL BE VOTED FOR SUBMITTING THE ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS TO SHAREHOLDERS EVERY YEAR.


MISCELLANEOUS

Independent Registered Public Accounting Firm

KPMG LLP acted as the independent registered public accounting firm for the Company in 2016. The Audit Committee is solely responsible for the selection, retention, oversight and, when appropriate, termination of the Company’s independent registered public accounting firm.

The fees to KPMG LLP for the fiscal years ended December 31, 2016, and 2015 were as follows:

  

2016

  

 

2015

 

Audit Fees(1)

 $373,000  $383,645 

Audit-Related Fees(2)

  101,456   102,344 

Tax Fees(3)

  94,734   94,676 

All Other Fees

  --   -- 

Total

 $569,190  $580,665 

___________________

 

(1)

Auditthe cost savings that the Company expects as a result of annual financial statements, reviewno longer paying dividends on the 1,775,684 shares of financial statements includedclass B common stock being cashed out in Form 10-Qthe Reverse Split.

These forward-looking statements are subject to a number of risks and uncertainties, and future events and actual results could differ materially from those described in, contemplated by or underlying these forward-looking statements. These risks and uncertainties include, but are not limited to:

the occurrence of any event, change or other circumstance that could give rise to the delay or abandonment of the Proposed Transaction;

the commencement of any legal proceedings relating to the Proposed Transaction or the termination of the registration of the class B common stock with the SEC and other services normally providedthe delisting of the class B common stock with Nasdaq, and the outcome of any such proceedings that may be instituted; and

the amount of the costs, fees, expenses and charges that the Company incurs in connection with statutory and regulatory filings.

(the 2)Proposed Transaction.

Information security readiness assessment and information security audit services.

(3)Tax consultations and tax return preparation including out-of-pocket expenses.

 

For these reasons, you should not place undue reliance on any forward-looking statements included in this proxy statement. The Audit Committee has established pre-approval policiesforward-looking statements included in this proxy statement are made only as of the date of this proxy statement, and proceduresthe Company expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events of circumstances, except as required by law.

Because the Proposed Transaction is technically a “going private” transaction within the meaning of Rule 13E-3 under the Exchange Act by reason of delisting and deregistering our class B common stock, the forward-looking statements contained in this proxy statement made in connection with respect to audit and permitted non-audit services to bethe Proposed Transaction are excluded from the safe harbor protection provided by its independent registered public accounting firm.the Private Securities Litigation Reform Act of 1995, as amended, and Section 27A of the Securities Act . In addition, the forward-looking statements made in periodic reports incorporated by reference to this proxy statement are excluded from the safe harbor protection provided by the Private Securities Litigation Reform Act of 1995, as amended, and Section 27A of the Securities Act.

MISCELLANEOUS

The Company does not currently intend to bring before the Special Meeting any matters other than those set forth herein. Pursuant to these policies and procedures,our By-Laws, no matters may be brought before the Audit Committee may form, and delegate authority to, subcommittees consistingSpecial Meeting other than as set forth in the attached Notice of one or more members when appropriate to grant such pre-approvals, provided that decisionsSpecial Meeting of such subcommittee to grant pre-approvals are presented to the full Audit Committee at its next scheduled meeting. The Audit Committee’s pre-approval policies do not permit the delegation of the Audit Committee’s responsibilities to management. In 2016, the Audit Committee pre-approved all services provided by our independent registered public accounting firm, and no fees to the independent registered public accounting firm were approved pursuant to the de minimis exception under the Securities and Exchange Commission’s rules.Shareholders.

 

Expenses

 

The cost of soliciting proxies will be borne by the Company. In addition to soliciting proxies by mail, proxies may be solicited personally and by telephone by certain officers and regular associates of the Company. Such individuals will not be paid any additional compensation for such solicitation. The Company will reimburse brokers and other nominees for their reasonable expenses in communicating with the persons for whom they hold Common Stock.

 


 

Multiple Shareholders SharingPlease see the Same Address

Pursuant tosection entitled “Additional Information Regarding the rulesProposed Transaction – Source and Amount of Funds and Expenses” for a more detailed discussion of the Securities and Exchange Commission, services that deliver the Company’s communications to shareholders that hold their stock through a bank, broker or other holder of record may deliver to multiple shareholders sharing the same address a single copyestimated expenses of the Company’s annual report to shareholders and proxy statement, unless the Company has received contrary instructions from one or more of the shareholders. Upon written or oral request, the Company will promptly deliver a separate copy of the annual report to shareholders and/or proxy statement to any shareholder at a shared address to which a single copy of each document was delivered. For future deliveries of annual reports to shareholders and/or proxy statements, shareholders may also request that we deliver multiple copies at a shared address to which a single copy of each document was delivered. Shareholders sharing an address who are currently receiving multiple copies of the annual report to shareholders and/or proxy statement may also request delivery of a single copy. Shareholders may notify the Company of their requests by calling or writing Kevin R. Karas, Secretary, NRC Health, at (402) 475-2525 or 1245 Q Street, Lincoln, Nebraska 68508.Proposed Transaction.

 

Shareholder Proposals

 

Proposals that shareholders of the Company intend to present at and have included in the Company’s proxy statement for the 2018 annual meeting pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (“Rule 14a-8”), must be received by the Company by the close of business on December 4, 2017. In addition, a shareholder who otherwise intends to present business at the 2018 annual meeting (including nominating persons for election as directors) must comply with the requirements set forth in the Company’s By-Laws. Among other things, to bring business before an annual meeting, a shareholder must give written notice thereof, complying with the By-Laws, to the Secretary of the Company not less than 60 days and not more than 90 days prior to the second Wednesday in the month of April (subject to certain exceptions if the annual meeting is advanced or delayed a certain number of days). Under the By-Laws, if the Company does not receive notice of a shareholder proposal submitted otherwise than pursuant to Rule 14a-8 (i.e., proposals shareholders intend to present at the 2018 annual meeting but do not intend to include in the Company’s proxy statement for such meeting) prior to February 10, 2018, then the notice will be considered untimely and the Company will not be required to present such proposal at the 2018 annual meeting. If the Board chooses to present such proposal at the 2018 annual meeting, then the persons named in proxies solicited by the Board for the 2018 annual meeting may exercise discretionary voting power with respect to such proposal.

 


 

Multiple Shareholders Sharing the Same Address

Pursuant to the rules of the SEC, services that deliver the Company’s communications to shareholders that hold their stock through a bank, broker or other holder of record may deliver to multiple shareholders sharing the same address a single copy of this proxy statement, unless the Company has received contrary instructions from one or more of the shareholders. Upon written or oral request, the Company will promptly deliver a separate copy of this proxy statement to any shareholder at a shared address to which a single copy of this proxy statement was delivered. For future deliveries of annual reports to shareholders and/or proxy statements, shareholders may also request that we deliver multiple copies at a shared address to which a single copy of each document was delivered. Shareholders sharing an address who are currently receiving multiple copies of the annual report to shareholders and/or proxy statement may also request delivery of a single copy. Shareholders may notify the Company of their requests by calling or writing Kevin R. Karas, Secretary, National Research Corporation, at (402) 475-2525 or 1245 Q Street, Lincoln, Nebraska 68508.

By Order of the Board of Directors

NATIONAL RESEARCH CORPORATION

Kevin R. Karas
Secretary

October [●], 2017


Appendix A

 

 

 

Kevin R. Karas

SecretaryPROPOSED FORM OF
REVERSE STOCK SPLIT AMENDMENT

 

April 3, 2017The second paragraph of Article 2 of the Amended and Restated Articles of Incorporation of National Research Corporation is hereby amended and replaced in its entirety as follows:

Upon this amendment to the Amended and Restated Articles of Incorporation becoming effective pursuant to the Wisconsin Business Corporation Law (the “Effective Time”), and without any further action on the part of the corporation or its shareholders, each 1,764,560 shares of the Class B Common Stock then issued and outstanding shall be automatically converted into one (1) fully-paid and nonassessable share of Class B Common Stock (the “Reverse Split”). Notwithstanding the foregoing, no fractional shares of Class B Common Stock shall be issued, and any shareholder who would otherwise be entitled to receive a fraction of a share of Class B Common Stock shall, in lieu of receiving such fractional share, be entitled to receive a cash payment equal to the number of shares of Class B Common Stock held immediately prior to the Effective Time multiplied by $53.44, without interest. Notwithstanding anything in these Amended and Restated Articles of Incorporation to the contrary, including, without limitation, Section B(4) of this Article 2, the Reverse Split may occur without a simultaneous split of the Class A Common Stock.


Appendix B

PROPOSED FORM OF
FORWARD STOCK SPLIT AMENDMENT

The second paragraph of Article 2 of the Amended and Restated Articles of Incorporation of National Research Corporation is hereby amended and replaced in its entirety as follows:

Upon this amendment to the Amended and Restated Articles of Incorporation becoming effective pursuant to the Wisconsin Business Corporation Law (the “Effective Time”), and without any further action on the part of the corporation or its shareholders, each share of the Class B Common Stock then issued and outstanding shall be automatically converted into 1,764,560 fully-paid and nonassessable shares of Class B Common Stock (the “Forward Split”). Notwithstanding anything in these Amended and Restated Articles of Incorporation to the contrary, including, without limitation, Section B(4) of this Article 2, the Forward Split may occur without a simultaneous split of the Class A Common Stock.

 


 

PROXY

 

 PLEASE SIGN, DATE AND RETURN USING THE ENVELOPE PROVIDED 

 

NATIONAL RESEARCH CORPORATION

D/B/A NRC HEALTH

20SPECIAL17 ANNUAL MEETING OF SHAREHOLDERS

This Proxy is Solicited on Behalf of the Board of Directors

 

The undersigned hereby appoints Michael D. Hays and Kevin R. Karas, and each of them, as Proxies with the power of substitution (to act jointly or if only one acts then by that one) and hereby authorizes them to represent and to vote as designated below all of the shares of class A common stock and/or class B common stock of National Research Corporation held of record by the undersigned on March 14,October [●], 2017, at the AnnualSpecial Meeting of Shareholders to be held on May 9,November [●], 2017, or any adjournment or postponement thereof.

 

This proxy when properly executed will be voted in the manner directed herein by the undersigned shareholder. If no direction is made, this proxy will be voted “FOR” the election of the Board’s nominees, “FOR the ratification of the appointment of KPMG LLP as our independent registered public accounting firm for 2017,“FOR” approval of the Reverse compensation of our named executive officers as disclosed inStock Split and “FOR” the accompanying proxyForward statementStock , and Split“EVERY YEAR” on the frequency of the advisory shareholder vote on the compensation of our named executive officers.. THE BOARD RECOMMENDS A VOTE “FOR” THE ELECTION OF THEREVERSE NOMINEESTOCK SSPLIT AND FOR DIRECTOR, “FOR” the ratification of the appointment of KPMG LLP as our independent registered public accounting firm for 2017FORWARD ,STOCK SPLIT.“FOR” approval of Although the compensation of our named executive officers as disclosed inReverse Stock Split and the accompanying proxy statement, and “EVERY YEAR”Forward Stock Split are being voted on the frequency of the advisory shareholder vote on the compensation of our named executive officersseparately, neither will be implemented unless both are approved..

1.    1ELECTION.     APPROVAL OF DIRECTORS:

1.AN AMENDMENT TO THE COMPANY’S AMENDED AND RESTATED ARTICLES OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT OF THE COMPANY’S OUTSTANDING SHARES OF CLASS B COMMON STOCK AT A RATIO OF 1-FOR-1,764,560 JoAnn M. Martin (Term expiring atand waive the 2020 Annual Meeting)

2.    Barbara J. Mowry (Term expiring atapplication to such reverse stock split of any provision in THE COMPANY’S AMENDED AND RESTATED ARTICLES OF INCORPORATION to the 2020 Annual Meeting)contrary, including, without limitation, Section B(4) of Article 2

☐     FOR the nominees listed:

  above (except as specified below).

☐       WITHHOLD AUTHORITY to vote for the

          nominees listed above.

 

(Instructions: To withhold authority to vote for any    indicated nominee(s), write the name(s) of the nominee(s)
in the box provided to the right.)FOR

   AGAINST

   ABSTAIN

 

2.     VOTE ONAPPROVAL OF AN AMENDMENT TO THE RATIFICATIONCOMPANY’S AMENDED AND RESTATED ARTICLES OF INCORPORATION TO EFFECT A FORWARD STOCK SPLIT OF THE APPOINTMENTCOMPANY’S OUTSTANDING SHARES OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2017:CLASS B COMMON STOCK AT A RATIO OF 1,764,560-FOR-1 IMMEDIATELY FOLLOWING THE REVERSE STOCK SPLIT and waive the application TO SUCH FORWARD STOCK SPLIT of any provision in THE COMPANY’S AMENDED AND RESTATED ARTICLES OF INCORPORATION to the contrary, including, without limitation, Section B(4) of Article 2:

 

☐     FOR

   AGAINST

☐      ABSTAIN

3.    ADVISORY VOTE ON THE APPROVAL OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE ACCOMPANYING PROXY STATEMENT:

☐     FOR

   AGAINST

☐   ABSTAIN

4.    ADVISORY VOTE ON THE FREQUENCY OF THE ADVISORY SHAREHOLDER VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS:

 ☐  EVERY YEAR                                       ☐     2 YEARS                                  ☐     3 YEARS                                      ☐      ABSTAIN 

Note: In their discretion, the Proxies are authorized to vote upon such other business as may properly come before the meeting. 

 


 

 

Check appropriate box indicating

changes below:

 

Address Change? ☐  Name Change? ☐

DateDate__________________________, 2017

 

  NO. OF SHARES __________              

 

☐  Please check this box if you plan to attend the AnnualSpecial Meeting.
 
Number of persons attending: _____.

 

(Registered Owner)

 

(Registered Owner if held jointly)

 
 

 

 

Signature(s) in Box

Please sign exactly as name appears hereon. When shares are held by joint tenants, both should sign. When signing as attorney, executor, administrator, trustee or guardian, please give full title as such. If a corporation, please sign in full corporate name by President or other authorized officer. If a partnership, please sign in partnership name by authorized person.